Firenze Fiera Congress & Exhibition Center Florence, Italy

March 8-11, 2017

PROGRAM

www.SRNT.org SRNT 2017 · Florence, Italy

TABLE OF CONTENTS

Abstract Reviewers ...... 8 Badges ...... 16 Board of Directors ...... 17 Conference Safety Rules and Guidelines ...... 18 Continuing Education Credits ...... 14 Educational Objectives ...... 13 Exhibitors ...... 24 Evaluation ...... 16 Future Meetings ...... 18 Meeting Room Floor Plans ...... 25 Index–Author ...... 93 Internet Access ...... 13 Lunches ...... 14 Meet-the-Editor Sessions ...... 17 Message from the Program Chair ...... 3 Members Meetings ...... 16 Network Advisory Committee ...... 7 Past Presidents and Program Chairs ...... 11 Poster Session Setup Schedule ...... 15 Program Committee ...... 6 Registration ...... 13 Remembrances of Pioneers for Whom SRNT’s 2017 Awards Are Named ...... 19 Schedule-at-a-Glance ...... 107

Session Summary: Wednesday, March 8, 2017 ...... 29 Thursday, March 9, 2017 ...... 41 Friday, March 10, 2017 ...... 59 Saturday, March 11, 2017 ...... 77

Speaker Ready Room ...... 16 SRNT Supporters ...... 13 Target Audience ...... 13

1 SRNT 2017 · Florence, Italy

2 SRNT 2017 · Florence, Italy

MESSAGE FROM THE PROGRAM CHAIR

Dear Colleagues,

On behalf of the SRNT Program Committee, we welcome you to the 23rd Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT), in the wonderful city of Florence!

As always the meeting offers you a transdisciplinary collection of cutting-edge science across the full spectrum of basic and applied research on nicotine and tobacco. This year there will be presen- tations on a number of pivotal clinical trials, plus hot topics in the field of tobacco use epidemiology, genomics, biomarkers, cue reactivity, e-cigarettes, cigar use, waterpipes, smokeless tobacco, secondhand exposure, and tobacco product regulation. However, you will notice this year that there is a strong focus on concurrent use of tobacco with other psychoactive substances and drugs. We will discuss findings from basic science, pre-clinical and clinical studies to understand complex interactions between nicotine and other substances. Whilst the overall prevalence of smoking is decreasing in many countries, a significant proportion of tobacco smokers also use various psychoactive substances. Also, smoking rates are high among those who are addicted to various legal and illegal drugs, including marijuana, alcohol, and opioids. These populations need to be a focus of tobacco control policies and interventions moving forward, so that “no man is left behind” in our efforts to reduce smoking prevalence. In this manner equity is the focus, not just equality.

Several key highlights for the meeting are: Wednesday, March 8, 2017 5:00 p.m.-6:00 p.m. Keynote Presidential Symposium (Opening Session) Nicotine + Other Addictive Behaviors: Addressing the Added Complexities Across the Translational Continuum Speakers: Neal L. Benowitz MD, Chief, Division of Clinical Pharmacology, University of California San Francisco, USA; Ron Borland PhD, FASSA, Nigel Gray Distinguished Fellow in Cancer Prevention, The Cancer Council Victoria, Melbourne, Australia; Joanna E. Cohen, PhD, Director, Institute for Global Tobacco Con- trol, Johns Hopkins Bloomberg School of Public, Baltimore, USA; Judith J. Prochaska, PhD, MPH, Associate Professor of Medicine, Department of Medicine, Stanford University, USA; Robert West, PhD, Professor of Health Psychology, University College London, UK

Thursday, March 9, 2017 9:30 a.m.-10:30 a.m. Epidemiology and Public Health Themed Lecture and 2017 Doll-Wynder Award Recipient How to Think—Not Feel—About Tobacco Harm Reduction Kenneth E. Warner; Avedis Donabedian Distinguished University Professor of Public Health at the University of Michigan, USA.

Thursday, March 9, 2017 2:00 p.m.-3:00 p.m. Pre-Clinical Theme Lecture Genetic Overlap Between Cigarette Smoking and Other Sub- stance Use Jacqueline Vink, Professor, Behavioral Science Institute, Devel- opmental Psychopathology, Radboud University Nijmegen, The Netherlands

3 SRNT 2017 · Florence, Italy

Friday, March 10, 2017 9:00 a.m.-10:00 a.m. Clinical Theme Lecture Treatment of Patients With Tobacco Addiction: Improving Current Practice and Future Perspectives Professor Serena Tonstad, Head Physician, Preventive Cardiol- ogy section, Department of Endocrinology, Obesity and Preventive Medicine at Oslo University Hospital, Oslo, Norway and a Profes- sor, School of Public Health, Loma Linda University, Loma Linda, California.

Friday, March 10, 2017 2:00 p.m.-3:00 p.m. Public Policy Theme Lecture Population Level Policies to Prevent Chronic Disease: Apply- ing Lessons From Nicotine and Tobacco Research Professor Linda Bauld, Professor of Health Policy, University of Stirling and Chair in Behavioral Research for Cancer Prevention, Cancer Research UK. President-elect of SRNT-Europe.

Also, not to be missed:

●● The Opening Reception on Wednesday, March 8, from 6:00 p.m.-7:30 p.m., which will include hors d’oeuvres. All attend- ees are welcome! ●● The Opening Remarks and Awards Ceremony on Thursday, March 9, from 9:00 a.m.-9:30 a.m., with special recognition of SRNT awardees: Doll-Wynder Award Winner, Dr. Kenneth E. Warner; John Slade Award Winner, Dr. Martin Raw; and Jarvik-Russell Award Winner, Dr. Thomas Kirchner. ●● The SRNT-Europe Members Meeting on Friday, March 10, 8:15 a.m.-8:45 a.m. ●● The SRNT Members Meeting on Saturday, March 11, 8:15 a.m.-8:45 a.m. ●● Gala Dinner hosted by the SRNT-Europe organization at the breathtaking Palazzo Borghese Florence on Friday, March 10, at 7:30 p.m. (available at an additional fee) ●● New this year, SRNT is proud to announce ‘Meet-the-Editor’ sessions on Thursday, Friday, and Saturday during the Annual Meeting. We have created an opportunity for all participants to join editors of the leading tobacco and nicotine journals for conversation. Meet-the-Editor is a chance to put members of the editorial boards in the hotseat. Editor of each journal will host a face-to-face session with the participants of the meeting. The editor will be available to answer questions, hear ideas, and discuss any comments about the journals. All are welcome but graduate students and postdocs are particularly invited. For meeting attendees arriving early, there are 10 pre-conference workshops that will be held on Wednesday, March 8 (available at an additional fee). These include:

●● SRNT-E Satellite Symposium: Comparing Regulations on Tobacco and Nicotine Products ●● Novel Approaches to Implementing Tobacco Treatment Within Health Systems ●● Is Nicotine Reduction Really a Viable Policy Option for To- bacco Control? ●● Developing Evidence-Based Control Policies Targeting Water- pipe Tobacco Smoking: Time for Action

4 SRNT 2017 · Florence, Italy

●● Working Globally to Support Rapid Learning for E-Cigarette Policy, Surveillance, and Policy Research ●● Introduction to the Multiphase Optimization Strategy (Most) for Building More Effective, Efficient, Economical, and Scalable Behavioral and Biobehavioral Interventions ●● FDA’s Population Health Standard: Balancing the Risks and Benefits in Regulatory Decision-Making ●● Tobacco and Marijuana Co-Use in Adolescents and Young Adults ●● Reducing the Impacts of Commercial Tobacco on Indig- enous Peoples: Best Practices for Engaging With Indigenous Peoples in Research ●● What Does Our Tobacco Work Mean to Us? Translating Knowledge Through Art in Florence To follow, and as part of the general registration, please join us for the highly interactive Transdisciplinary Topical Discussions on Wednesday afternoon from 3:30 p.m.-4:45 p.m.:

●● E-Health Smoking Cessation Interventions: Do They Really Work? ●● NRT Bought Over the Counter: Are Gums and Patches Pos- sibly Not Effective in the Real World? ●● Polysubstance Abuse: How to Treat Tobacco Alongside Other Addictions? ●● Financial Incentives for Quitting Tobacco: An Effective and Ethical Approach? ●● Making the Delivery of Tobacco Cessation Treatment Routine in Health Care Systems: What Are the Challenges? ●● Vape Shops: Just Another Tobacco Product Retailer or a Smoking Cessation Service? ●● How Do We Reduce Children’s Exposure to Second-Hand Tobacco Smoke Globally? For the first time in SRNT history, we have received over one thousand (!!!) abstracts submissions. Over the past six months, we have worked thoughtfully to create a timely and high-quality scientific program spanning the full breath of the nicotine and tobacco research field. Our early registration numbers indicate attendance may break another record, being even higher than last years’ meeting in Chicago. Back by popular demand, we are utiliz- ing nine consecutive rooms during podium presentations, so yes, we anticipate hearing it is hard to choose!

We encourage you to attend sessions that stretch and expand your expertise, that you engage the company of your colleagues and seek out new connections, and importantly, that you enjoy the meeting and the true spirit of Italy!

Kind Regards, Maciej L. Goniewicz, PhD, PharmD Program Chair Rachel Grana, PhD, MPH, and Daniel Kotz, PhD, MsC, MPH Program Co-Chairs

5 SRNT 2017 · Florence, Italy

PROGRAM COMMITTEE

Maciej L. Goniewicz, PhD, Kamran Siddiqi, MBB, MPH, PharmD PhD Roswell Park Cancer Institute, University of York, UK USA Program Chair Karl Fagerström, MD, PhD Fagerström Consulting, Sweden Rachel Grana, PhD, MPH National Cancer Institute, USA Kelly Blake, ScD Program Co-Chair National Cancer Institute, USA Daniel Kotz, PhD, McS, MPH Kelvin Choi, PhD Dusseldorf University Hospital, National Institutes of Health, Germany USA Program Co-Chair Kola Okuyemi, MD Andrea Villanti, PhD University of Minnesota, USA Legacy Foundation, USA Mandeep Virk-Baker, PhD Andrew Harris, PhD National Cancer Institute, USA University of Minnesota, USA Marc Willemsen, PhD Angela Attwood, PhD Maastricht University, University of Bristol, UK Netherlands Bartosz Koszowki, PharmD, Mark Parascandola, PhD PhD National Cancer Institute, USA Battelle, USA Natalie Nardone, PhD Bernard Le Foll, MD, PhD, University of California San MCFP Francisco, USA University of Toronto, Canada Natalie Walker, PhD Christie Fowler, PhD University of Auckland, New The Scripps Research Institute, Zealand USA Noah Gubner, PhD Christopher Kahler, PhD University of California San Brown University, USA Francisco, USA Dunja Przulj, PhD Olivia Wackowski, PhD Queen Mary University of Rutgers University, USA London, UK Philip Tonnesen, MD, PhD Eden Evins, MD, MPH Gentofte Hospital, Denmark Harvard University USA Rachel Cassidy, PhD Gorkem Yarbara, MD, PhD Brown University, USA Ege University, Turkey Ramzi Salloum, PhD Guadalupe P. Rodriquez, PhD University of Florida, USA Ciudad Universitaria, Mexico Reiner Hanewinkel, PhD Hua Yong, PhD Institute for Therapy & Health Cancer Council Victoria, Research, Germany Australia Richard O’Connor, PhD Ivan Berlin, MD, PhD Roswell Park Cancer Institute, Pitié-Salpêtrière University USA Hospital, France Ron Borland, PhD James Thrasher, PhD Cancer Council Victoria, Canada University of South Carolina, Serena Tonstad, MD, PhD USA Oslo, University Hospital, Jamie Brown, PhD Norway University College of London, Suzanne Gage, PhD England University of Bristol, UK Jean-Francois Etter, PhD Tellervo Korhonen, PhD University of Geneva, University of Helsinki, Finland Switzerland Thomas Kirchner, PhD New York University, USA 6 SRNT 2017 · Florence, Italy

NETWORK ADVISORY COMMITTEE

Adolescent Health Disparities

Suzanne Colby, PhD, Brown Steven Fu, MD, MSCE, Univer- University sity of Minnesota

Robin Mermelstein, PhD, Uni- Norval Hickman, PhD, MPH, versity of Illinois at Chicago. University of California

Basic Science Public Health Policy

Christie Fowler, PhD, Univer- Andrea Villanti, PhD, MPH, sity of California, Irvine CHES, Truth Initiative

Mariella De Biasi, PhD, Univer- Sara Hitchman, PhD, King’s sity of Pennsylvania College London

Genetics Trainee

Marissa Ehringer, PhD, Univer- Erika Bloom, PhD, Brown sity of Colorado University

Anu Loukala, PhD, University Meg Fluharty, PhD, University of Helsinki of Bristol

Stephen Heishman, PhD, National Institutes of Health

Global Health Treatment

Scott McIntosh, PhD, Uni- Lisa Fucito, PhD, Yale Uni- versity of Rochester Medical versity Center Megan Piper, PhD, University Carla Berg, PhD, Emory of Wisconsin-Madison University

7 SRNT 2017 · Florence, Italy

ABSTRACT REVIEWERS

Adam Cole, MSc Deborah Robson, PhD Adam Leventhal, PhD Deborah Scharf, PhD Alexandra Pankova, MD Debra Bernat, PhD Alexey Mukhin, MD Dennis Thomas, M. Pharm Allison Carroll, MS Dennis Trinidad, PhD Allison Kurti, PHD Donna Shelley, MD, MPH Amanda Johnson, MHS Doug Levy, PhD Allison Glasser, MPH Amanda Mathew, PhD Ed Stephens, PhD Amer Siddiq Amer Nordin, Elena Ratschen, PhD MBChC, MPM Eleni Vangeli, Dpsych, MSc Amy Cohn, PhD Elias Klemperer, PhD Amy Endacott, BSc Elisardo Becona, PhD Amy Taylor, PhD Elizabeth Klein, PhD, MPH Andre Der-Avakian, PhD Elyse Park, PhD André Szklo, PhD Emily Brennan, BSc Andrew Anesetti-Rothermel, Emily Herbert, PhD PhD Emily Peterson, PhD Andrew Moriarty, MBcHB Emma Beard, PhD Andrew Waa, MPH, B. Soc, Sc Erika Bloom, PhD Andy Skinner, PhD Erin L. Sutfin, PhD Angelo DiBello, PhD Erin Mead, PhD Anh Lê, PhD Eva Králíková, MD, PhD Anh Nguyen, PhD F. Javier Ayesta, MD, PhD Anil Batra, MD, PhD Farahnaz Islam, MSPH Ann Post, PhD Felix Naughton, PhD Anna Phillips, PhD Francine Schneider, PhD Anne-Laurence La Faou, MD, Frank Bandiera, PhD PhD Annette Kaufman, PhD, MPH Gary Giovino, PhD Arei Dijkstra, PhD Gaurave Kumar, PhD Ashely Sanders-Jackson, PhD Gemma Taylor, PhD Genevieve Sansone, PhD Babalola Faseru, MD, MPH Gera Nagelhout, PhD Ban Majeed, PhD Gérard Peiffer, MD Benjamin Toll, PhD Gideon St. Helen, PhD Benoit Forget, PhD Glenda Lassi, PhD Bettina Hoepnner, PhD Goedele Louwagie, MBBS, Billie Bonevski, PhD MPH, PhD Brain Hitsman, PhD Greg Hartwell, MSc Brain King, PhD Brandon Henderson, PhD Hadii M. Mamudu, PhD, MPA Brantley Jarvis, PhD Hakan Kayir, MD, PhD Bryan Heckman, PhD Hayden McRobbie, PhD Heath Smith, PhD Camille Morgan, MS Heather D’Angelo, PhD, MHS Carlijn van der Aalst, PhD Hedieh Mehrtash, MS Cassandra Gipson-Reichardt, PhD Imad Damaj, PhD Charl Els, MD, PhD Irina Stepanova, PhD Charlotte Smith, PhD Isabelle Boileau, MD, PhD Chris Bullen, MBChC, PhD Jacques Le Houezec, PhD Christine Czoli, PhD Candidate Jamie Hartmann-Boyce, PhD Christopher Russell, PhD Janet Hoek, MA, PhD Cristina Martínez, PhD Jen Dahne, PhD Daisy Thompson-Lake, MSc Jennifer Cantrell, DrPH, MPA Daniel Giovenco, PhD Jennifer Cornacchione, PhD Daniel Thomas, MD Jennifer Pearson, PhD Darren Mays, PhD, MPH Jennifer Shearston, BS Dave Hammond, PhD Jennifer Tiday, PhD David J. Drobes, PhD Jenny Hatchard, PhD David Nelson, MD Jessica Cook, PhD David Portnoy, PhD, MPH Jessica Pepper, PhD David Thomas, PhD, FAFPHM Jin Kim, PhD

8 SRNT 2017 · Florence, Italy

Jin Yoon, PhD Matthew Ford, PhD João Mauricio Castaldelli Maia, Matthew Palmatier, PhD MD Matthew Powers, PhD Jodi Gilman, PhD Meg Fluharty, MSc Johannes Thrul, PhD Megan Moran, PhD John Hughes, MD Megan Passey, MD, PhD Jonathan Bricker, PhD Megan Piper, PhD Jordan Braciszewski, PhD Melissa Blank, PhD Jose Trigo, PhD Michael Dunbar, PhD Juan Miguel Re Pino, PhD Michael Farrell, PhD Judith McCool, PhD Michael Ussher, PhD Judith Prochaska, PhD Michael Weitzman, MD Julie Blendy, PhD Michelle Manderski, PhD Michelle Scollo, PhD Karen Kasza, PhD Mikael Ekblad, MD, PhD Karin Hummel, MSc Mirte Kuipers,PhD Karine Gallopel-Marvan, PhD Mitch Nides, PhD Karma McKelvey, PhD Mohammad Siahpush, PhD Katarzyna Cambell, PhD Mohammed Jawad, MBcHB, Katherine Clegg-Smith, PhD MPH Kathleen Garrison, PhD Mollie Miller, PhD Kathryn Ross, PhD Morgane Bennett, MPH Katie Smith, PhD Muhammad Darawad, PhD Katy Ross, PhD Muhammad Irfan, MBBS, Kelly Cosgrove, PhD FCPS Kelly Young-Wolf, PhD Muhammed Jami Husain, PhD Ken Wassum, BA Kevin Welding, PHD Nancy Fleischer, PhD, MPH Khalid Kheirallah, PhD Nancy Jao, MS Kim Goodyear, PHD Nancy Rigotti, MD Kim Lyngby Mikkleson, MD Nasir Mushtaq, MBBS, PhD Kristi Gamarel, PhD Nicola Lindson-Hawley, PhD Kristie Foley, PhD, MS Niveen Abu-Rmeileh, PhD Kristie Soar, PhD Kristina Patja, MD, PhD Olivia Maynard, PhD Kym Sterling, DrPH Ollie Ganz, MSPH Omar El Shahaway, PhD Laura Gibson, PhD Omara Dogar, MD Laura Jones, PhD Lauren Dutra, ScD, MA Patricia Bunney, PhD Lauren Pacek, PhD Patricia Cioe, PhD Laurence Galanti, MD, PhD Patricia Di Ciano, PhD Lazaros Mbulo, PhD Peter Hajek, PhD Lila Rutten, PhD, MPH Peter Selby, PhD Lin Li, PhD Philip Tönnessen, MD, PhD Lion Shahab, PhD Rachel Cassidy, PhD Lisa Carter-Harris, PhD, RN Rachel Denlinger-Apt, MPH Lisa Henrikson, PhD Rachna Begh, PhD Louisa Holmes, PhD Raika Durusoy, MD Lucía Pérez, MPsych Ralph Caraballo, PhD Lucy Papova, PhD Randah Hamadeh, D.Phil Luz Myriam Reynales, PhD Ray Niaura, PhD Lynn Kozlowksi, PhD Raymond Boyle, PhD Lynne Dawkins, PhD Rebecca Anderson, MSc Maansi Bansal-Travers, PhD Rebecca Ashare, PhD Marc Willemsen, PhD Renee Bittoun, PhD Marcel Pieterse, PhD Renee O’Leary, PhD Marewa Glover, PhD Reuven Dar, PhD Margriet van Laar, PhD Richard Brown, PhD Maria Cooper, PhD Richard Edwards, MB, Bchir, Maria Duaso, PhD MPH, MD Maria Melchior, PhD Rick Bevins, PhD Marian Shahid, MSc Rifat Haider, MBBS, MHE Mark LeSage, PhD Rima Nakkash, DrPH Mary Brunette, MD Ritesh Mistry, PHD Matthew Carpenter, PhD Robert Loddenkemper, MD, Matthew Farrelly, PhD PhD

9 SRNT 2017 · Florence, Italy

Roberta Ferrence, PhD Shelley Golden, PhD Rumana Huque, PhD Shyanika Rose, PhD, MA Ryan Courtney, PhD Sophie Orton, PhD Ryan Kennedy, PhD Stella Vlachou, PhD Ryan Redner, PhD Stuart Feruson, PhD Ryan Vandrey, PhD Sue Cooper, PhD Sven Schneider, MD, PhD Sally Adams, PhD Samuel Tomczky, MSc Tara Elton-Marshall, PhD Sara Hitchman, PhD Taru Kinnunen, PhD Sarah Snuggs, MSc Tim Coleman, MD, PhD Sarrah Peerbux, MSc Timea Partos, PhD Sarwat Shah, MBBS, MPH Tracey Barnett, PhD Saul Shiffman, PhD Tracy Smith, PhD Sean Barrett, PhD Serena Tonstad, MD, PhD Ulrich John, PhD Seth Noar, PhD Ute Mons, PhD Shahrdad Loftipour, PhD Vanessa Ochoa, PhD Shannon Gravely, PhD Vaughan Rees, PhD Shari Feirmand, PhD Vinu Ilakkuvan, MPH Sharon Allen, PhD, MD Sharon Cox, PhD Zaheera Chatra, BSc Sharon Rabinovitz-Shenkar, Zuzana Justinova, MD, PhD PhD

10 SRNT 2017 · Florence, Italy

PAST PRESIDENTS AND PROGRAM CHAIR(S)

1995 President: Ovide Pomerleau, PhD Program Chair(s): Kenneth Perkins, PhD, Chair 1996 President: John Hughes, PhD Program Chair(s): Steve Heishman, PhD, Chair 1997 President: Neal Benowitz, MD Program Chair(s): Steve Heishman, PhD, Chair 1998 President: Maxine Stitzer, PhD Program Chair(s): Scott J. Leischow, PhD, Chair 1999 President: Jack Henningfield, PhD Program Chair(s): Joy Schmitz, PhD, Chair 1999-2000 President: Dorothy Hatsukami, PhD Program Chair(s): David Wetter, PhD, Chair 2000-2001 President: William Corrigall, PhD Program Chair(s): David Wetter, PhD, Chair Thomas Eissenberg, PhD, Co-Chair 2001-2002 President: Kenneth Perkins, PhD Program Chair(s): Thomas Eissenberg, PhD, Chair 2002-2003 President: Harry Lando, PhD Program Chair(s): Thomas Eissenberg, PhD, Chair Laura Cousino Klein, PhD, Co-Chair 2003-2004 President: Nancy Rigotti, MD Program Chair(s): Laura Cousino Klein, PhD, Chair David Drobes, PhD, Co-Chair 2004-2005 President: Ken Warner, PhD Program Chair(s): David Drobes, PhD, Chair Suzanne Colby, PhD, Co-Chair Robert West, PhD, Co-Chair 2005-2006 President: David Balfour, PhD Program Chair(s): Suzanne Colby, PhD, Chair Eric C. Donny, PhD, Co-Chair Jennifer Tidey, PhD, Co-Chair 2006-2007 President: Ellen R. Gritz, PhD Program Chair(s): Eric C. Donny, PhD, Chair Janet E. Audrain-McGovern, PhD, Co-Chair Cynthia A. Conklin, PhD, Co-Chair

11 SRNT 2017 · Florence, Italy

2007-2008 President: Ray Niaura, PhD Program Chair(s): Janet Audrain-McGovern, PhD, Chair Bernard Le Foll, MD, PhD, Co-Chair Robert Scholl, PhD, Co-Chair 2008-2009 President: Scott J. Leischow, PhD Program Chair(s): Bernard Le Foll, MD, PhD, Chair Marcus Munafò, PhD, MSc, Chair Ann McNeill, BSc, PhD, Co-Chair Robert A. Schnoll, PhD, Co-Chair 2009-2010 President: Sue Curry, PhD Program Chair(s): Robert A. Schnoll, PhD, Chair Darlene Brunzell, PhD, Co-Chair Lisa Dierker, PhD, Co-Chair 2010-2011 President: Caryn Lerman, PhD Program Chair(s): Thomas Gould, PhD, Chair Lisa Dierker, PhD, Co-Chair Megan Piper, PhD, Co-Chair 2011-2012 President: Robert West, PhD Program Chair(s): Megan Piper, PhD, Chair Joanna Cohen, PhD, Co-Chair Kelly Cosgrove, PhD, Co-Chair 2012-2013 President: Gary Swan, PhD Program Chair(s): Joanna Cohen, PhD, Chair Cristiano Chiamulera, PharmD, Co-Chair Sean P. David, MD, SM, DPhil, Co-Chair 2013-2014 President: Anne Joseph, MD, MPH Program Chair(s): Sean P. David, MD, SM, DPhil, Chair Angela Attwood, PhD, Co-Chair Judith Prochaska, PhD, MPH, Co-Chair 2014-2015 President: Thomas Gould, PhD Program Chair(s): Judith Prochaska, PhD, MPH, Chair Maciej L. Goniewicz, PhD, PharmD Natalie Walker, PhD 2015-2016 President: Robin Mermelstein, PhD Program Chair(s): Natalie Walker, PhD, Chair Maciej L. Goniewicz, PhD, PharmD Rachel Grana, PhD, MPH 2016-2017 President: Deborah Ossip, PhD Program Chair(s): Maciej L. Goniewicz, PhD, PharmD Rachel Grana, PhD, MPH Daniel Kotz, PhD, Msc, MPH

12 SRNT 2017 · Florence, Italy

SRNT SUPPORTORS

SRNT would like to thank Battelle, BioVirtus Research Site and Pfizer for their financial support of the 2017 Annual Meeting, and SRNT’s mission to stimulate the generation and dissemination of new knowledge concerning nicotine in all its manifestations, from cellular to societal.

REGISTRATION

Conference registration will be open daily located in the PIAZZA ADUA Reception Area of the Firenze Fiera Congress & Exhibition Center during the Annual Meeting. Hours for the SRNT registra- tion desk during the conference are as follows:

Tuesday, March 7 ...... 3:00 p.m.-5:00 p.m. Wednesday, March 8 ...... 7:30 a.m.-5:00 p.m. Thursday, March 9 ...... 8:00 a.m.-5:00 p.m. Friday, March 10 ...... 8:00 a.m.-5:00 p.m. Saturday, March 11 ...... 8:00 a.m.-11:00 a.m. *SRNT‘s registration area is located at the street address: 1 Piazza Adua. The PIAZZA ADUA reception area is an entrance area located next to the Palazzo Degli Affari (PDA) Building dedi- cated for registration and also used as the Main Entrance to the Firenze Fiera Congress & Exhibition Center. Using this entrance gives SRNT attendees private and easy access to the two build- ings that will house the SRNT session meetings located near the reception desk, known as the Palazzo Degli Affari (PDA) and the Palazzo dei Congressi (PDC) buildings.

INTERNET ACCESS

Complimentary Internet access will be available in the Congress Center meeting space available to all SRNT attendees. We kindly request ONE device per person. Instructions will be given on site.

EDUCATIONAL OBJECTIVES

●● Address nicotine and tobacco’s role in the changing health care environment ●● Describe new research and clinical data on the effects of nicotine and tobacco ●● Discuss recent advances in nicotine and tobacco research ●● Highlight international research on tobacco control ●● Through scientific exchange, integrate current research with implications for clinical practice ●● Address clinical and public health implications of concurrent use of tobacco with other psychoactive substances and drugs.

TARGET AUDIENCE

The 23rd Annual Meeting of SRNT is geared toward individuals involved in the research of nicotine and tobacco. This includes basic, clinical, policy, and public health scientists from academia, government, and industry.

Please note: Symposia that take place in advance of the meeting, after the meeting’s conclusion, or during evening hours are not

13 SRNT 2017 · Florence, Italy part of the SRNT Official Program unless specifically noted. The Program Committee has not reviewed the scientific content of Satellite Symposia. Satellite Symposia presenters are responsible for providing disclosures during their session.

CONTINUING EDUCATION CREDIT FOR PSYCHOLOGISTS

Continuing education credits have been approved for licensed psychologists. Postgraduate Institute for Medicine (PIM) is ap- proved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibil- ity for this program and its content. Full attendance at the sessions and evaluation of each individual session attended is required to receive CE credit for psychologists. Partial credit will not be awarded. Late arrivals or early departures will preclude awarding of CE credits.

CONTINUING EDUCATION CREDIT FOR PHYSICIANS

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accredita- tion Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and the Society for Research on Nicotine and Tobacco. Penn State Col- lege of Medicine is accredited by the ACCME to provide continu- ing medical education for physicians.

Physicians who have completed an MD, DO, or equivalent medi- cal degree from another country, or who have obtained a Fifth Pathway certificate, are eligible to receive AMA PRA Category 1 Credit(s)TM.

REQUIREMENTS TO RECEIVE CREDIT (AMA OR APA)

Evaluation of the sessions is integral to the education process. To receive AMA PRA Category 1 credit(s)TM credit, participants are required to: A. Complete the attendance form, indicating only those ses- sions attended in their entirety;

B. Complete the overall evaluation form and corresponding individual evaluation pages; and

C. Return the forms to the CME registration table to receive CME Certificate.

LUNCHES

Boxed lunches will be served on Wednesday, Thursday, and Friday (see below). Bring your badge with you, as it will serve as your ticket for lunch.

Wednesday, March 8, 2017 All Pre-Conference Workshop attendees are entitled to a boxed lunch. The lunches will be available for distribution in the Firenze Congress Center in the building Palazzo dei Congressi (PDC), meeting space: Passi Perduti starting at 11:45 a.m.

Thursday, March 9, 2017 Boxed lunches will be distributed in the Firenze Congress Center in the building Palazzo dei Congressi (PDC), meeting space: Passi Perduti starting at 12:15 p.m. Plan to attend Poster Ses- sion 1 while eating your boxed lunch!

14 SRNT 2017 · Florence, Italy

Friday, March 10, 2017 Boxed lunches will be distributed in the Firenze Congress Center in the building Palazzo dei Congressi (PDC), meeting space: Passi Perduti starting at 11:45 a.m. Plan to attend Poster Ses- sion 3 while eating your boxed lunch!

POSTER SESSION SETUP SCHEDULE

Poster sessions have specific times designated for the authors to be present to discuss their posters with attendees in the building Palazzo dei Congressi (PDC), meeting space: Passi Perduti. Have your SRNT badge at all times to gain access to this area. An attendant will be checking badges at all times. (Refer to the SRNT area maps for location of this building.) Building hours are 8:00 a.m.-6:30 p.m. daily, however, no SRNT attendee will have access to this space before 10:00 a.m. or after 6:30 p.m. All posters must be removed immediately during the designated dismantle time for each session.

The schedule for poster presentation assembly, authors present, and dismantle is as follows:

Thursday, March 9, 2017 Poster Session 1 10:00 a.m.-11:00 a.m...... Presenters set up posters 12:30 p.m.-2:00 p.m...... Poster Session 1 Presenters available at their poster 2:00 p.m.-2:30 p.m...... Presenters remove their poster

Poster Session 2 2:30 p.m.-3:30 p.m...... Presenters set up posters 5:00 p.m.-6:00 p.m...... Poster Session 2 Presenters available at their poster 6:00 p.m.-6:30 p.m...... Presenters remove their poster

Friday, March 10, 2017 Poster Session 3 10:00 a.m.-11:00 a.m...... Presenters set up posters 12:00 p.m.-1:30 p.m...... Poster Session 3 Presenters available at their poster 1:30 p.m.-2:00 p.m...... Presenters remove their poster

Poster Session 4 2:30 p.m.-3:30 p.m...... Presenters set up posters 5:00 p.m.- 6:00 p.m...... Poster Session 4 Presenters available at their poster 6:00 p.m.-6:30 p.m...... Presenters remove their poster

Saturday, March 11, 2017 Poster Session 5 10:00 a.m.-11:00 a.m...... Presenters set up posters 12:30 p.m.-2:00 p.m...... Poster Session 5 Presenters available at their poster 2:00 p.m.-2:30 p.m...... Presenters remove their poster

15 SRNT 2017 · Florence, Italy

EVALUATION

Thank you again for attending the meeting! We hope you enjoy the sessions and Florence, Italy. An overall program evaluation will be emailed to all Annual Meeting participants following the conference. Your feedback is greatly appreciated!

BADGES

Your badge will admit you to all of the educational sessions, wel- come reception, and the poster sessions at the Annual Meeting. Wear your badge at all times. Thank you.

SPEAKER READY ROOM

Important Information for All Oral Presentations:

The Speaker Ready Room is located in the meeting room Retropresidenza, in the PASSI PERDUTI area. The Speaker Ready Room is on the Lowest Level of the Palazzo dei Congressi (PDC) building, located behind the General Session Auditorium. Each speaker using computerized audio-visual equipment for their presentation at the 2017 Annual Meeting MUST report to the Speaker Ready Room to load their presentation (or verify online upload) on the laptop computer that will be used in their session room. Please review the following schedule and make note of these important times:

If Your Presentation Date/ Then Your Time to Load Time is….. Your Presentation is…. Thursday, March 9 between Report to the Speaker Ready 8:00 a.m.-12:00 noon Room between 1:00 p.m.-6:30 p.m. on Wednesday, March 8 Thursday, March 9 between Report to the Speaker Ready 1:00 p.m.-5:00 p.m. Room no later than 11:00 a.m. on Thursday, March 9 Friday, March 10 between Report to the Speaker Ready 8:00 a.m.-12:00 noon Room no later than 3:00 p.m. on Thursday, March 9 Friday, March 10 between Report to the Speaker Ready 1:00 p.m.-5:00 p.m. Room no later than 11:00 a.m. on Friday, March 10 Saturday, March 11 between Report to the Speaker Ready 8:00 a.m.-12:30 p.m. Room no later than 3:00 p.m. on Friday, March 10

A technician from our audio-visual company will be available in the Speaker Ready Room to assist you. The Speaker Ready Room will be open at the following times:

Wednesday, March 8 ...... 1:00 p.m.-6:30 p.m. Thursday, March 9 ...... 8:00 a.m.-5:00 p.m. Friday, March 10 ...... 8:00 a.m.-5:00 p.m. Saturday, March 11 ...... 8:00 a.m.-11:00 a.m. MEMBERS MEETINGS

●● The E-SRNT will be holding its Members Meeting on Friday, March 10, from 8:15 a.m.-8:45 a.m. in the building Palazzo dei

16 SRNT 2017 · Florence, Italy

Congressi (PDC), meeting room: Sala Verde (located on the second floor). All E-SRNT members are encouraged to attend. ●● The SRNT will be holding its Members Meeting on Saturday, March 11, from 8:15 a.m.-8:45 a.m. in the building Palazzo dei Congressi (PDC), meeting room: Sala Verde (located on the second floor). All SRNT members are encouraged to attend.

MEET-THE-EDITOR SESSIONS

SRNT is proud to announce Meet-the-Editor sessions. During the 2017 SRNT meeting we have created an opportunity for all partici- pants to join editors of the leading tobacco and nicotine journals for conversation. Meet-the-Editor is a chance to put members of the editorial boards in the “hot seat.” Editor of each journal will host a face-to-face session with the participants of the meeting. After a presentation by the editor, the session opens up to ques- tions from the floor, giving you the opportunity to get an insight into the review process and clear up any submissions queries you may have. The editor will be available to answer questions, hear ideas, and discuss any comments about the journals. All are welcome but graduate students and postdocs are particularly invited.

Editor Journal Time Joanna Cohen, Tobacco Control Thursday, March 9, Deputy Editor 2017; 12:45 p.m.- 1:45 p.m. Marcus Munafo, Nicotine and Thursday, March 9, Editor-in-Chief Tobacco 5:00 p.m.-6:00 p.m. Research Robert West, Addiction Friday, March 10, Editor-in-Chief 12:15 p.m.- 1:15 p.m. Scott Leischow, Tobacco Friday, March 10, Editor-in-Chief Regulatory 5:00 p.m.-6:00 p.m. Science Renee Bittoun, Journal of Saturday, March Editor-in-Chief Smoking 11, 10:30 a.m.- Cessation 11:30 a.m. Adam Leventhal, Drug and Alcohol Saturday, March Associate Editor Dependence 11, 12:30 p.m.- for Nicotine and 1:30 p.m. Tobacco

2016-2017 SRNT BOARD OF DIRECTORS

President Deborah Ossip, PhD, MS, BA

President-Elect Jodi Prochaska

Immediate Past-President Robin Mermelstein, PhD

Secretary/Treasurer Megan Piper, PhD

17 SRNT 2017 · Florence, Italy

Journal Editor-in-Chief Marcus Munafo, PhD

Member Delegate At-Large 2016-2019 Jennifer McClure, PhD

Member Delegate, Europe 2015-2018 Tellervo Korhonen, PhD

Member Delegate, AAOLA 2014-2017 Naoruart Charoenca, PhD

Member Delegate, North America 2016-2019 Jasjit Ahluwalia, MD, MPH

FUTURE SRNT MEETINGS

SRNT 24th Annual Meeting February 21-24, 2018 Hilton Baltimore, Baltimore, Maryland

SRNT 25th Annual Meeting February 20-24, 2019 Hilton San Francisco, San Francisco, California

SRNT 26th Annual Meeting March 11-14, 2020 Hilton New Orleans Riverside, New Orleans, Louisiana

SRNT 27th Annual Meeting February 24-27, 2021 Hilton Baltimore, Baltimore, Maryland

CONFERENCE SAFETY RULES AND GUIDELINES

To ensure the safety and security of our attendees and guests, we have composed the following list of safety rules and guidelines for this conference.

1. When inside the conference venue, nametags should be worn and visibly displayed at all times. For security reasons, we recommend that you DO NOT wear your badge outside of the conference venue. If you lose your badge, please notify registration immediately. 2. If you witness a disruption or security issue, please contact any member of the SRNT staff or security. The Congress center reception desk number: 055 49721. 3. In the event of a medical or other emergency, the Italian medical emergency number dial 118. You may also notify any SRNT staff, &/or Congress Center security/staff person. 4. Please do not leave any bags or articles unsecured in any display area, meeting room, or public area of the Congress Center. 5. If you note any suspicious articles, packages, persons, or ac- tivity please contact the SRNT staff, or security immediately. 6. Do not give your lodging information to any person. You should not open your room door or grant access to any per- son claiming to be with the event or hotel staff without proper identification. If you have any doubt, do not open your room door and contact the front desk or security.

18 SRNT 2017 · Florence, Italy

7. When leaving the hotel, you should take care to secure your identification, cash and credit cards. Valuables in your hotel room should be secured in the room safe or a lock box at the hotel. 8. When venturing outside of the conference facility, take rea- sonable care to protect yourself. Whenever possible, travel with another person. Remove any conference ID badges and make sure that someone knows where you are going and when you expect to return. 9. Take precautions to protect your personal information. Do not discard your conference materials, receipts, or other personal information without destroying it first. Any documents contain- ing account numbers, social security numbers, or other non- public personal information should not be discarded in public trash receptacles. 10. Attendees at this conference are expected to maintain a level of decorum appropriate to the nature and purpose of our meeting. While exchange and debate is welcome where appropriate, any person who is disruptive or abusive in language or manner will be removed and barred from further conference proceedings. 11. Individual photography is not permitted at the conference. SRNT reserves the right to inspect any and all packages or bags. (Photo Release: By attending the SRNT Annual Meet- ing all attendees should acknowledge that SRNT may take professional photos and those photos may be placed on the SRNT website without formal consent. Thank you.)

REMEMBRANCES OF PIONEERS FOR WHOM SRNT’S 2017 AWARDS ARE NAMED

SRNT’s annual awards presentation will be Thursday, March 9, at 9:00 a.m. in the building Palazzo dei Congressi (PDC), meeting room: Auditorium. Our awards are named after pioneers in the field of nicotine and tobacco research, and we are pleased to remember those pioneers.

THE JOHN SLADE AWARD

The John Slade Award honors individuals who have made out- standing contributions to public health and tobacco control through science-based public policy and public advocacy.

2017 Award Recipient: Martin Raw, PhD Director, International Centre for Tobacco Cessation Visiting Scholar, New York University School of Medicine, USA Honorary Associate Professor, UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Nottingham, UK

JOHN SLADE

Dr. John Slade was an expert on the treatment of alcohol, tobac- co, and drug addiction, and one of America’s pioneer advocates for tobacco control.

He was a member of the team that conducted the first scholarly analysis of previously secret documents from the Brown and Williamson Tobacco Company, which formed the basis for the film “The Insider.” John›s analysis led to a landmark series of articles in the Journal of the American Medical Association in 1995, as well as a book, “The Cigarette Papers.” His groundbreaking

19 SRNT 2017 · Florence, Italy research to prove that cigarettes are nicotine delivery devices helped make it possible for the Food and Drug Administration to claim regulatory authority over tobacco products under then-FDA Commissioner Dr. David Kessler.

John was appointed Professor of Medicine, Robert Wood Johnson Medical School of the UMDNJ, in 1998. He emerged as a leader in substance abuse prevention and tobacco control for the state of New Jersey through his teaching and clinical work as well as through his active involvement with the Medical Society of New Jersey and the New Jersey Public Health Association. John played a major role in helping New Jersey develop its tobacco prevention and treatment program, funded as part of the 1998 $206 billion settlement with tobacco companies.

He co-edited the first major clinical textbook on nicotine addic- tion and founded the Committee on Nicotine Dependence of the American Society of Addiction Medicine (ASAM).

THE JARVIK-RUSSELL NEW INVESTIGATOR AWARD

The Jarvik-Russell Young Investigator Award, named after Murray Jarvik and Michael Russell, recognizes scientists early in their careers who have made extraordinary contributions to the field of nicotine and tobacco research.

2017 Award Recipient:

Thomas R. Kirchner, PhD Clinical Associate Professor of Public Health, Medicine, and Urban Science NYU College of Global Public Health New York, USA

MURRAY E. JARVIK

Dr. Murray Jarvik was born in New York City in 1923. Following medical school, Murray worked at the Yerkes Laboratory in Flor- ida. It was here that he serendipitously witnessed a monkey that would smoke cigarettes. A Fellowship at Mount Sinai Hospital in New York followed, where Murray became one of the pre-eminent researchers studying a newly discovered substance: LSD.

LSD research pivoted Murray into the emerging field of psycho- pharmacology in the mid-1950’s and to a professorial position at the newly created Albert Einstein School of Medicine. It was here that Murray established himself as a premier researcher on effects of drugs on learning and behavior.

Murray’s interests in the mid-1960s turned toward tobacco smok- ing. Although Murray continued, initially, to study the effects of other drugs and memory, he eventually shifted his focus to smok- ing and nicotine addiction almost entirely.

One of the first projects he attempted, spurred by the very memo- rable observation at Yerkes, was to attempt to get monkeys to smoke. This was partially successful and led to experiments with humans and rats so that by 1970 Murray had collected sufficient data to suggest that nicotine was key in the reinforcement of smoking. His work was included in subsequent Surgeon General Reports on smoking and nicotine addiction.

Perhaps Murray Jarvik’s most notable achievement was work done with Jed Rose in the 1980’s investigating the possibility of delivering nicotine through the skin in sufficient quantities to

20 SRNT 2017 · Florence, Italy affect smoking behavior. At first, their approach was quite simple, a basic poultice of nicotine. After much development, they were able to patent the concept of a nicotine transdermal patch, which they turned over to UCLA. It soon made it into production as the second FDA-approved pharmacologic treatment for smoking ces- sation after nicotine gum. With both established efficacy and ease of use, it was highly successful, for several years among the top three most profitable patents for the University of California.

MICHAEL RUSSELL

By the 1960s, the emerging evidence of the danger of cigarette smoking was clear, but there was very little understanding of why people smoked. Cigarette smoking was generally thought of as a habit, with pharmacological factors receiving little or no attention.

Michael Russell was the man who did most to revolutionize our understanding. His research led to the 1988 report of the US Sur- geon General, Nicotine Addiction, which finally brought recognition that cigarette smoking is a classic drug dependence. Russell was a psychiatrist in training at the Maudsley hospital, in south Lon- don, when he chose the topic of cigarette smoking for his research thesis in 1967. Based on his review of what was then fragmentary research literature, he concluded in a 1971 paper that the drug nicotine was the motivating force underlying smoking behavior. He made the study of the interacting pharmacological and psychologi- cal determinants of tobacco dependence his life’s work.

Mike is regarded by many as the father of effective treatment to help smokers quit. But he is probably best known in the cessation field for a non-pharmacological intervention. In 1979 he published a trial examining the effectiveness of brief advice to quit smoking given by GPs in the course of routine consultations. The one-year success rate was 5%, compared with less than 1% in controls. A successful trial of nicotine chewing gum combined with brief ad- vice in primary care followed. Mike Russell moved toward the con- cept of an integrated district smoking cessation service, in which routine delivery of advice and pharmacological therapy in primary care was combined with intensive clinic support. That vision has now been realized in Great Britain’s National Health Service.

THE DOLL-WYNDER AWARD

The Doll-Wynder Award honors scientists who have made ground- breaking advances in public health, public policy or epidemiologi- cal research.

2017 Award Recipient:

Kenneth E. Warner Avedis Donabedian Distinguished University Professor of Public Health at the University of Michigan, USA.

RICHARD DOLL

Sir William Richard Shaboe Doll was a British physiologist who became the foremost epidemiologist of the 20th century, turning the subject into a rigorous science. He was a pioneer in research linking smoking to health problems. With Ernst Wynder, Bradford Hill and Evarts Graham, he was credited with being the first to prove that smoking caused lung cancer and increased the risk of heart disease.

In 1948 he joined a research team under Dr. Francis Avery-Jones at the Central Middlesex Hospital, run under the auspices of the

21 SRNT 2017 · Florence, Italy statistical research unit of the Medical Research Council. Over a 21-year career in the unit, Doll rose to become its director. In 1950, he undertook with Austin Bradford Hill a study of lung cancer patients in 20 London hospitals, at first under the belief that it was due to the new material tarmac, or motor car fumes, but rapidly discovering that tobacco smoking was the only factor they had in common. Doll himself stopped smoking as a result of his findings, published in the British Medical Journal in 1950, which concluded; “The risk of developing the disease increases in proportion to the amount smoked. It may be 50 times as great among those who smoke 25 or more cigarettes a day as among non-smokers.”

Four years later, in 1954 the British doctors study, a study of some 40,000 doctors over 20 years, confirmed the suggestion, based on which the government issued advice that smoking and lung cancer rates were related.

In 1966 Doll was elected to the Royal Society. The citation stated: Doll is distinguished for his researches in epidemiology, and par- ticularly the epidemiology of cancer where in the last 10 years he has played a prominent part in (a) elucidating the causes of lung cancer in industry (asbestos, nickel & coal tar workers) and more generally, in relation to cigarette smoking, and (b) in the investiga- tion of leukaemia particularly in relation to radiation, where using the mortality of patients treated with radiotherapy he has reached a quantitative estimate of the leukaemogenic effects of such radia- tion. In clinical medicine he has made carefully controlled trials of treatments for gastric ulcer. He has been awarded the United Nations prize for outstanding research into the causes and control of cancer and the Bisset Hawkins medal of the Royal College of Physicians for his contributions to preventative medicine.

Doll was made a Fellow of the Royal Society in 1966, Knighted in 1971, and awarded the Edward Jenner Medal of the Royal Society of Medicine in 1981. In 1996 he was made a Companion of Honour for “services of national importance”. International honours included the Presidential Award of the New York Academy of Sci- ences as well as a UN Award for his research into cancer. In April 2005, he was awarded the Saudi Arabian King Faisal International Prize for medicine jointly with Richard Peto for their work on dis- eases related to smoking. In 2004, he was awarded the inaugural Shaw Prize for Life Sciences and Medicine for his contribution to modern cancer epidemiology. He was also awarded honorary degrees by thirteen different universities.

ERNST WYNDER

Ernst Ludwig Wynder was an American epidemiology and public health researcher who studied the risk factors of smoking tobacco. His 1950 coauthored publication of “Tobacco Smoking as a Pos- sible Etiologic Factor in Bronchiogenic Carcinoma: A Study of 684 Proved Cases” appeared in the Journal of the American Medical Association. It was one of the first major scientific publications identifying smoking as a contributory cause of lung cancer.

Wynder began collaborating with his coauthor on the article, Evarts Ambrose Graham, as a medical student at Washington University in St. Louis in 1947. The previous summer he had conducted epidemiological studies of smoking behavior among 146 lung cancer patients in New York City. The project was funded by the American Cancer Society. Now, with Graham, Wynder col- lected extensive data on 604 patients with lung cancer at hospitals across the United States. Departing from a tradition of using an- ecdotal evidence (e.g., clinical interviews) to develop explanations

22 SRNT 2017 · Florence, Italy of disease causation, Wynder and Graham applied rudimentary statistical methods to their study. They divided patients into crude categories of “moderate” or “heavy” smokers, based on retrospec- tive interviews of each patient’s smoking behavior over a twenty- year period. They also measured and controlled for important confounding factors (e.g., age, types of tobacco use, inhalation level). Most importantly, with regard to an ability to demonstrate causation, Wynder and Graham also studied a control group of cancer-free individuals in hospitals. They used this control group to systematically compare their lung cancer patients.

On May 27, 1950 the Journal of the American Medical Associa- tion published the resulting scientific report. Wynder and Graham found that lung cancer could develop among nonsmokers, such that smoking is not the single factor in the induction of disease. But they identified smoking’s role as a significant risk factor for lung cancer, providing four reasons to support this argument: 1) lung cancer prevalence was found to be rare in nonsmokers; 2) among patients with lung cancer, cigarette use tended to be high; 3) lung cancer prevalence among men and women matched patterns of smoking behavior in men and women; and, lastly, 4) “the enormous increase in the sale of cigarettes in this country approximately parallels the increase in [lung cancer].” As further scientific evidence of smoking’s role in causing lung cancer began to mount in the United States and Great Britain, Wynder and Graham investigated the biological plausibility of the association between smoking and lung disease. In 1950, they initiated a study of the impact of tars from tobacco smoke on mice. After a year of exposure to tar, 44 percent of the mice developed cancers. Wynder also discovered specific carcinogens in tar (e.g., benzo- pyrenes, arsenic), but was unable to identify the contributions of these chemicals to cancer.

2017 SRNT TRAVEL AWARD WINNERS

• Monika Arora, Bangladesh • Oana Blaga, Romania • Sandra Braun, Argentina • Deepa Camenga, USA • Richard Holliday, United Kingdom • Munir Gunes Kutlu, USA • Ming Li, China • Nigar Nargis, India • Eeva-Liisa Tuovinen, Finland • Emily Stockings, Australia • Erikas Simonavicius, United Kingdom • Raydel Valdes Salgado, USA

23 SRNT 2017 · Florence, Italy

2017 SRNT SPONSORS & EXHIBITORS

Plan time in your schedule to visit with the SRNT sponsors and exhibitors. They will be located in the building Palazzo dei Congressi (PDC), Salone Club (lower level). Located in the pre-function space of the Auditorium. Thanks to all the companies exhibiting this year.SRNT appreciates their financial support!

Exhibit Hours:

Wednesday, March 8, 2017 ...... 5:00 p.m.-7:00 p.m.

Thursday, March 9, 2017 ...... 9:00 a.m.-3:30 p.m.

Friday, March 10, 2017 ...... 9:30 a.m.-3:30 p.m.

24 SRNT 2017 · Florence, Italy

MEETING ROOM FLOOR PLANS

SRNT 2017 Area Maps

Overview: Firenze Fiera Congress & Exhibition Center Florence, Italy

VIALE FILIPPO STROZZI

1 AUDITORIUM PALAZZO PDC ENTRANCE DEI CONGRESSI (PDC)

VIA FAENZA VIA VALFONDA VIA

VILLA VITTORIA

LIMONAIA 2

PDA ENTRANCES

VIA CENNINI PALAZZO DEGLI 4 AFFARI 3 PIAZZA ADUA (PDA) (SRNT REGISTRATION) Main Entrance

STAZIONE DI SANTA MARIA NOVELLA (TRAIN STATION)

* See the following pages for detailed information on the numbered buildings in this diagram.

25 SRNT 2017 · Florence, Italy

MEETING ROOM FLOOR PLANS SRNT 2017 Area Maps Building One: Palazzo Dei Congressi (PDC)

4 AUDITORIUM 5 3 6 2 8 1 7

9

VILLA 1. VILLA VITTORIA - PIANO TERRA - GROUND FLOOR VITTORIA 2. VILLA VITTORIA - PIANO PRIMO - FIRST FLOOR 3. VILLA VITTORIA - PIANO SECONDO - SECOND FLOOR 4. VILLA VITTORIA - BELVEDERE 5. ANFITEATRO - AMPHITHEATRE 6. AUDITORIUM - LOWER LEVEL 7. SALONE CLUB - LOWER LEVEL 8. PASSI PERDUTI - BASEMENT - LOWEST LEVEL 9. RETROPRESIDENZA - LOWEST LEVEL SRNT Floor Usage*

1. VILLA VITTORIA - PIANO TERRA - GROUND FLOOR SRNT will be using SALA 4, SALA 5, SALA 6, SALA 9, and SALA Onice on this floor. (SALA translates to “Room” in English.) 2. VILLA VITTORIA - PIANO PRIMO - FIRST FLOOR SRNT will be using SALA 101, SALA 104, SALA 105, and SALA 106 on this floor. 3. VILLA VITTORIA - PIANO SECONDO - SECOND FLOOR SRNT will be using SALA Verde on this floor. 4. VILLA VITTORIA - BELVEDERE SRNT will not be using this floor. 5. ANFITEATRO - AMPHITHEATRE (Located Outside) SRNT will not be using this space. 6. AUDITORIUM - LOWER LEVEL SRNT will be using the Auditorium on this floor, as the General Session. (Use the main entrance to the Villa Vittoria to access the Auditorium via stairs or elevator.) 7. SALONE CLUB - LOWER LEVEL SRNT’s Exhibit Area will be held in this space. 8. PASSI PERDUTI - BASEMENT - LOWEST LEVEL SRNT will be using the Passi Perduti. Boxed Lunch pick-up area. Poster Sessions will be located in this space and on the Balcony. Refreshment Break area. 9. RETROPRESIDENZA - LOWEST LEVEL SRNT’s Speaker Ready Room is located on this level.

* Refer to the SRNT Program-at-a-Glance for when SRNT meeting space is in use in this building.

Building Two: Limonaia (Lemon House) Located inside the centuries-old park of Villa Vittoria, between Palazzo dei Congressi and Palazzo degli LIMONAIA Affari, the Limonaia (Lemon House) represents the meeting point of the two venues, in the garden-area between the two buildings. This building will not be used by SRNT.

26 SRNT 2017 · Florence, Italy

MEETING ROOM FLOOR PLANS SRNT 2017 Area Maps Building Three: Piazza Adua (Reception Area)

Located next to the PDA building, 4 , but not directly connected, is a reception area dedicated as the SRNT Registration Area. It is located at 1 Piazza PIAZZA ADUA Adua, and is the Main Entrance to the Congress (REGISTRATION) Center to easily access the PDA, and PDC buildings. Main Entrance Be sure to have your SRNT badge at all times, in order to gain access to all sessions and events. An attendant will be checking badges at all times.

Building Four: Palazzo Degli Affari (PDA)

6 5 4 3

PALAZZO 2

DEGLI 1 AFFARI

1. PIANO INFERIORE - BASEMENT 2. PIANO TERRA - GROUND FLOOR 3. PRIMO PIANO - FIRST FLOOR 4. SECONDO PIANO - SECOND FLOOR 5. TERZO PIANO - THIRD FLOOR 6. QUARTO PIANO - FOURTH FLOOR

SRNT Floor Usage*

1. PIANO INFERIORE - BASEMENT SRNT will be using the Basement Level. 2. PIANO TERRA - GROUND FLOOR SRNT will be using the Ground Floor. 3. PRIMO PIANO - FIRST FLOOR SRNT will be using the First Floor, also known as Sala Centrale (Main Hall). SRNT will also be using SALA ADUA 1 4. SECONDO PIANO - SECOND FLOOR SRNT will be using the Second Floor, also known as Sala Centrale (Main Hall). SRNT will also be using SALA ADUA 2. 5. TERZO PIANO - THIRD FLOOR SRNT will not be using this floor. 6. QUARTO PIANO - FOURTH FLOOR SRNT will be using this floor.

* Refer to the SRNT Program-at-a-Glance for when SRNT meeting space is in use in this building.

27 SRNT 2017 · Florence, Italy

28 SRNT 2017 · Florence, Italy

SESSION SUMMARY WEDNESDAY MARCH 8, 2017 Wednesday, March 8, 2017 March Wednesday,

29 SRNT 2017 · Florence, Italy

30 SRNT 2017 · Florence, Italy

WEDNESDAY, MARCH 8, 2017

8:00 a.m.-5:00 p.m. Piazza Adua Reception Area (The Reception area is the main entrance area to the Firenze Fiera Congress & Exhibition Center located next to the Palazzo Degli Affari (PDA) Building.) Registration 8:30 a.m.-12:00 noon Pre-Conference Workshops (Available at an additional fee) 9:00 a.m.-12:00 noon Sala Auda 1 – Primo Piano (1st Floor) PDA Building (Palazzo Degli Affari Building) Pre-Conference Workshop #1 Novel Approaches to Implementing Tobacco Treatment Within Health Systems Speaker(s): Peter Selby, MBSS, CCFP MHSc FASAM, Centre for Addiction and Mental Health, Canada; Ben Toll, PhD, Medical University of South Carolina, US; Nancy Rigotti, MD, Massachusetts General Hospital/Harvard Medical School, US; Kamran Siddiqi, PhD, University of York, UK; Amanda Baker, PhD, University of Newcastle, Australia; Harry Lando, PhD, University of Minnesota School of Public Health, US; Robert West, PhD, University College London, UK Moderator(s): Lisa Fucito, PhD, Yale University, US; Megan Piper, PhD, University of Wisconsin, Madison, US Sponsored by the SRNT Treatment Network 9:00 a.m.-12:00 noon Sala Affari: Room 2 – Primo Piano (1st Floor) PDA Building Pre-Conference Workshop #2 Is Nicotine Reduction Really a Viable Policy Option for Tobacco Control? Speaker(s): Karl Fagerstrom, MD, PhD, Fagerström Consulting, Sweden; Tracy Smith, PhD, University of Pittsburgh, US; Eric

Donny, PhD, University of Pittsburgh, US; Ann McNeill, BSc, 8, 2017 March Wednesday, PGCE, PhD, King’s College London, UK; Neal Benowitz, MD, Center for Tobacco Control, US; Dorothy Hatsukami, PhD, University of Minnesota, US; Natalie Walker, PhD, University of Auckland, New Zealand Moderator(s): Scott Leischow, PhD, Mayo Clinic, US; Natalie Walker, PhD, University of Auckland, New Zealand 9:00 a.m.-12:00 noon Sala Affari: Room 1 – Secondo Piano (2nd Floor) PDA Building Pre-Conference Workshop #3 Developing Evidence-Based Control Policies Targeting Waterpipe Tobacco Smoking: Time for Action. Speaker(s): Kenneth D. Ward, PhD, University of Memphis School of Public Health, U.S.; Rima Afifi, PhD, MPH, Faculty of Health Sciences, American University of Beirut, Lebanon; Alan Shihadeh, DrPH, Faculty of Engineering and Architecture, American University of Beirut, Lebanon; Scott Sherman, MD, MPH, New York University School of Medicine, US; Ramzi Salloum, PhD, Department of Health Outcomes and Policy, Uni- versity of Florida, US; Taghrid Asfar, MD, MSPH, Scientist, Uni- versity of Miami Miller School of Medicine, US; Wasim Maziak, MD, PhD, Department of Epidemiology, Florida International University, US, Syrian Center for Tobacco Studies, Syria. Moderator(s): Rima Afifi, PhD, American University of Beirut, Lebanon; Fouad Fouad, MD, American University of Beirut, Lebanon Sponsored by NIDA, TBC

31 Program · Wednesday, March 8, 2017

9:00 a.m.-12:00 noon Sala Affari: Piano Terra (Ground Floor) PDA Building Pre-Conference Workshop #4 Working Globally to Support Rapid Learning for E-Cigarette Policy, Surveillance and Policy Research Speaker(s): Linda Bauld, PhD, University of Stirling and Cancer Research UK; Alison Cox, BA, Cancer Research UK; Susan J. Curry, PhD, University of Iowa College of Public Health, US; Allison Glasser, MPH, Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, US; Thomas J. Glynn, PhD, Stanford Prevention Research Center, US; Cheryl Healton, DrPH, College of Global Public Health at New York University, US; Ryan Kennedy, PhD, Johns Hopkins Bloomberg School of Public Health, US; Matt Myers, JD, Campaign for Tobacco-Free Kids, US; Raymond Niaura, PhD, Schroeder Institute for Tobacco Research and Policy Stud- ies at Truth Initiative, US; Tracy Orleans PhD, Robert Wood Johnson Foundation, US; Jennifer Pearson, PhD, Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, US; Andrea Villanti, PhD, Schroeder Institute for To- bacco Research and Policy Studies at the Truth Initiative, US Moderator(s): Joanna Cohen, PhD; Institute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public Health, US Sponsored by Johns Hopkins Bloomberg School of Public Health, Truth Initiative, Robert Wood Johnson Foundation, Cancer Research UK 9:00 a.m.-12:00 noon Sala Affari: Room 2 – Secondo Piano (2nd Floor) PDA Building Pre-Conference Workshop #5 Introduction to the Multiphase Optimization Strategy (MOST) for Building More Effective, Efficient, Economical, And Scalable Behavioral and Biobehavioral Interventions Speakers: Linda M. Collins, The Methodology Center and Department of Human Development & Family Studies, Penn State Moderator(s): Linda M. Collins, The Methodology Center and Department of Human Development & Family Studies, Penn State 8:30 a.m.-12:00 noon Villa Vittoria: Sala Verde (2nd Floor) PDC Building Pre-Conference Workshop #6 FDA’s Population Health Standard: Balancing the Risks and Benefits in Regulatory Decision-making Speaker(s): Mitchell Zeller, JD, Center for Tobacco Products; David L. Ashley, PhD, Center for Tobacco Products; Ii-Lun Chen, MD, Center for Tobacco Products; Cathy L. Backinger, PhD, MPH, Center for Tobacco Products; Jamie Hartmann- Boyce, MA, University of Oxford; Eric K. Soule, PhD, MPH, Virginia Commonwealth University; Bridget Ambrose, PhD, MPH, Center for Tobacco Products Panelist(s): Geoffrey T. Fong, PhD, University of Waterloo, Canada; Dorothy K. Hatsukami, PhD, University of Minnesota, U.S.; Andrew Hyland, PhD, Roswell Park Cancer Institute, US, Peter Hajek, PhD, Queen Mary University of London, UK Moderator(s): Mitchell Zeller, JD and Cathy L. Backinger, PhD, MPH, Center for Tobacco Products, U.S. Food and Drug Administration, US Sponsored by the Center for Tobacco Products, FDA

32 SRNT 2017 · Florence, Italy

9:00 a.m.-12:00 noon Sala Affari: Room 1 – Primo Piano (1st Floor) PDA Building Pre-Conference Workshop #7 Tobacco and Marijunana Co-use in Adolescents and Young Adults Speaker(s): Amy M. Cohn, PhD, Schroeder Institute for To- bacco Research and Policy Studies, Washington, DC, USA; Grace Kong, PhD, Yale University, New Haven, CT, USA; Erin A. McClure, PhD, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA; Erica N. Peters, PhD, Battelle Public Health Center for Tobacco Research, Baltimore, MD, USA; Sherry Emery, PhD, NORC at the University of Chicago, Chicago, IL USA Discussant: Robin Mermelstein, PhD, Institute for Health Research and Policy and Psychology Department, University of Illinois at Chicago Moderator(s): Suzanne Colby, PhD, Brown University Center for Alcohol & Addiction Studies, and Alexandra Loukas, PhD, Department of Kinesiology & Health Education, University of Texas at Austin Sponsored by the SRNT Adolescent Network 8:30 a.m.-12:00 noon Sala Affari: Auda 2 – Secondo Piano (2nd Floor) PDA Building Pre-Conference Workshop #8 Reducing The Impacts of Commercial Tobacco on Indigenous Peoples: Best Practices For Engaging with Indigenous Peoples in Research Speaker(s): Rob Schwartz, PhD, Canada; Ray Lovett, PHD, Australia National University, Australia; Patricia Nez Hender- son, MD, MPH, USA; David Thomas, PhD, Australia; Raglan Maddox, PhD, Australia; El-Shadan Tautolo, PhD, New Zealand; Heather Gifford, PhD, New Zealand; Andrew Waa, MPH, New Zealand Moderator(s): Andrew Waa, MPH, New Zealand 9:00 a.m.-12:00 noon

Sala Affari: Quarto Piano – Top Floor (4th Floor) 8, 2017 March Wednesday, PDA Building Pre-Conference Workshop #9 What Does Our Tobacco Work Mean to Us? Translating Knowledge Through Art in Florence Speaker(s): Gillian S Gould, PhD, MA (Arts Therapy), MBChB, Grad Dip Experiential and Creative Arts Therapy, Dip Drama. National Health and Medical Research Council and Cancer Institute New South Wales Research Fellow, University of Newcastle, Australia Moderator(s): Gillian S Gould, PhD, MA (Arts Therapy), MB- ChB, Grad Dip Experiential and Creative Arts Therapy, Dip Drama; National Health and Medical Research Council and Cancer Institute New South Wales Research Fellow, Univer- sity of Newcastle, Australia; Cheryl Gould, BA (Hons) Fine Art Sculpture, Member of Royal Society of British Sculptures, Life Drawing Tutor, Harrow Arts Centre, Middlesex, London, UK Sponsored by Faculty of Health and Medicine, University of Newcastle, Australia

33 Program · Wednesday, March 8, 2017

8:30 a.m.-12:00 noon Villa Vittoria: Sala Onice (Ground Floor) PDC Building SRNT-E Satellite Symposium: Comparing Regulations on Tobacco and Nicotine Products Speaker(s): Anna-Eva Ampelas, LL.M., DG SANTE, European Commission, Brussels, Belgium; Deborah Arnott, MBA FRCP (Hon), Action on Smoking and Health, UK; Natalie Walker, PhD, National Institute for Health Innovation, University of Auckland, New Zealand; Quan Gan, PhD, The International Union Against Tuberculosis and Lung Disease (Tobacco Control Depart- ment), China; Ron Borland, PhD, Cancer Council Victoria, Melbourne, Australia Discussant(s): Jaakko Kaprio, MD, PhD, University of Helsinki, Helsinki, Finland; Maciej Goniewicz, PhD, PharmD, Roswell Park Cancer Institute, USA Moderator(s): Michael Cummings, PhD, Medical University of South Carolina, Charleston, SC, USA; Tellervo Korhonen, PhD, University of Helsinki, Helsinki, Finland Sponsored by SRNT-Europe 1:00 p.m.-6:30 p.m. Retropresidenza (Passi Perduti - Lowest Level) PDC Building Speaker Ready Room 1:00 p.m.-3:15 p.m Network Meetings Plan to join your colleagues and attend the Network meeting of interest. All meetings will be located in the PDC Building. 1:00 p.m.-2:00 p.m Adolescent Network Meeting: Villa Vittoria: Sala 101 - Primo Piano (1st Floor) Genetics Network Meeting: Villa Vittoria: Sala Onice - Terra Piano (Ground Floor) Global Health Network Meeting: Villa Vittoria: Sala 9 - Terra Piano (Ground Floor) Health Disparities Network Meeting: Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor) 2:15 p.m.-3:15 p.m. Basic Science Network Meeting: Villa Vittoria: Sala Onice - Terra Piano (Ground Floor) Public Health Policy Network Meeting: Villa Vittoria: Sala 4 - Terra Piano (Ground Floor) Treatment Network Meeting: Villa Vittoria: Sala Verde - Secondo Piano (2nd Floor) 3:30 p.m.-4:45 p.m Transdisciplinary Topical Discussions #1-#7 are held concurrently These roundtable sessions have been selected to address a diverse array of pressing questions in our field. They will be moderated by world leading experts who will stimulate and encourage group discussion. These sessions are designed to be transdisciplinary–covering preclinical and clinical research and diverse methodologies. You do not need to be an expert in the subject area to attend a session. In fact, we encourage that you cross boundaries and take the opportunity to participate in new topical discussions that will develop novel ideas and viewpoints. TTD #1 Sala Affari: Room 1 – Primo Piano (1st Floor) PDA Building E-Health Smoking Cessation Interventions: Do They Re- ally Work? Electronic health (e-health) interventions for smoking cessation have become increasingly popular during recent

34 SRNT 2017 · Florence, Italy

years due to technological advances and facilitation by the Internet. Such interventions can potentially reach large numbers of smokers at low cost, and their flexibility enables personalised tailored support. On the other hand, many e-health interventions are anonymous by nature and less obliging than face-to-face behavioural support, leading to lower adherence. As they can be developed and maintained at relatively low cost, there is an excess supply of interventions available, in particular regarding smartphone apps. Moreover, evidence of their effectiveness is often lacking and also difficult to obtain due to methodological challenges. Moderator(s): Saul Shiffman, PhD, University of Pittsburgh, USA TTD #2 Sala Auda 1 – Primo Piano (1st Floor) PDA Building NRT Bought Over the Counter: Are Gums and Patches Possibly Not Effective in the Real World? Evidence from over 150 randomised controlled trials clearly demonstrates the efficacy of nicotine replacement therapy (NRT) for smoking cessation. NRT in its various forms of delivery (gum, patch etc.) are the most frequently used pharmacotherapy for smoking cessation. In many countries, NRT is also available over the counter (i.e., without prescription and behavioural support from a health professional). Due to the efficacy of NRT, proven by clinical trials, and its popularity as and aid to cessation, NRT bought over the counter seems to be a powerful method to improve the population’s health. However, recent studies have raised concerns about the effectiveness of NRT bought over the counter in the real world, outside of clinical trials. Moderator(s): Ann McNeill, PhD, King’s College, London, United Kingdom TTD #3 Sala Affari: Auda 2 – Secondo Piano (2nd Floor) PDA Building Polysubstance Abuse: How to Treat Tobacco Alongside

Other Addictions 8, 2017 March Wednesday, Tobacco addiction is strongly associated with other addictions, in particular alcohol use disorders. The health risks of single addictions are many and may be amplified by polysubstance abuse, highlighting the need for effective cessation treatments. Currently each addiction is usually treated independently, but it may be advantageous to treat multiple co-occurring addictions simultaneously. However, there are challenges to this approach, which include insufficient knowledge on how to develop new, effective, multi-target treatments with interacting treatment components and how to implement these in patient care. Moderator(s): Carla Berg, PhD, Emory University Woodruff Health Sciences Center, Atlanta, USA TTD #4 Sala Affari: Room 2–Primo Piano (1st Floor) PDA Building Financial Incentives for Quitting Tobacco: An Effective and Ethical Approach? Quitting tobacco is vital to reduce health risks, but also very difficult due to the addictive nature of nicotine. There are evidence-based behavioural and pharmacological treatments for smoking cessation, but their success rates are limited. Recent studies have investigated whether providing financial incentives might increase smoking cessation rates, particularly in specific subgroups of the smoking population such as pregnant smokers and smokers with low socioeconomic status. There are concerns, however, about the long-term

35 Program · Wednesday, March 8, 2017

effectiveness beyond the period of reward and the ethics of paying people to change their behaviour, as well as who should defray associated costs. Moderator(s): Stephen Higgins, PhD, University of Vermont, USA TTD #5 Sala Affari: Room 1 –Secondo Piano (2nd Floor) PDA Building Making the Delivery of Tobacco Cessation Treatment Rou- tine in Health Care Systems: What Are the Challenges? Tobacco use remains a leading preventable cause of morbidity and mortality. During the past decades, various effective and cost-effective behavioural and pharmacological smoking cessation treatments have been developed and tested. Clinical guidelines recommend clinicians to offer evidence-based treatment to every smoking patient. Yet, far too few smoking patients receive competent smoking cessation advice and the offer of evidence-based treatment when consulting their health care provider. It seems that, despite the necessity to routinely deliver evidence-based treatment, implementation in our health care systems remains challenging. Moderator(s): Nancy Rigotti, PhD, Massachusetts General Hospital and Harvard Medical School, Boston, USA TTD #6 Sala Affari: Piano Terra (Ground Floor) PDA Building Vape Shops: Just Another Tobacco Product Retailer or a Smoking Cessation Service? Stores that sell electronic nicotine delivery systems (ENDS) as their primary product are an emerging phenomenon. Such “vape shops” provide consumers a place to purchase and discuss e-cigarettes and offer an environment that serves as a place of recreation with customers lounging once inside. Their growing presence and marketing raise important questions about how these shops might potentially affect the public’s health. They may attract novice ENDS users and non-smokers alike, and may influence social norms around ENDS use, particularly around acceptability for use indoors. On the other hand, vape shop owners are in a unique position to serve as frontline consumer educators regarding the benefits and risks of ENDS. This unique context highlights the importance of understanding the interactions between vape shop owners, workers and customers. Moderator(s): Maciej L. Goniewicz, PhD, Pharm D, Roswell Park Cancer Institute, Buffalo, USA TTD #7 Sala Affari: Quarto Piano–Top Floor (4th Floor) PDA Building How Do We Reduce Children’s Exposure to Second-Hand Tobacco Smoke Globally? Exposure to secondhand tobacco smoke (SHS) has been causally linked with mortality and morbidity in non-smokers and disproportionately affects the health of children. Globally, hundreds of millions of children are regularly exposed to SHS, especially in their home. New evidence is emerging on how to reduce children’s exposure to SHS, but there are still significant gaps in the knowledge and there is discussion about future directions in research and policy. Moderator(s): Megan Passey, PhD, University of Sydney, Australia

36 SRNT 2017 · Florence, Italy

5:00 p.m.-6:00 p.m. Auditorium-General Session Room PDC Building Keynote Presidential Symposium (Opening Session) Nicotine + Other Addictive Behaviors: Addressing the Added Complexities Across the Translational Continuum Chairs: Maciej L. Goniewicz, PhD, Roswell Park Cancer Institute, USA and Rachel Grana Mayne, PhD, National Cancer Institute, USA Title of presentation The Global Epidemiology of Polysubstance Use Speaker: Joanna E. Cohen, PhD, Director, Institute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public, Baltimore, USA Pharmacokinetic and Pharmacodynamic Interactions Between Nicotine and Other Drugs of Abuse Speaker: Neal L. Benowitz MD, Chief, Division of Clinical Phar- macology, University of California San Francisco, USA Understanding Propensity to Addiction Speaker: Robert West, PhD, Professor of Health Psychology, University College London, UK Public Health Implications of Polysubstance Use Speaker: Ron Borland PhD, FASSA, Nigel Gray Distinguished Fellow in Cancer Prevention, The Cancer Council Victoria, Melbourne, Australia Treating Tobacco Addiction in Smokers With Co-occur- ring Disorders Speaker: Judith J. Prochaska, PhD, MPH, Associate Professor of Medicine, Department of Medicine, Stanford University, USA Whilst the overall prevalence of smoking is decreasing in many countries, a significant proportion of tobacco smokers also use various psychoactive substances. Smoking rates are high among those who are addicted to various legal and illegal drugs, includ- ing marijuana, alcohol, and opioids. These populations need to be a focus of tobacco control policies and interventions moving forward, so that ‘no man is left behind’ in our efforts to reduce

smoking prevalence. During this symposium, we will address 8, 2017 March Wednesday, the added complexities of nicotine and other addictive behaviors across the translational continuum. First, Dr. Cohen will present the scope of use of other drugs by tobacco users, and use of tobacco by users of other drugs. Dr. Benowitz will review phar- macokinetic and pharmacodynamics interactions between nico- tine and alcohol, cannabis, opiates and stimulants. Dr. West will show how a general model of behavior can provide a framework for understanding patterns of association with addictive disorders and how this can be used to guide interventions to combat ciga- rette addiction in people who also suffer from other addictions. The public health challenge is to develop a framework that leads to the least harmful use of the least harmful products or mix of products. Dr. Borland will discuss how tobacco smoking and nicotine fit into that agenda. Dr. Prochaska will present new data and review the literature on treating tobacco addiction in smok- ers with co-occurring alcohol and other drug use disorders. 6:00 p.m.-7:30 p.m. Passi Perduti (Basement - Lowest Level) PDC Building Opening Reception (All attendees are welcome! Cash bar and hors d’oeuvres)

37 SRNT 2017 · Florence, Italy

38 SRNT 2017 · Florence, Italy

39 SRNT 2017 · Florence, Italy

40 SRNT 2017 · Florence, Italy

SESSION SUMMARY THURSDAY MARCH 9, 2017 Thursday, March 9, 2017 March Thursday,

41 SRNT 2017 · Florence, Italy

42 SRNT 2017 · Florence, Italy

THURSDAY, MARCH 9, 2017

8:00 a.m.-5:00 p.m. Piazza Adua (Reception Area) Registration 8:00 a.m.-5:00 p.m. Retropresidenza (Passi Perduti - Lowest Level) PDC Building Speaker Ready Room 9:00 a.m.-3:30 p.m. Salone Club (Lower level) PDC Building Exhibits Open 9:00 a.m.-10:30 a.m. Sala Auditorium (Lower Level) PDC Building Welcome/Awards/Plenary 9:00 a.m. Welcome & Opening Remarks by the Presidents of SRNT-E & SRNT Ivan Berlin, PhD Deborah Ossip, PhD 9:10 a.m. Awards Tom Glynn, PhD Chair, Awards Sub-Committee John Slade Award Martin Raw, PhD Director, International Centre for Tobacco Cessation Honorary Associate Professor, UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Not- tingham, UK Visiting Professor, National Institute of Alcohol and Drug Policies, Federal University of Sao Paulo, Brazil Thursday, March 9, 2017 March Thursday, Jarvik-Russell New Investigator Award Thomas R. Kirchner, PhD Clinical Associate Professor of Public Health, Medicine, and Urban Science at NYU College of Global Public Health, USA Doll-Wynder Award Kenneth E. Warner, PhD Avedis Donabedian Distinguished University Professor of Public Health at the University of Michigan, USA 9:30 a.m. Plenary Epidemiology and Public Health Themed Lecture and 2017 Doll-Wynder Award Winner “How to Think - Not Feel - About Tobacco Harm Reduction” Kenneth E. Warner; Avedis Donabedian Distinguished University Professor 10:30 a.m.-11:00 a.m. Salone Club (Lower level) PDC Building Exhibitor Time Refreshment Break - Passi Perduti (Basement - Lowest Level)

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 43 Program · Thursday, March 9, 2017

11:00 a.m.-12:30 p.m. Affari (2nd Floor) - Auda 2 Podium Presentation 1 Symposium 1 HEALTH COMMUNICATION FOR NON-CIGARETTE TOBACCO PRODUCTS Chair: Erin L. Sutfin, PhD, USA Discussant: Seth M. Noar, PhD Audience: P, I, LMIC SYM1A: DEVELOPING A POINT-OF-SALE HEALTH COMMUNICATION CAMPAIGN FOR CIGARILLOS AND WATERPIPE TOBACCO Presenters: Erin L. Sutfin, PhD; Jennifer Cornacchione, PhD; Allison Lazard, PhD; Elizabeth Orlan; Cynthia Suerken, MS; Kimberly D. Wiseman, MS; Beth A. Reboussin, PhD; Mark Wolfson, PhD; Seth M. Noar, PhD SYM1B: THE FIRST NATIONAL SMOKELESS TOBACCO PREVENTION CAMPAIGN: PRESENTATION OF FORMATIVE RESEARCH LEADING TO DEVELOP HEALTH MESSAGING Presenters: Tesfa Alexander, PhD; Matthew W. Walker, DrPh, MPH SYM1C: IDENTIFYING PROMISING CAMPAIGN THEMES FOR A MASS MEDIA CAMPAIGN TO PREVENT YOUTH INITIATION OF VAPING AND E-CIGARETTE USE Presenters: Angeline Sangalang, PhD; Allyson C. Volinsky, MA; Qinghua Yang, PhD; Jiaying Liu, MA; Stella Lee, MA; Laura A. Gibson, PhD; Robert C. Hornik, PhD SYM1D: DEVELOPING AND EVALUATING HEALTH COMMUNICATION MESSAGES ABOUT ENDS FOR CURRENT SMOKERS Presenters: Scott R. Weaver, PhD; Lucy Popova, PhD; Mi- chael P. Eriksen, ScD 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Room 1 Podium Presentation 1 Symposium 2 EXPLORING MARIJUANA AND TOBACCO CO-USE: A PROBLEMATIC RELATIONSHIP THAT CAN NO LONGER BE IGNORED Chair: Erin A McClure, PhD, USA Discussant: Kimber P Richter, PhD, MPH Audience: PH/E, PC, HD, I SYM2A: COMBUSTED PRODUCT USE AMONG A SAMPLE OF US ADULTS WHO CO-USE TOBACCO AND MARIJUANA Presenters: Erica N Peters, PhD; Zachary R Rosenberry, BS; Gillian L Schauer, PhD, MPH SYM2B: DIMENSIONS OF PERCEIVED HARM OF TOBACCO, MARIJUANA, AND ELECTRONIC VAPORIZERS AMONG YOUNG ADULTS IN COLORADO: A QUALITATIVE STUDY Presenters: Lucy Popova, PhD; Emily A McDonald, PhD; Sohrab Sidhu, MD, MPH; Rachel A Barry, MS; Tracey A Richers Maruyama, MA; Nicolas M Sheon, PhD; Pamela M Ling, MD, MPH SYM2C: EXPLORING PATTERNS OF TOBACCO AND CANNABIS CO-USE IN PATIENTS WITH SCHIZOPHRENIA VERSUS CONTROLS: THE EFFECTS OF CANNABIS ABSTINENCE Presenters: Rachel A Rabin, PhD; Tony P George, MD

44 SRNT 2017 · Florence, Italy

SYM2D: A RANDOMIZED CONTROLLED TRIAL TARGETING TOBACCO USE DURING TREATMENT FOR CANNABIS USE DISORDER Presenters: Dustin C Lee, PhD; Alan J Budney, PhD; Denise D Walker, PhD; Mary F Brunette, MD; John R Hughes, MD; Jean-Francois Etter, PhD; Samantha Auty; Catherine Stanger, PhD SYM2E: ASSESSING REGULATORY SYSTEMS FOR RETAIL MARIJUANA WITHIN A TOBACCO CONTROL FRAMEWORK: EVIDENCE FROM URUGUAY AND THE UNITED STATES Presenters: Rachel A Barry, MA 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Room 2 Podium Presentation 1 Symposium 3 IN MEMORY OF ATHINA MARKOU: A LEGACY OF TRANSITIONAL SCIENCE ON NICOTINE WITHDRAWAL AND REWARD Chair: Jason A Oliver, PhD, USA Co-Chair: Andre Der-Avakian, PhD, USA Discussant: Eric C Donny, PhD Audience: BS, PC, T SYM3A: EFFECTS OF KETAMINE ON NICOTINE WITHDRAWAL- AND STRESS-INDUCED DEFICITS IN BRAIN REWARD FUNCTION IN RATS Presenters: Andre Der-Avakian, PhD SYM3B: MOVING BEYOND IMMEDIATE REWARD: DOES NICOTINE WITHDRAWAL IMPACT REINFORCEMENT LEARNING? Presenters: Jason A Oliver, PhD; Nicolette Sullivan, PhD; Merideth A Addicott, PhD; Francis J McClernon, PhD; David E Evans, PhD; Thomas H Brandon, PhD; David J Drobes, PhD SYM3C: CLINICAL MANIFESTATIONS OF ANHEDONIA IN

TOBACCO WITHDRAWAL 9, 2017 March Thursday, Presenters: Adam M Leventhal, PhD SYM3D: DEPRESSION AND NICOTINE WITHDRAWAL AT THE POPULATION LEVEL Presenters: Michele L Pergadia, PhD; John W Newcomer, MD; David G Gilbert, PhD 1:00 a.m.-12:30 p.m. Affari (2nd Floor) Podium Presentation 1 Symposium 4 EXPLORING DIMENSIONS OF FLAVORS: TOXICITY, PREFERENCE, AND USE Chair: Cathy L Backinger, PhD, MPH, USA Discussant: Suchitra Krishnan-Sarin, PhD Audience: BS, PC, PH/E, I SYM4A: A REVIEW OF AGE-RELATED DIFFERENCES IN FLAVOR PREFERENCES Presenters: Allison C Hoffman, PhD; Raydel Valdes Salgado, PhD, MPH, MS; Carolyn Dresler, MD, MPA; Rachel Williams Faller, MPH; Christopher Bartlett, PhD SYM4B: INHALATION TOXICITY OF FLAVORINGS IN ELECTRONIC NICOTINE DELIVERY SYSTEMS (ENDS) Presenters: Maciej L Goniewicz, PhD, PharmD

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 45 Program · Thursday, March 9, 2017

SYM4C: ANALYSIS AND BEHAVIORAL EFFECTS OF HIGH- INTENSITY SWEETENERS IN ALTERNATIVE TOBACCO PRODUCTS Presenters: Sairam Jabba, DVM, PhD; Cheenu Tiwari; Pamela Bonner, MBS; Tamara deWinter, PhD; Shida Miao, PhD; Evan S Beach, PhD; Toby J Sommer, PhD; Julie B Zimmerman, PhD; Sven-Eric Jordt, PhD SYM4D: ARE YOUTH AND YOUNG ADULTS WHO FIRST TRY A FLAVORED TOBACCO PRODUCT MORE LIKELY TO CONTINUE USING TOBACCO? FINDINGS FROM THE PATH STUDY Presenters: Andrea C Villanti, PhD, MPH 11:00 a.m.-12:30 p.m. Palazzo dei Congressi: Verde Podium Presentation 1 Symposium 5 THE ECONOMICS OF TOBACCO CONTROL: KEY FINDINGS FROM THE NCI & WHO TOBACCO CONTROL MONOGRAPH Chair: Mark Parascandola, PhD, USA Co-Chair: Geoffrey Fong, PhD, Canada Discussant: Hana Ross, PhD Audience: P, I, LMIC SYM5A: BEST PRACTICES IN TOBACCO TAXATION Presenters: Frank J Chaloupka, PhD SYM5B: GLOBALIZATION OF THE TOBACCO INDUSTRY AND IMPLICATIONS FOR TOBACCO CONTROL Presenters: Ayda Yurekli, PhD SYM5C: THE ECONOMIC IMPACT OF TOBACCO USE AND TOBACCO CONTROL Presenters: Evan Blecher, PhD 11:00 a.m.-12:30 p.m. Affari (4th Floor) Podium Presentation 1 Symposium 6 THE CHRNA5-A3-B4 GENE CLUSTER: FROM DISCOVERY TO CAUSALITY, MECHANISM, AND THERAPEUTICS Chair: Glenda Lassi, PhD, UK Discussant: Mariella De Biasi, PhD Audience: BS, PC, I SYM6A: FROM GENETICS TO CAUSALITY Presenters: Marcus R Munafò, PhD SYM6B: THE CHRNA5-A3-B4 GENE CLUSTER: FROM GENOTYPE TO PHENOTYPE Presenters: Glenda Lassi, PhD; Tim Eisen, PhD SYM6C: NICOTINIC RECEPTOR CIRCUITS MEDIATING REINFORCEMENT AND AVERSION Presenters: Christie Fowler, PhD SYM6D: IN VIVO PHARMACOLOGICAL PROFILE OF THE SELECTIVE A3B4 NACHR PARTIAL AGONIST AT-1001, IN NICOTINE SELF-ADMINISTRATION, REINSTATEMENT AND WITHDRAWAL: ROLE OF A3B4 NACHR AS A TARGET FOR SMOKING CESSATION PHARMACOTHERAPY Presenters: Nurulain T Zaveri, PhD

46 SRNT 2017 · Florence, Italy

11:00 a.m.-12:30 p.m. Auditorium-General Session Room PDC Building Podium Presentation 1 Paper Session 1 NOVEL FINDINGS FROM CLINICAL TRIALS Chair: Sue Curry, PhD, USA Audience: C,T,I 11:00 a.m. - 11:15 a.m. EFFECTIVENESS OF INTENSIVE PRACTICE NURSE COUNSELLING VERSUS BRIEF GENERAL PRACTITIONER ADVICE IN COMBINATION WITH VARENICLINE FOR SMOKING CESSATION: A RANDOMISED PRAGMATIC TRIAL IN PRIMARY CARE Daniel Kotz, PhD*; Carolien van Rossem, MSc; Mark Spigt, PhD; Wolfgang Viechtbauer, PhD; Annelies Lucas, MD; Onno C.P. van Schayck, PhD 11:15 a.m. - 11:30 a.m. REAL WORLD EFFECTIVENESS OF VARENICLINE AND BUPROPION FOR SMOKING CESSATION: AN INTERNET- BASED RANDOMIZED CONTROLLED TRIAL (MATCH) Helena Zhang, BSc*; Bernard Le Foll, MD, PhD; Peter Selby, MBBS; Laurie Zawertailo, PhD 11:30 a.m. - 11:45 a.m. CARDIOVASCULAR SAFETY OF VARENICLINE, BUPROPION AND NICOTINE PATCH: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL Neal L Benowitz, M.D.*; Robert West, Ph D.; Andrew Pipe, CM, BA, MD, LLD (Hons), DSc (Hons); Taylor Hays, M.D.; Lisa St. Aubin, Ph D.; Thomas McRae, Ph D.; Robert An- thenelli, M.D. 11:45 a.m. - 12:00 noon ASSOCIATION OF ELECTRONIC CIGARETTE USE WITH SMOKING CESSATION AMONG SMOKERS WHO PLAN TO QUIT AFTER HOSPITAL DISCHARGE: A LONGITUDINAL ANALYSIS Nancy A Rigotti, MD*; Yuchiao Chang, PhD; Hilary A Tindle, 9, 2017 March Thursday, MD, MPH; Susan Regan, PhD; Sara M Kalkhoran, MD, MAS; Jennifer H Kelley, RN, MA; Elyse R Park, PhD, MPH; Thomas Ylioja, MSW; Daniel E Singer, MD 12:00 noon - 12:15 p.m. THE NATURALISTIC UPTAKE AND IMPACT OF E-CIGARETTES: RESULTS FROM A PILOT RANDOMIZED TRIAL Matthew J Carpenter, PhD*; Bryan W Heckman, PhD; Amy E Wahlquist, MS; Amy Boatright; Brett Froeliger, PhD; Kevin M Gray, MD; K. Michael Cummings, PhD, MPH 12:15 p.m. - 12:30 p.m. YOGA AS A COMPLEMENTARY THERAPY IN COGNITIVE BEHAVIORAL SMOKING CESSATION: A RANDOMIZED CLINICAL TRIAL Beth C Bock, PhD*; Shira Dunsiger, PhD; Ernestine Jennings, PhD; Rochelle Rosen, PhD; Bess H Marcus, PHD 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Auda 1 Podium Presentation 1 Paper Session 2 SECONDHAND EXPOSURE ASSESSMENT Chair: Yi Nam Suen, PhD, Hong Kong Co-Chair: Luk Tzu Tsun Kevin, PhD, Hong Kong Audience: PC, PH/E, I, LMIC

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 47 Program · Thursday, March 9, 2017

11:00 a.m. - 11:15 a.m. SECONDHAND SMOKE EXPOSURE AMONG THOSE WHO SHOULD NOT BE EXPOSED: A U.S. NATIONAL ESTIMATE Taghrid Asfar, MD, MSPH.*; Kristopher Arheart; Tulay Koru- Sengul; David Lee 11:15 a.m. - 11:30 a.m. SECONDHAND SMOKE EXPOSURE AMONG A VULNERABLE POPULATION OF ADOLESCENTS Natalie Nardone, PhD*; Shonul Jain, MD; Delia Dempsey, MD; Peyton Jacob, PhD; Neal L Benowitz 11:30 a.m. - 11:45 a.m. SECOND HAND SMOKE EXPOSURE AMONG PREGNANT WOMEN IN ARGENTINA. ROLE OF HEALTH CARE PROFESSIONALS Paola Morello, MD MPH*; Mabel Berrueta, MD; Luz Gibbons, PhD; Jose Belizan, MD; Fernando Althabe, MD 11:45 a.m. - 12:00 noon USING AIR-QUALITY FEEDBACK TO FACILITATE SMOKE- FREE HOMES Amanda Amos, BA, MSc, PhD*; Steve Turner, MBBS, FR- CPCH, MD; Rachel O’Donnell, BSc, PhD; Susan Lyttle, BSc, MPH; Tracey Henderson; Lynn Adams, BSc; Sean Semple, BSc, MSC, PhD 12:00 noon - 12:15 p.m. EFFECTS OF HOOKAH SMOKING ON INDOOR AIR QUALITY IN HOMES Lily Lee, *; Michael Weitzman, MD; Afzal Hussein Yusufali, PhD; Fatma Bali, MD; MJ Ruzmyn Vilcassim, MS; Shashank Ghandhi, MS; Richard Peltier, PhD; Arthur Nadas, PhD; Scott E Sherman, MD; Zhang Hong, MS; Jenni A Shearston, BA; Su Hyun Park, PhD; Terry Gordon, PhD 12:15 p.m. - 12:30 p.m. SECONDHAND AND THIRDHAND EXPOSURE TO NICOTINE FROM ELECTRONIC CIGARETTES Lisa M Vogl, MPH*; Zachary Dunbar, BS; Eric Jensen; Mark Travers, PhD; Maciej L Goniewicz, PhD, PharmD 11:00 a.m.-12:30 p.m. Affari (Ground Floor) Podium Presentation 1 Paper Session 3 CORRELATES OF NOVEL PRODUCT USE Chair: Rachel Grana, PhD, MPH, USA Audience: PH/E, P, HD, I, LMIC 11:00 a.m. - 11:15 a.m. WHAT FACTORS ARE ASSOCIATED WITH SMOKERS USING OR STOPPING E-CIGARETTE USE? Leonie S Brose, PhD*; Erikas Simonavicius, MSc; Deborah Arnott, MBA; Ann McNeill, PhD 11:15 a.m. - 11:30 a.m. THE SOCIAL ENVIRONMENT AND FUTURE USE OF CIGARETTES AND E-CIGARETTES Robert Urman, PhD*; Jessica L Barrington-Trimis, PhD, MA, MS; Rob McConnell, MD 11:30 a.m. - 11:45 a.m. WHY DO YOUTH AND YOUNG ADULTS USE E-CIGARETTES? MOTIVATIONS AND EXPECTANCIES Jessica M Rath, PhD, MPH*; Morgane A Bennett, MPH; Lyubov Teplitskaya, MS; Elizabeth C Hair, PhD; Jennifer Cantrell, DrPH, MPA; Jennifer L Pearson, PhD, MPH; Donna M Vallone, PhD, MPH

48 SRNT 2017 · Florence, Italy

11:45 a.m. - 12:00 noon PREDICTING CIGARETTE INITIATION AMONG YOUNG ADULTS: A SURVIVAL ANALYSIS EXAMINING THE INFLUENCE OF E-CIGARETTE USE Alexandra Loukas, PhD*; C. Nathan Marti, PhD; Maria R. Cooper, PhD; Keryn E. Pasch, PhD; Cheryl L. Perry, PhD 12:00 noon - 12:15 p.m. RESULTS FROM AN E-CIGARETTE PREVENTION PILOT TEST IN 25 USA MIDDLE SCHOOLS WITH 1371 STUDENTS: CATCH MY BREATH PROGRAM Steven H Kelder, PhD, MPH*; Duncan Van Dusen, MPH; Megan M Grayless, MPH 12:15 p.m. - 12:30 p.m. SUSCEPTIBILITY MEDIATES THE ASSOCIATION BETWEEN PSYCHOSOCIAL FACTORS AND YOUTHS’ SUBSEQUENT HOOKAH INITIATION MeLisa Creamer, PhD, MPH*; Maria Cooper, PhD; Christina Ly, PhD, MPH; Brittani Crook, PhD; Melissa B Harrell, PhD, MPH; Cheryl L Perry, PhD 12:30 p.m.-2:00 p.m. Passi Perduti PDC Building Poster Session 1: Clinical 12:30 p.m.-2:00 p.m. Passi Perduti (Basement - Lowest Level) Lunch Break Pick up your complimentary boxed lunch, starting at 12:15 p.m. 12:45 p.m.-2:00 p.m. Villa Vittoria: Sala 101 - Primo Piano (1st Floor) Past Presidents Luncheon (by invitation only) 12:45 p.m.-1:45 p.m. Villa Vittoria: Sala 4 – Terra Piano (Ground Floor)

Meet-the-Editor 9, 2017 March Thursday, Joanna Cohen, Deputy Editor Tobacco Control Journal 2:00 p.m.- 3:00 p.m. Auditorium-General Session Room PDC Building Pre-Clinical/Basic Science Plenary Themed Lecture Genetic Overlap Between Cigarette Smoking and Other Substance Use Jacqueline Vink, Professor, Behavioral Science Institute, Radboud University, Nijmegen, The Netherlands 3:00 p.m.- 3:30 p.m. Salone Club (Lower level) PDC Building Exhibitor Time Refreshment Break - Passi Perduti (Basement - Lowest Level) 3:30 p.m.-5:00 p.m. Affari (4th Floor) Podium Presentation 2 Symposium 7 ENDOCANNABINOID MODULATION OF NICOTINE DEPENDENCE: SYMPOSIUM IN MEMORIAM OF DR. LARRY PARSONS Chair: Christie D Fowler, PhD, USA Co-Chair: Matthew W Buczynski, PhD, USA Discussant: Christie D Fowler, PhD Audience: BS, PC, I

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 49 Program · Thursday, March 9, 2017

SYM7A: DIACYLGLYCEROL LIPASE DISINHIBITS VTA DOPAMINE NEURONS FOLLOWING CHRONIC NICOTINE EXPOSURE Presenters: Matthew W Buczynski, PhD; Melissa A Herman; Ku-Lung Hsu; Ilham Y Polis; Benjamin F Cravatt; Marisa Roberto; Loren H Parsons SYM7B: ROLE OF N-ACYLETHANOLAMINES IN NICOTINE EFFECTS ON MIDBRAIN DOPAMINE NEURONS Presenters: Miriam Melis, PhD; Marco Pistis, MD SYM7C: ROLE OF TRANSIENT RECEPTOR POTENTIAL VANILLOID 1 IN THE CONTROL OF BOTH NICOTINE- RELATED BEHAVIORS AND NICOTINE-INDUCED DOPAMINE NEURONAL ACTIVITY IN MICE Presenters: Anne-Emilie Alain; Marie-Line Fournier; Oceane Aribo; Martine Cador; Sandrine S Bertrand; Stéphanie Caillé-Garnier, PhD SYM7D: ROLE OF THE ENDOCANNABINOID SYSTEM IN NICOTINE ADDICTION Presenters: Jose M Trigo, PhD; Bernard Le Foll, MD, PhD, MCFP 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Room 2 Podium Presentation 2 Symposium 8 GLOBAL TOBACCO CONTROL DISPARITIES: WHERE ARE WE? WHERE ARE WE GOING? Chair: Jennifer Cantrell, DrPH, MPA, USA Co-Chair: Carla Berg, PhD, USA Discussant: Joanna Cohen, PhD, MHSc ; Jim F Thrasher, PhD, MA, MS Audience: P, HD, I, LMIC SYM8A: SOCIODEMOGRAPHIC PATTERNING OF CESSATION BEHAVIOR ACROSS LOW AND MIDDLE- INCOME COUNTRIES: EMERGING EVIDENCE FROM THE GLOBAL ADULT TOBACCO SURVEYS AND INTERNATIONAL TOBACCO CONTROL SURVEYS Presenters: Nigar Nargis, PhD; Hua-Hie Yong, PhD, MPsych; Pete Driezen, PhD Candidate, MSc; Lazarous Mbulo, PhD; Geoffrey Fong, PhD; Mary Thompson, PhD; Ron Borland, PhD, MAPS; Krishna Palipudi, PhD; Gary Giovino, PhD, MS; Jim F Thrasher, PhD, MA, MS SYM8B: TOBACCO CONTROL POLICY IMPLEMENTATION AND EVALUATION: A PROPOSED FRAMEWORK FOR LOW- AND MIDDLE-INCOME COUNTRIES Presenters: Ryan D Kennedy, PhD; Stephen A Tamplin, MSE; Lisa P Lagasse, PhD; Joanna E Cohen, PhD SYM8C: LINKING GLOBAL TOBACCO CONTROL AND THE SUSTAINABLE DEVELOPMENT GOALS: OPPORTUNITIES AND CHALLENGES FOR RESEARCH AND ADVOCACY Presenters: Monika Arora, PhD, MSc, MSc; Shikha Bhasin, MPH, BDS; Amit Yadav, LLM, MPhil; Alice Grainger-Gasser, BSN 3:30 p.m.-5:00 p.m. Affari (2nd Floor) Podium Presentation 2 Symposium 9 CONTRIBUTIONS OF BASIC SCIENCE TO PUBLIC POLICY Chair: Tracy T Smith, PhD, USA Discussant: Jonathan Foulds, PhD Audience: BS, P, I

50 SRNT 2017 · Florence, Italy

SYM9A: TESTING INHALATION TOXICITY OF NOVEL TOBACCO PRODUCTS USING IN VITRO MODELS - IMPLICATIONS FOR REGULATORY SCIENCE AND POLICY Presenters: Maciej L Goniewicz, PhD, PharmD SYM9B: INTRAORAL FLAVORANTS ENHANCE DOPAMINE SIGNALING AND NICOTINE-TAKING IN A PRECLINICAL RAT MODEL Presenters: Nii A Addy, PhD; Robert J Wickham, PhD; Eric J Nunes, PhD; Phillip R Silva, BS; Jinwoo Park, PhD SYM9C: BEHAVIORAL ECONOMIC ASSESSMENTS OF THE IMPACT OF NICOTINE REDUCTION ON RAT SELF- ADMINISTRATION AND HUMAN SMOKING Presenters: Tracy T Smith, PhD; Rachel N Cassidy, PhD; Joseph S Koopmeiners, PhD; Xianghua Luo, PhD; Laura E Rupprecht, BS; Alan F Sved, PhD; Jennifer W Tidey, PhD; Dorothy K Hatsukami, PhD; Eric C Donny, PhD SYM9D: EXAMINING TOBACCO CONTROL AND REGULATORY SCIENCE QUESTIONS IN THE CLINICAL LABORATORY SETTING Presenters: Stephen T Higgins, PhD 3:30 p.m.-5:00 p.m. Affari (Ground Floor) Podium Presentation 2 Symposium 10 UNDERSTANDING NON-ADHERENCE TO SMOKING INTERVENTIONS: DETECTION, REASONS, INDIVIDUAL DIFFERENCES, AND CONSEQUENCES Chair: Sarah S Dermody, PhD, Canada Discussant: Neal Benowitz, PhD Audience: C, T, I SYM10A: REASONS FOR NON-COMPLIANCE IN A CIGARETTE NICOTINE REDUCTION CLINICAL TRIAL Presenters: Natalie Nardone, PhD; Neal Benowitz, MD; Tracy Smith, PhD; Joseph Koopmeiners, PhD; Dorothy Hatsukami, PhD; Eric C Donny, PhD Thursday, March 9, 2017 March Thursday, SYM10B: COMPENSATORY SMOKING OF REDUCED NICOTINE CONTENT CIGARETTES IN CONFINED SMOKERS Presenters: Neal Benowitz, MD; Natalie Nardone, PhD; Tracy Smith, PhD; Rachel Denlinger, MPH; Joseph S. Koop- meiners, PhD; Dorothy Hatsukami, PhD; Eric C Donny, PhD SYM10C: ESTIMATING THE IMPACT OF MANDATED REDUCTIONS IN THE NICOTINE CONTENT OF CIGARETTES FROM DATA COLLECTED IN AN UNREGULATED WORLD Presenters: Joseph S Koopmeiners, PhD; Jeffery A Boatman; David M Vock, PhD; Eric C Donny, PhD SYM10D: THE EFFECTS OF ADHERENCE WITH EXCLUSIVELY SMOKING VERY LOW NICOTINE CONTENT CIGARETTES ON WITHDRAWAL SYMPTOMS Presenters: Sarah S Dermody, PhD; F. Joseph McClernon, PhD; Neal Benowitz, MD; Joseph Koopmeiners, PhD; Xianghua Luo, PhD; Jennifer Tidey, PhD; Ryan Vandry, PhD; Dorothy Hatsukami, PhD; Eric C Donny, PhD

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 51 Program · Thursday, March 9, 2017

SYM10E: MEASURES AND PREDICTORS OF VARENICLINE ADHERENCE IN THE TREATMENT OF NICOTINE DEPENDENCE Presenters: Mark Morales, BA; Annie R Peng, BSc; E. Paul Wileyto, PhD; Ning Chen, PhD; Larry W Hawk Jr., PhD; Paul Cinciripini, PhD, MD; Tony P George, MD; Neal Benow- itz, MD; Nikka L Nollen, PhD; Caryn Lerman, PhD; Rachel F Tyndale, PhD; Robert Schnoll, PhD 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Auda 1 Podium Presentation 2 Symposium 11 DEVELOPMENT AND TESTING OF SMARTPHONE APPS FOR SMOKING CESSATION Chair: Kathleen A Garrison, PhD, USA Co-Chair: Reuven Dar, PhD, Israel Discussant: Saul M Shiffman, PhD Audience: PC, C, T, I SYM11A: A NOVEL SMOKING CESSATION APP UTILIZING BIG DATA OVER WEARABLES: A PILOT STUDY Presenters: Reuven Dar, PhD SYM11B: UX DESIGN AND N-OF-1 TRIALS OF LEARN TO QUIT, A NOVEL SMOKING CESSATION APP FOR CHRONIC MENTAL ILLNESS Presenters: Roger Vilardaga, PhD; Javier Rizo, BA; Arpita Bhattacharya, BS; Emily Y Zeng, BS; Brain Marr, BA; Julie Kientz, PhD; Richard Ries, MD SYM11C: USING OUR SMARTPHONES TO LEARN TO PAY ATTENTION AND QUIT SMOKING: SMARTPHONE APP-BASED MINDFULNESS TRAINING FOR SMOKING CESSATION Presenters: Kathleen A Garrison, PhD; Prasanta Pal, PhD; Stephanie S O’Malley, PhD; Judson A Brewer, MD, PhD 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Room 1 Podium Presentation 2 Symposium 12 TIME-VARYING EFFECT MODELING TO SHED NEW LIGHT ON THE DEVELOPMENTAL COURSE OF NICOTINE PRODUCT USE IN THE US Chair: Stephanie T Lanza, PhD, USA Discussant: Megan E Piper, PhD Audience: PH/E, P SYM12A: AGE-VARYING RATES OF NICOTINE PRODUCT USE THROUGHOUT ADOLESCENCE Presenters: Jessica L Braymiller, MS; Stephanie T Lanza, PhD SYM12B: LOW FAMILY SES AND SMOKING: AGE-VARYING ASSOCIATIONS FROM ADOLESCENCE TO YOUNG ADULTHOOD Presenters: Michael A Russell, PhD; Sara A Vasilenko, PhD; Stephanie T Lanza, PhD SYM12C: AGE-VARYING RISK FOR INITIATION AND ESCALATION ACROSS MAJOR SMOKING MILESTONES DURING ADOLESCENCE Presenters: Lisa Dierker, PhD; Jennifer S Rose, PhD; Arielle S Selya, PhD

52 SRNT 2017 · Florence, Italy

3:30 p.m.-5:00 p.m. Auditorium-General Session Room PDC Building Podium Presentation 2 Symposium 13 THE POTENTIAL OF ELECTRONIC CIGARETTES FOR REDUCING THE HARM OF TOBACCO IN PRIORITY POPULATIONS: PEOPLE, PLACES, POLICIES, PROMOTION, AND PRACTICES Chair: Billie Bonevski, BA(Hons), PhD, Australia Discussant: Amanda Baker, PhD Audience: PH/E, P, HD, I, LMIC SYM13A: SOCIOECONOMIC DIFFERENCES IN USE OF VAPORIZED NICOTINE: FINDINGS FROM THE ITC FOUR COUNTRY SURVEYS Presenters: Ron Borland, PhD; Hua-Hie Yong, PhD; Michael K Cummings, PhD; Geoffrey Fong, PhD; Ann McNeill, PhD SYM13B: USE OF ELECTRONIC CIGARETTES BY AUSTRALIAN SMOKERS IN SUBSTANCE ABUSE TREATMENT: REASONS FOR USE, AND PLACE OF PURCHASE Presenters: Billie Bonevski, PhD; Ashleigh Guillaumier, PhD; Eliza Skelton, BA(Hons); Anthony Shakeshaft, PhD; Michael Farrell, PhD; Flora Tzelepis, PhD; Adrian Dunlop, PhD; Chris Paul, PhD; Catherine D’Este, PhD SYM13C: “VAPING NOT ONLY SAVED MY LIFE, BUT FREED ME FROM A CAGE”: A QUALITATIVE ANALYSIS OF SOCIAL MEDIA DISCUSSIONS ABOUT MOTIVATIONS FOR AND BARRIERS TO SMOKERS WITH MENTAL ILLNESS SWITCHING TO E-CIGARETTES Presenters: Ratika Sharma, M.DenSurg; Britta Wigginton, PhD; Carla Meurk, PhD; Pauline Ford, PhD; Coral Gartner, PhD SYM13D: HEALTH PRACTITIONERS’ ATTITUDES TOWARD TOBACCO HARM REDUCTION APPROACHES FOR SMOKERS FROM PRIORITY POPULATIONS WITH CO- MORBIDITIES. 9, 2017 March Thursday, Presenters: Coral Gartner, PhD; Stephanie Bell, BSc; Ratika Sharma, M.DenSurg; Carla Meurk, PhD; Judith Dean, PhD; Charles F Gilks, PhD; Mark Boyd, PhD SYM13E: WHAT ROLE DO E-CIGARETTES HAVE IN A COUNTRY WITH A SMOKEFREE GOAL? Presenters: Chris Bullen, MBChB, PhD; Natalie Walker, PhD 3:30 p.m.-5:00 p.m. Palazzo dei Congressi: Verde Podium Presentation 2 Paper Session 4 TREATMENT IN SMOKERS WITH COMORBIDITIES Chair: Peter Selby, PhD, Canada Audience: C, HD, I, T 3:30 p.m. - 3:45 p.m. A SMOKING CESSATION TRIAL IN PEOPLE LIVING WITH HIV (PLWH) IN SOUTH AFRICA Jonathan E Golub, PhD, MPH*; Limakatso Lebina; Katlego Motlhaoleng; Sandy Chon; Nikhil Gupte; Ray Niaura; David Abrams; Ebrahim Variava; Neil Martinson

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 53 Program · Thursday, March 9, 2017

3:45 p.m. - 4:00 p.m. EFFECTIVENESS OF A CLINICAL PRACTICE CHANGE INTERVENTION IN INCREASING THE PROVISION OF TREATMENT FOR SMOKING IN INPATIENT PSYCHIATRIC FACILITIES: AN IMPLEMENTATION TRIAL Emily A Stockings, PhD*; Paula M Wye, PhD; Jenny A Bow- man, PhD; Christopher Oldmeadow, PhD; John H Wiggers, PhD 4:00 p.m. - 4:15 p.m. HELPING CANCER PATIENTS QUIT SMOKING BY IMPROVING THEIR RISK COMMUNICATION: A RANDOMIZED CONTROLLED TRIAL Ho Cheung, William Li, PhD, RN*; Tsz Yan, Yannes Cheung, PhD; Siu Chee, Sophia Chan, PhD; Tai-Hing Lam, MBBS, MD(HK), MSc(Occupational Medicine)(Lond), FAFOM RACP, FFPH, FFOM(Lond), Hon.FHKCCM, FHKAM(Community Medicine), FRCP(Edin) 4:15 p.m. - 4:30 p.m. BRIEF INTERVENTION TO PROMOTE SMOKING CESSATION AND IMPROVE GLYCEMIC CONTROL IN SMOKERS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL Yannes Tsz-Yan Cheung, *; William Ho-Cheung Li; Sophia Siu Chee Chan; Tai-Hing Lam 4:30 p.m. - 4:45 p.m. CARDIOVASCULAR AND NEUROPSYCHIATRIC RISKS OF VARENICLINE IN SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RETROSPECTIVE COHORT STUDY USING A NATIONAL GENERAL PRACTICE DATABASE Daniel Kotz, PhD*; Wolfgang Viechtbauer, PhD; Colin Simp- son, PhD; Onno C.P. van Schayck, PhD; Robert West, PhD; Aziz Sheikh, PhD 4:45 p.m. - 5:00 p.m. DOES DISEASE PROGRESSION POTENTIATE THE EFFECTS OF POLYTOBACCO USE? A CHARACTERIZATION OF INTENTION TO QUIT AMONG NEWLY DIAGNOSED HIV SEROPOSITIVE SMOKERS Micah J Savin, *; Ellen R Gritz, PhD; Summer Frank; Roberto C Adruino, MD; Damon J Vidrine, DrPH, MS 3:30 p.m.-5:00 p.m. Affari (2nd Floor) - Auda 2 Podium Presentation 2 Paper Session 5 TAX AND PRICE POLICY Chair: Frank Chaloupka, PhD, USA Audience: P, I, LMIC 3:30 p.m. - 3:45 p.m. 6 YEARS, 15 COUNTRIES, 30 MILLION LIVES: LESSONS ON TOBACCO TAXATION FROM THE BLOOMBERG INITIATIVE Rajeev Cherukupalli, PhD* 3:45 p.m. - 4:00 p.m. TAXATION, DISPARITIES, AND REDUCTIONS IN SMOKING IN THE U.S., 2001-2011 Lucie Kalousova, *; Nancy L Fleischer, PhD, MPH; David T Levy, PhD; James F Thrasher, PhD, MA, MS; Paula M Lantz, PhD, MS, MA; Rafael Meza, PhD

54 SRNT 2017 · Florence, Italy

4:00 p.m. - 4:15 p.m. UNDERSTANDING TOBACCO INDUSTRY PRICING AND WHETHER IT UNDERMINES TOBACCO TAX POLICIES Rosemary Hiscock, PhD*; Anna B Gilmore, MBBS (hons), DTM&H MSc (dist) PhD FFPH; Robert Branston, PhD; Sara C Hitchman, PhD; Timea Partos, PhD; Ann McNeill, PhD 4:15 p.m. - 4:30 p.m. EVALUATION OF NEW YORK CITY’S CIGAR PRICING AND PACKAGING LAW Todd Rogers, PhD*; Elizabeth Brown, MPH; Matthew Eggers, MPH; Doris Gammon, MS; James Nonnemaker; Tarsha Mc- Crae 4:30 p.m. - 4:45 p.m. E-CIGARETTE USE AMONG ADULTS IN THE UNITED STATES: SHOULD WE ENCOURAGE E-CIGARETTES TAXATION? Omar El Shahawy, MD, MPH, PhD*; Su Park, PhD, MPH; Lily Lee; Dustin T. Duncan, ScD; Kosuke Tamura, PhD; Jenni A. Shearston, BA; Scott E. Sherman, MD, MPH; Michael Weitzman, MD\r 4:45 p.m. - 5:00 p.m. ESTIMATED COST PER QUITTER FOR SMOKERS USING A SMOKING CESSATION SERVICE IN ENGLAND Vasiliki Kiparoglou, PhD* 5:00 p.m.-6:00 p.m. Villa Vittoria: Sala Onice – Terra Piano (Ground Floor) Meet-the-Editor Marcus Munafo, Deputy Editor Nicotine and Tobacco Re- search Journal 5:00 p.m.-6:00 p.m. Passi Perduti PDC Building Poster Session 2: Policy, Pre-Clinical Thursday, March 9, 2017 March Thursday,

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 55 SRNT 2017 · Florence, Italy

56 SRNT 2017 · Florence, Italy

57 SRNT 2017 · Florence, Italy

58 SRNT 2017 · Florence, Italy

SESSION SUMMARY FRIDAY MARCH 10, 2017 Friday, March 10, 2017 March Friday,

59 SRNT 2017 · Florence, Italy

60 SRNT 2017 · Florence, Italy

FRIDAY, MARCH 10, 2017

8:00 a.m.-5:00 p.m. Piazza Adua (Reception Area) Registration 8:00 a.m.-5:00 p.m. Retropresidenza (Passi Perduti - Lowest Level) PDC Building Speaker Ready Room 8:15 a.m.-8:45 a.m. Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor) PDC Building SRNT-Europe Members Meeting (All members are welcome to attend.) 9:00 a.m.-10:00 a.m. Auditorium-General Session Room PDC Building Clinical Plenary Themed Lecture Treatment of Patients With Tobacco Addiction: Improving Cur- rent Practice and Future Perspectives Serena Tonstad, MD, MPH, PhD, Head Physician, Preventive Cardiology section, Department of Endocrinology, Obesity and Preventive Medicine at Oslo University Hospital, Oslo, Norway and a Professor, School of Public Health, Loma Linda University, Loma Linda, California 9:30 a.m.-3:30 p.m. Salone Club (Lower level) PDC Building Exhibits Open 10:00 a.m.- 10:30 a.m. Salone Club (Lower level) PDC Building Exhibitor Time Refreshment Break - Passi Perduti (Basement - Lowest Level) Friday, March 10, 2017 March Friday, 10:30 a.m.-12:00 noon Affari (2nd Floor) - Auda 2 Podium Presentation 3 Symposium 14 NATURAL, ORGANIC, ADDITIVE-FREE, AND ECO-FRIENDLY THEMES IN CIGARETTE PACKAGING AND ADVERTISING: THE NEW “LIGHT,” “LOW,” AND “MILD”? Chair: David Hammond, PhD, MSc, Canada Discussant: Robin Koval, CEO Audience: PH/E, P, I SYM14A: MISPERCEPTIONS OF HARM AMONG AMERICAN SPIRIT SMOKERS: RESULTS FROM WAVE 1 OF THE POPULATION ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY (2013-2014) Presenters: Jennifer L. Pearson, MPH, PhD; Amanda John- son, MHS; Andrea Villanti, MPH, PhD; Allison M. Glasser, MPH; Lauren Collins, MPH; Amy Cohn, PhD; Shyanika W. Rose, MA, PhD; Raymond Niaura, PhD; Cassandra A. Stanton, PhD SYM14B: THE USE OF IMAGERY AND TEXT THAT COULD CONVEY REDUCED HARM IN AMERICAN SPIRIT ADVERTISEMENTS Presenters: Meghan B. Moran, PhD; John P Pierce, PhD; Caitlin Weiger, BA; Mary C. Cunningham, BA; James D. Sargent, MD

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 61 Program · Friday, March 10, 2017

SYM14C: AMERICAN SPIRIT DIRECT MAIL: BUILDING RELATIONSHIPS WITH CONSUMERS AND REINFORCING BRAND POSITIONING Presenters: M. Jane Lewis, DrPH; Mia Zimmerman, MPH; Chris Ackerman, MPH; Eugene Talbot, MPH SYM14D: THE USE OF NATURAL, ORGANIC, AND NATURE APPEALS ON TOBACCO PACKS IN 14 LOW AND MIDDLE INCOME COUNTRIES Presenters: RD Kennedy, PhD; Kevin Welding, PhD; Meghan B. Moran, PhD; Katherine Clegg Smith, PhD; Jo- anna E. Cohen, PhD 10:30 a.m.-12:00 noon Auditorium-General Session Room PDC Building Podium Presentation 3 Symposium 15 E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: FINDINGS FROM THE U.S. SURGEON GENERAL’S REPORT Chair: Brian A King, PhD, MPH, USA Discussant: Jonathan M Samet, MD, MS Audience: PH/E, P, I SYM15A: FINDINGS FROM THE SURGEON GENERAL’S REPORT ON E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: HISTORICAL BACKGROUND AND PATTERNS OF USE Presenters: Melissa B Harrell, PhD, MPH; MeLisa Creamer, PhD, MPH; Steven Kelder, PhD; Leslie Norman, MBA; Brian A King, PhD, MPH; Cheryl Perry, PhD SYM15B: FINDINGS FROM THE SURGEON GENERAL’S REPORT ON E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: HEALTH EFFECTS Presenters: Steven Kelder, PhD; Leslie Norman, MBA; Cher- yl Perry, PhD; Melissa Harrell, PhD, MPH; MeLisa Creamer, PhD, MPH; Brian A King, PhD, MPH SYM15C: FINDINGS FROM THE SURGEON GENERAL’S REPORT ON E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: ACTIVITIES OF THE E-CIGARETTE COMPANIES Presenters: MeLisa Creamer, PhD, MPH; Cheryl Perry, PhD; Steven Kelder, PhD; Melissa B Harrell, PhD, MPH; Brian A King, PhD, MPH; Leslie Norman, MBA SYM15D: FINDINGS FROM THE SURGEON GENERAL’S REPORT ON E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS: E-CIGARETTE POLICY AND PRACTICE IMPLICATIONS Presenters: Brian A King, PhD, MPH; Melissa B Harrell, PhD, MPH; Leslie Norman, MBA; MeLisa Creamer, PhD, MPH; Cheryl Perry, PhD; Steven Kelder, PhD Audience: PH/E, P, I 10:30 a.m.-12:00 noon Affari (Ground Floor) Podium Presentation 3 Symposium 16 CYTISINE UPDATE: MOVING RESEARCH FORWARD TOWARD A GLOBALLY AFFORDABLE TOBACCO CESSATION MEDICAITON Chair: Nancy A Rigotti, MD, USA Discussant: Hayden McRobbie, MB, ChB, PhD Audience: C, T, I

62 SRNT 2017 · Florence, Italy

SYM16A: MEASURING PLASMA CYTISINE CONCENTRATIONS, CIGARETTE CRAVING, WITHDRAWAL, SMOKING SATISFACTION AND MOOD TO INVESTIGATE THE CONCENTRATION-EFFECT RELATIONSHIP IN SMOKERS Presenters: SooHee Jeong, PhD; David Newcombe, PhD; Janie Sheridan, PhD; Malcolm Tingle, PhD SYM16B: CYTISINE FOR SMOKING CESSATION IN TB PATIENTS: A MULTI-COUNTRY RANDOMIZED CONTROLLED TRIAL IN SOUTH ASIA Presenters: Kamran Siddiqi, PhD; Omara Dogar, MBBS, MPH SYM16C: CYTISINE VERSUS VARENICLINE FOR SMOKING CESSATION: TWO CLINICAL TRIALS FROM THE AUSTRALASIAN CYTISINE TRIALIST GROUP Presenters: Ryan Courtney, PhD; Natalie Walker, PhD SYM16D: THE REGULATORY SCIENCE OF CYTISINE: RESULTS FROM PRE-CLINICAL GLP-REGULATED SAFETY ASSESSMENT Presenters: David Shurtleff, PhD; Craig Hopp, PhD; Hanna Ng, PhD; Gary W Wolfe, PhD SYM16E: THE CHALLENGE TO GETTING CYTISINE LICENSED FOR USE WORLD-WIDE: POLICY CONSIDERATIONS Presenters: Natalie Walker, PhD, MSc, DPH 10:30 a.m.-12:00 noon Affari (1st Floor) - Room 1 Podium Presentation 3 Symposium 17 EXAMINING LINKS BETWEEN MENTHOL USE AND SMOKING PERSISTENCE IN VULNERABLE POPULATIONS Chair: Jennifer W Tidey, PhD, USA Co-Chair: Laura R Stroud, PhD, USA Discussant: Raymond Niaura, PhD Audience: PC, PH/E, HD, I, LMIC Friday, March 10, 2017 March Friday, SYM17A: MENTHOL TOBACCO USERS’ RESPONSE TO RESTRICTIONS ON MENTHOL CIGARETTES: RESULTS AMONG US YOUNG ADULTS Presenters: Shyanika W Rose, PhD; Amy C Cohn, PhD; Jen- nifer L Pearson, PhD; Ashley Mayo, MPH; Andrea C Villanti, PhD SYM17B: HIGH RATES OF MENTHOL USE IN PREGNANT SMOKERS: PRELIMINARY REPORT FROM TWO PREGNANCY COHORTS Presenters: Laura Stroud, PhD; Chrystal Vergara-Lopez, PhD; Allison Gaffey, PhD; Margaret Bublitz, PhD; Raymond Niaura, PhD SYM17C: MENTHOL EFFECTS ON WITHDRAWAL AND CRAVING IN SMOKERS WITH SCHIZOPHRENIA Presenters: Jennifer W Tidey, PhD; Mollie E Miller, PhD; Rachel L Denlinger, MPH 10:30 a.m.-12:00 noon Affari (1st Floor) - Room 2 Podium Presentation 3 Symposium 18 BEYOND PLAIN PACKAGING: PACK INSERTS AND DISSUASIVE CIGARETTES Chair: David Hammond, PhD, Canada Discussant: Linda Bauld, PhD Audience: P, PC, I, LMIC

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 63 Program · Friday, March 10, 2017

SYM18A: ADULT SMOKERS’ PERCEPTIONS OF CIGARETTE PACK INSERTS WITH CESSATION MESSAGES: A FOCUS GROUP STUDY Presenters: Crawford Moodie, PhD SYM18B: CAN CIGARETTE PACKAGE INSERTS PROMOTE CESSATION-RELATED BELIEFS? AN EXPERIMENT WITH ADULT SMOKERS IN THE US Presenters: James F Thrasher, PhD; Dien Ashari; Farah Islami; David Hammond, PhD; Ramzi Salloum, PhD SYM18C: CONSUMER PERCEPTIONS OF CIGARETTE DESIGN IN FRANCE Presenters: Karine Gallopel-Morvan, PhD; Romain Guignard, PhD; Crawford Moodie, PhD; Figen Eker; Emmanuelle Beguinot; Viet Nguyen-Thanh SYM18D: ADOLESCENT PERCEPTIONS OF DISSUASIVE STICKS: A WEB SURVEY AMONG 16-20 YEAR OLDS IN NORWAY Presenters: Ingeborg Lund; Janne Scheffels, PhD 10:30 a.m.-12:00 noon Palazzo dei Congressi: Verde Podium Presentation 3 Symposium 19 THE BRIGHTER SIDE OF NICOTINE: BEYOND NICOTINE ADDICTION AND TOWARDS DEVELOPMENT OF BENEFICIAL NICOTINIC DRUGS. Chair: Jill Turner, PhD, USA Co-Chair: Kenneth Kellar, PhD, USA Discussant: Mariella DeBiasi, PHD Audience: PC, C, T, I SYM19A: NICOTINIC INVOLVEMENT IN ATTENTION, LEARNING, AND MEMORY: BASIC DISCOVERIES AND THERAPEUTIC DEVELOPMENT. Presenters: Edward Levin, PHD SYM19B: DIVERGENT RESPONSES TO NICOTINE IN MODELS OF ANXIETY MAY REPRESENT DIFFERING CIRCUITRY EFFECTS IN THE HIPPOCAMPUS AND ORBITOFRONTAL CORTEX. Presenters: Jill R Turner, PHD SYM19C: TRANSGENERATIONAL EFFECTS OF NICOTINE AND STRESS: INTERACTIONS ACROSS GENERATIONS. Presenters: Nicole Yohn, PHD; Julie A Blendy, PHD SYM19D: DESENSITIZATION OF NICOTINIC RECEPTORS: THERAPEUTIC IMPLICATIONS FOR OBESITY PHARMACOTHERAPY Presenters: Ghazaul Dezfuli, PHD; Kenneth J Kellar, PHD 10:30 a.m.-12:00 noon Affari (4th Floor) Podium Presentation 3 Paper Session 6 Nicotine and Animal Models Chair: Marina Picciotto, PhD, USA Audience: BS, PC 10:30 a.m. - 10:45 a.m. DEVELOPMENTAL NICOTINE EXPOSURE INDUCES PERSISTENT ALTERATIONS IN ACCUMBENS GLUTAMATERGIC CIRCUITRY Gregory L Powell, PhD*; Julianna Goenaga; Armani Del Franco; Michael C Holter; Raul Garcia; Annika Vannan; Janet L Neisewander, PhD; Cassandra D Gipson, PhD

64 SRNT 2017 · Florence, Italy

10:45 a.m. - 11:00 a.m. TRANSGENERATIONAL EFFECTS OF PATERNAL NICOTINE EXPOSURE ON FEAR RESPONSE AND CHOLINERGIC FUNCTION Munir Gunes Kutlu, PhD.*; Rob Cole; Jessica M Tumolo; Vinay Parikh, PhD; Thomas J Gould, PhD 11:00 a.m. - 11:15 a.m. CHRONIC INTERACTIONS OF SEROTONERGIC AND DOPAMINERGIC TREATMENTS WITH NICOTINE INFUSIONS FOR DECREASING NICOTINE SELF- ADMINISTRATION IN RATS Edward D Levin, PhD*; Devon DiPalma; Blair Willette; Corinne Wells; Susan Slade; Brandon J Hall, PhD; Amir H Rezvani, PhD 11:15 a.m. - 11:30 a.m. NICOTINE WITHDRAWAL-INDUCED ANXIETY AND DEPRESSION-LIKE BEHAVIOR IN C57BL6 MICE: AN ANIMAL MODEL FOR NICOTINE PHYSICAL DEPENDENCE Ranjithkumar Chellian*, M.Pharm*; Vijayapandi Pandy, PhD; Zahurin Mohamed, PhD 11:30 a.m. - 11:45 a.m. EXAMINING SELF-MEDICATION OF NICOTINE IN SCHIZOPHRENIA USING RODENT MODELS OF NICOTINE SELF-ADMINISTRATION FOLLOWING SUB CHRONIC KETAMINE EXPOSURE Mohammed Shoaib, PhD, BSc* 11:45 a.m. - 12:00 noon MENTHOL DECREASES ORAL NICOTINE AVERSION IN C57BL/6 MICE THROUGH A TRPM8-DEPENDENT MECHANISM Sairam V Jabba, DVM, PhD*; Lu Fan, MD, PhD; Shrilatha Balakrishna, PhD; Pamela E Bonner, MS; Seth R Taylor, PhD; Marina R Picciotto, PhD; Sven-Eric Jordt, PhD 10:30 a.m.-12:00 noon Affari (1st Floor) - Auda 1 Podium Presentation 3 10, 2017 March Friday, Paper Session 7 Smoking in Low and Medium Income Countries Chair: Pal-Istvan Kikeli, PhD, Romania Audience: PH/E, P, LMIC 10:30 a.m. - 10:45 a.m. VERY UNSUCCESSFUL ATTEMPTS TO QUIT: EXAMINING CORRELATES IN THE 13 COUNTRIES WHERE ALMOST 2/3 OF SMOKERS LIVE João Mauricio Castaldelli-Maia, MD* 10:45 a.m. - 11:00 a.m. COMPARING PACK DESIGN AND BRANDING APPEALS BETWEEN THE MOST EXPENSIVE AND THE CHEAPEST CIGARETTE PACKS FROM 14 LOW AND MIDDLE INCOME COUNTRIES Katherine C Smith, PhD*; Kevin Welding, PhD; Joanna E Cohen, PhD 11:00 a.m. - 11:15 a.m. SMOKERS’ REACTIONS TO TEXT AND GRAPHIC WARNINGS ON CIGARETTE PACKAGES: FINDINGS FROM ITC AFRICAN COUNTRIES Susan C Kaai, PhD*; Geoffrey T Fong, PhD; Gang Meng, PhD; Anne C.K Quah, PhD; Annika C Green, MPH; Fastone Goma, MD, PHD; Premduth Burhoo, MRes; Jane Ong’ang’o, MD

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 65 Program · Friday, March 10, 2017

11:15 a.m. - 11:30 a.m. SALE OF SINGLE CIGARETTES NEAR PRIMARY AND SECONDARY SCHOOLS IN 10 COUNTRIES Jennifer L Brown, MPH*; Ashley Grant, MPH; Caitlin Weiger; Joanna Cohen, PhD 11:30 a.m. - 11:45 a.m. WATERPIPE SMOKING AMONG EAST-AFRICANS: A COMMUNITY-BASED PARTICIPATORY RESEARCH TRIAL INVESTIGATING THE POTENTIAL ROLE OF RELIGION IN CESSATION Prashasti Bhatnagar, *; Abdi Jibril, MS; Abdullahi Sheikh, MS; Kamran Siddiqi, MBBS,MRCP, MPH, FFPH, PhD; Hemen Muleta, BA; Janet Thomas, PhD, LP 11:45 a.m. - 12:00 noon THE ECONOMICS OF TOBACCO FARMING IN LOW- AND MIDDLE-INCOME COUNTRIES Jeffrey Drope, PhD*; Raphael Lencucha, PhD 10:30 a.m.-12:00 noon Affari (2nd Floor) Podium Presentation 3 Paper Session 8 Smoking and E-Cigarette Use in Pregnancy Chair: Gillian Gould, PhD, Australia Co-Chair: Yael Bar-Zeev, PhD, Australia Audience: PH/E, C, HD, I 10:30 a.m. - 10:45 a.m. SMOKING DURING PREGNANCY IN THE UNITED STATES, 2005-2014: THE ROLE OF PSYCHOLOGICAL DISTRESS AND DEPRESSION Renee D Goodwin, PhD, MPH*; Keely Cheslack-Postava, PhD; Melanie M Wall, PhD; Deborah Hasin, PhD; Deborah Nelson, PhD; Philip Smith, PhD 10:45 a.m. - 11:00 a.m. PREVALENCE OF E-CIGARETTE USE AND CHARACTERISTICS IN A U.S. NATIONALLY REPRESENTATIVE SAMPLE OF PREGNANT WOMEN Allison N Kurti, PhD*; Janice Y Bunn, PhD; Stephen T Hig- gins, PhD; Ryan Redner, PhD; Alexa A. Lopez, PhD; Diana R Keith, PhD; Cassandra A. Stanton, PhD; Diann E. Gaalema, PhD; Nathan J. Doogan, PhD; Antonio Cepeda-Benito, PhD; Megan E. Roberts, PhD 11:00 a.m. - 11:15 a.m. POSTPARTUM CHANGES IN MOOD AND SMOKING- RELATED SYMPTOMATOLOGY: AN INVESTIGATION USING ECOLOGICAL MOMENTARY ASSESSMENT Alicia M Allen, PhD, MPH*; Nicole Tosun, MS; Samantha Carlson, MPH; Sharon Allen, MD, PhD 11:15 a.m. - 11:30 a.m. PREDICTORS OF POSTPARTUM SMOKING RELAPSE INTENT IN A SAMPLE OF ROMANIAN WOMEN Oana M Blaga, MA*; Alexandra Brinzaniuc, MA; Razvan M Chereches, MD, PhD; Cristian I Meghea, PhD 11:30 a.m. - 11:45 a.m. HOW INCENTIVE PROGRAMS FOR PREGNANT INDIGENOUS WOMEN TO QUIT CHANGE IN PRACTICE. Marewa Glover, PhD*; Anette Kira, PhD; Keriata Paterson, PhD

66 SRNT 2017 · Florence, Italy

11:45 a.m. - 12:00 noon THE INFLUENCE OF PARTNER’S SMOKING ON FACTORS ASSOCIATED WITH INTENTION TO QUIT SMOKING AMONG PREGNANT SMOKERS ENROLLED IN A CESSATION INTERVENTION TRIAL Jonathan T Macy, PhD, MPH*; Rachel M Dowty, RN, MPH; Susan E Middlestadt, PhD; Alejandro Arrieta, PhD; Joan Duwve, MD, MPH; Stephen J Jay, MD 12:00 noon-1:30 p.m. Passi Perduti PDC Building Poster Session 3: Public Health 12:00 noon-1:30 p.m. Passi Perduti (Basement - Lowest Level) Lunch Break Pick up your complimentary boxed lunch, starting at 11:45 a.m. 12:00 noon-1:30 p.m. Villa Vittoria: Sala 9 – Terra Piano (Ground Floor) PDC Building Trainee Network Senior Investigator Roundtables 12:15 p.m.-1:15 p.m. Villa Vittoria: Sala 101 – Primo Piano (1st Floor) Meet-the-Editor Robert West, Deputy Editor Addiction Journal 1:30 p.m.-2:00 p.m. Auditorium-General Session Room PDC Building Jarvik-Russell New Investigator Awards Paper Session Ecological Momentary Tobacco Control Thomas R. Kirchner, PhD, Clinical Associate Professor of Public Health, Medicine, and Urban Science at NYU College of Global Public Health, USA 2:00 p.m.- 3:00 p.m. Friday, March 10, 2017 March Friday, Policy Theme Plenary Lecture Population Level Policies to Prevent Chronic Disease: Apply- ing Lessons From Nicotine and Tobacco Research Linda Bauld, Professor of Health Policy, University of Stirling and Chair in Behavioural Research for Cancer Prevention, Cancer Research UK. President-elect of SRNT-Europe 3:00 p.m.-3:30 p.m. Salone Club (Lower level) PDC Building Exhibitor Time (Last time to visit) Refreshment Break - Passi Perduti (Basement - Lowest Level) 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Room 2 Podium Presentation 4 Symposium 20 INCREASING REACH WITHIN AND BEYOND HEALTH CARE SETTINGS TO IMPROVE ACCESS TO TOBACCO USE TREATMENT: LEVERAGING COMMUNITY AND TREATMENT SETTINGS IN ASIA, AUSTRALIA AND THE UNITED STATES Chair: Christine L Paul, PhD, Australia Discussant: Amanda Baker, PhD Audience: C, T, I

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 67 Program · Friday, March 10, 2017

SYM20A: EFFECTIVENESS OF STRATEGIES FOR IMPLEMENTING TOBACCO USE TREATMENT GUIDELINES IN COMMUNITY CENTERS IN VIETNAM Presenters: Nina Siman, MSEd, MA; Nam Truong Nguyen, MD, DrPH; Charles M Cleland, PHD; Nancy VanDevanter, DrPH, RN, EdM, FAAN; Trang Thi Nguyen; Linh Thi Nguyen; Donna Shelley, MD, MPH SYM20B: ADDRESSING TOBACCO USE IN KOREAN AND VIETNAMESE SMOKING PATIENTS IN COMMUNITY HEALTH PRIMARY CARE SETTINGS IN CALIFORNIA, UNITED STATES Presenters: Janice Y Tsoh, PhD; Thu Quach, PhD; Thomas B Duong, BS; Emily (Sa Nan) Park, BS; Ching Wong, BS; Hy Lam, BS; Susan Huang, MS MD; Tung T Nguyen, MD SYM20C: AN ORGANISATIONAL CHANGE INTERVENTION FOR INCREASING THE DELIVERY OF SMOKING CESSATION SUPPORT IN ADDICTION TREATMENT CENTRES Presenters: Billie Bonevski, PhD; Ashleigh Guillaumier, PhD; Anthony Shakeshaft, PhD; Flora Tzelepis, PhD; Catherine D’Este, PhD; Michael Farrell, PhD; Christine L Paul, PhD; Adrian Dunlop; Scott Walsberger; Pete Kelly, PhD; Christo- pher Oldmeadow, PhD; Andrew Searles, PhD SYM20D: EMBEDDING SMOKING CESSATION SUPPORT IN CANCER CARE CLINICS IN NEW SOUTH WALES AUSTRALIA Presenters: Christine L Paul, PhD; Emma Sherwood; Megan Freund, PhD; Ann Dadich, PhD; Bettina Meiser, PhD; Nata- lie Taylor, PhD; Tim Shaw, PhD; Fiona Day, PhD; Megan Varlow; Sanchia Aranda, PhD 3:30 p.m.-5:00 p.m. Affari (2nd Floor) Podium Presentation 4 Symposium 21 E-CIGARETTES AND OTHER GLOBAL TOBACCO EXPOSURES DURING PREGNANCY. Chair: Gillian S Gould, PhD, MA, MBChB, Australia Discussant: Marewa Glover, PhD Audience: PH/E, HD, I SYM21A: ELECTRONIC CIGARETTES IN PREGNANCY: WHAT DO WE KNOW? Presenters: Linda Bauld, PhD SYM21B: ASSESSMENT OF EXCLUSIVE AND DUAL CIGARETTE AND HOOKAH SMOKING AMONG A SAMPLE OF PREGNANT WOMEN IN EGYPT. Presenters: Omar El Shahawy, MD, MPH, PhD; Kareem Labib, MD, MSc; Erin Mead, PhD, MHS; Ahmed Nagib, MD, MSc; Scott Sherman, MD, MPH; Cheryl Oncken, MD, MPH SYM21C: USING SIMULATION MODELING TO EXAMINE PERINATAL HEALTH CONSEQUENCES OF SMOKELESS TOBACCO USE AMONG PREGNANT INDIAN WOMEN. Presenters: Jean J Schensul, PhD; Saritha Nair, PhD; David Lounsbury, PhD SYM21D: ARE AUSTRALIAN CLINICIANS ASKING ABOUT CONTEMPORARY EXPOSURES TO TOBACCO, SMOKING AND NICOTINE DURING PREGNANCY IN AUSTRALIA? A NATIONAL CROSS-SECTIONAL SURVEY. Presenters: Gillian S Gould, PhD, MA, MBChB; Yael Bar- Zeev, MD, MPH; Laura Twyman, PhD; Christopher Old- meadow, PhD; Billie Bonevski, PhD

68 SRNT 2017 · Florence, Italy

3:30 p.m.-5:00 p.m. Auditorium-General Session Room PDC Building Podium Presentation 4 Symposium 22 TOBACCO USE TRANSITIONS AMONG YOUTH AND ADULTS: DESCRIPTIVE LONGITUDINAL DATA FROM WAVES 1 AND 2 OF THE PATH STUDY Chair: Kevin Conway, PhD, USA Co-Chair: Nicolette Borek, PhD, USA Discussant: Gary Giovino, PhD Audience: PH/E SYM22A: TOBACCO USE TRANSITIONS AMONG YOUTH AND ADULTS: DESCRIPTIVE LONGITUDINAL DATA FROM WAVES 1 AND 2 OF THE PATH STUDY Presenters: The PATH Study Team SYM22B: TOBACCO USE TRANSITIONS AMONG YOUTH AND ADULTS: DESCRIPTIVE LONGITUDINAL DATA FROM WAVES 1 AND 2 OF THE PATH STUDY Presenters: The PATH Study Team SYM22C: TOBACCO USE TRANSITIONS AMONG YOUTH AND ADULTS: DESCRIPTIVE LONGITUDINAL DATA FROM WAVES 1 AND 2 OF THE PATH STUDY Presenters: The PATH Study Team 3:30 p.m.-5:00 p.m. Affari (Ground Floor) Podium Presentation 4 Symposium 23 NICOTINE PRELOADING: EFFECTIVENESS AND MECHANISMS Chair: Stuart G Ferguson, PhD, Australia Co-Chair: Paul Aveyard, FRCGP PhD, UK Discussant: Larry Hawk, PhD Audience: C, T, I SYM23A: NICOTINE PRELOADING: A RANDOMISED TRIAL Presenters: Paul Aveyard, FRCGP PhD 10, 2017 March Friday, SYM23B: NICOTINE PRELOADING TRIAL: MEDIATION ANALYSIS Presenters: Peter Hajek, PhD SYM23C: SATISFACTION WITH SMOKING, AND SMOKING REDUCTION, DURING PRE-QUIT TREATMENT WITH NICOTINE PATCH OR VARENICLINE. Presenters: Stuart Ferguson, PhD SYM23D: DOES SMOKING REDUCTION WHILE ON NICOTINE PRELOADING PREDICT CESSATION? FINDINGS FROM THE PRELOADING TRIAL Presenters: Paul Aveyard, FRCGP PhD 3:30 p.m.-5:00 p.m. Affari (4th Floor) Podium Presentation 4 Symposium 24 ADVANCES IN UNDERSTANDING NICOTINE DEPENDENCE IN AFRICAN AMERICAN SMOKERS: A TRANSDISCIPLINARY PERSPECTIVE Chair: Lisa Sanderson Cox, PhD, USA Discussant: Jasjit S. Ahluwalia, MD Audience: PC, C, HD, I, LMIC

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 69 Program · Friday, March 10, 2017

SYM24A: VARENICLINE IS LESS EFFECTIVE IN AFRICAN AMERICAN COMPARED TO CAUCASIAN AMERICAN SMOKERS: RESULTS FROM A PROSPECTIVE STRATIFIED CLINICAL TRIAL Presenters: Nikki L. Nollen, PhD; Lisa Sanderson Cox, PhD; Matthew S. Mayo, PhD; Edward F. Ellerbeck, MD; Taneisha S. Scheuermann, PhD; Rachel F. Tyndale, PhD; Neal L. Benowitz, MD; Jasjit S. Ahluwalia, MD SYM24B: VARIATION IN NICOTINE METABOLISM AND RENAL TRANSPORT ALTER VARENICLINE TREATMENT IN AFRICAN AND CAUCASIAN SMOKERS Presenters: Rachel F. Tyndale, PhD; Annie R. Peng, BSc; Andy ZX. Zhu, PhD; Caryn Lerman, PhD SYM24C: SOCIOPHARMACOLOGICAL PREDICTORS OF TOBACCO WITHDRAWAL AMONGST AFRICAN AMERICANS Presenters: Adam M. Leventhal, PhD; Mariel S. Bello, BS; Mollie S. Pester, BA; Claudia Aguirre, BA; Madalyn M. Liautaud, BA; Matthew D. Stone, BA; Nicolas I. Goldenson, BA; Raina D. Pang, PhD; Matthew G. Kirkpatrick, PhD; Lara A. Ray, PhD 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Auda 1 Podium Presentation 4 Symposium 25 THE ROLE OF RESEARCH IN MEETING FCTC COMMITMENTS TO INDIGNEOUS PEOPLES: WHAT PROGRESS HAVE WE MADE? Chair: Andrew M Waa, MPH, DPH, BSco.Sc, New Zealand Discussant: Patricia N Henderson, MD, MPH Audience: PH/E, P, HD, I, LMIC SYM25A: FRAMEWORK CONVENTION ON TOBACCO CONTROL COMMITMENTS TO PEOPLES: HOW ARE WE DOING? Presenters: Andrew M Waa, MPH, DPH, B.Soc.Sc; Raglan Maddox, Ph.D, MPH, BSc SYM25B: UNDERSTANDING CAUSES OF DISPARITIES FOR INDIGENOUS PEOPLES: THE EXAMPLE OF THE ABORIGINAL AND TORRES STRAIT ISLANDER AUSTRALIANS AND THE TALKING ABOUT THE SMOKES PROJECT Presenters: David Thomas, PhD, MSc, DTM&H, MBBS SYM25C: THE TRIBAL TOBACCO EDUCATION AND POLICY INITIATIVE: FINDINGS FROM A COLLABORATIVE, PARTICIPATORY EVALUATION Presenters: Joanne D’Silva, MPH; Sheryl Scott, MPH; Bar- bara A Schillo, PhD; Nicole Villaluz, BA; Jaime L Martinez, MEd; Carol Hernandez, BA; Chris M Matter, BM SYM25D: INDIGENOUS ENGAGEMENT IN TOBACCO CONTROL RESEARCH: MAORI AND PACIFIC YOUNG ADULT VIEWS ON SMOKING AS AN INFORMED CHOICE Presenters: Heather Gifford, PhD, MPH, DPH; El-Shadan Tautolo, PhD, MHSc, PGDip Forensics, BSc

70 SRNT 2017 · Florence, Italy

3:30 p.m.-5:00 p.m. Affari (2nd Floor) - Auda 2 Podium Presentation 4 Symposium 26 NEW MECHANISTIC AND TRANSLATIONAL VIEWS OF THE HIPPOCAMPUS IN NICOTINE DEPENDENCE AND RELAPSE: EVIDENCE BRIDGING MOUSE AND HUMAN. Chair: Jill R Turner, PhD, USA Discussant: Brett Froeliger, PhD Audience: BS, PC, T SYM26A: ADOLESCENT NICOTINE EXPOSURE DISRUPTS ADULT HIPPOCAMPUS-DEPENDENT LEARNING AND ALTERS METHYLATION OF CHROMATIN-RELATED GENES IN THE DORSAL HIPPOCAMPUS. Presenters: Munir Kutlu; Miri Gitik; Erica Holiday; Yuan Qiaoping; Leung Ming; David Goldman; Thomas Gould, PhD SYM26B: A TRANSLATIONAL VIEW OF THE HIPPOCAMPUS IN NICOTINE DEPENDENCE AND RELAPSE: FROM ANIMAL MODELS TO HUMAN NEUROIMAGING TO CLINICAL INTERVENION. Presenters: F. Joseph McClernon, PHD SYM26C: CORTICOLIMBIC CIRCUITRY FUNCTION MEDIATING NEGATIVE EMOTION REGULATION IS ASSOCIATED WITH LAPSE VULNERABILITY. Presenters: Brett Froeliger, PHD; Christie Eichberg; Spencer Bell; Kevin Gray SYM26D: NICOTINE WITHDRAWAL INDUCED BEHAVIORS ARE DIFFERENTIALLY REGULATED BY CREB ACTIVITY WITHIN THE VENTRAL AND DORSAL HIPPOCAMPUS: POSSIBLE ROLE FOR NRG3 SIGNALING. Presenters: Miranda Fisher; Jill R Turner, PHD 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Room 1 Podium Presentation 4 Paper Session 9 10, 2017 March Friday, Tobacco Product Health Warnings Chair: Sara Hitchman, PhD, UK Audience: PC, P, I, LMIC 3:30 p.m. - 3:45 p.m. OVER-TIME IMPACTS OF NOVEL PICTORIAL HEALTH WARNING LABELS AND THEIR DIFFERENCES ACROSS SMOKER SUBGROUPS: RESULTS FROM SMOKERS IN AUSTRALIA AND CANADA Farahnaz Islam, MSPH*; James F Thrasher, PhD; Kamala Swayampakala, PhD; Hua Yong, PhD; Ron Borland, PhD; James W Hardin, PhD; Lin Li, PhD; David Hammond, PhD 3:45 p.m. - 4:00 p.m. MONITORING COMPLIANCE OF CIGARETTE PACK GRAPHIC HEALTH WARNING LABELS THREE MONTHS AFTER IMPLEMENTATION OF INDIA’S NEW HEALTH WARNING LABELS LAW Ernesto M Sebrie, MD, MPH*; Teresa E DeAtley, MPH; Van- dana Shah, LLM; Seema Gupta, MSW; Bhavna B Mukhopad- hyay, MS; Karoline Walter; Deirdre L Kittner, PhD, MPH 4:00 p.m. - 4:15 p.m. CHARACTERIZING SOCIAL INTERACTIONS ABOUT PICTORIAL WARNINGS ON CIGARETTE PACKS Jennifer C Morgan, MPH*; Seth M Noar, PhD; Kurt M Ribisl, PhD; Noel T Brewer, PhD

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 71 Program · Friday, March 10, 2017

4:15 p.m. - 4:30 p.m. LONGITUDINAL EFFECT OF EMOTIONAL GRAPHIC WARNING LABELS ON THE BRAIN An-Li Wang, Ph.D.*; Zhenhao Shi, Ph.D.; Victoria Fairchild; Catherine Aronowitz; Daniel Langleben 4:30 p.m. - 4:45 p.m. CHARACTERISTICS OF WARNING STATEMENTS PRINTED ON ELECTRONIC CIGARETTE LIQUID BOTTLES MANUFACTURED AND DISTRIBUTED IN THE UNITED STATES Pebbles Fagan, PhD, MPH*; Pallav Pokhrel, PhD, MPH; Thaddeus A Herzog, PhD; Mignonne C Guy, PhD; Kari-Lyn K Sakuma, PhD, MPH; Dennis R Trinidad, PhD, MPH; Kevin D Cassel, DrPH, MPH; Dorothy Jorgensen, MPH; Tania Lynch, MSN, MPH; Jamie Q Felicitas-Perkins, MPH; Sherilyn Palafox, BS;Faith Hamamura, BS;Sarah Maloney, BA; Kaylah Degree, BA;Thomas Eissenberg, PhD 4:45 p.m. - 5:00 p.m. EVALUATION OF WAYS TO COMMUNICATE HARMFUL AND POTENTIALLY HARMFUL CONSTITUENTS (HPHC) INFORMATION ON PRODUCT INSERTS: A DISCRETE CHOICE EXPERIMENT Ramzi G Salloum, PhD*; Jordan Louviere, PhD; Kayla R Getz, MPH; Farahnaz Islam; David Hammond, PhD; Richard J O’Connor, PhD; James F Thrasher, PhD 3:30 p.m.-5:00 p.m. Palazzo dei Congressi: Verde Podium Presentation 4 Paper Session 10 Attitudes Toward SH Exposure Policies Chair: Monica Tarcea, MD, PhD, Romania Audience: OH/E, P, I, LMIC 3:30 p.m. - 3:45 p.m. HOUSEHOLD SMOKING BANS AND YOUTH SMOKING BEHAVIOUR IN ITALY: FINDINGS FROM THE SIDRIAT LONGITUDINAL STUDY Giuseppe Gorini, MD*; Giulia Carreras, PhD; Barbara Cortini, BSc; Simona Verdi, BSc; Maria Grazia Petronio, MD; Pier- sante Sestini, MD; Elisabetta Chellini, MD 3:45 p.m. - 4:00 p.m. VALIDITY OF REPORTED MEASURES OF SECONDHAND SMOKE EXPOSURE IN INDIAN HOUSEHOLDS: MISHRI PREPARATION A POTENTIALLY OVERLOOKED SOURCE IN LOW-INCOME INDIAN COMMUNITIES Jessica L Elf, PhD MPH*; Aarti Kinikar; Sandhya Khadse; Vidya Mave; Nikhil Gupte; Nishi Suryavanshi; Priyanka Rai- chur; Joanna Cohen; Patrick Breysse; Amita Gupta; Jonathan Golub 4:00 p.m. - 4:15 p.m. KIDS SAFE AND SMOKEFREE: PARENTS’ SELF- EFFICACY, NOT COPING SKILLS OR HOME SMOKING RESTRICTIONS, MEDIATES COUNSELING TREATMENT EFFECTS ON LOW-INCOME PARENTS’ SMOKING CESSATION Bradley N. Collins, PhD*; Stephen J. Lepore, PhD; Donna L. Coffman, PhD 4:15 p.m. - 4:30 p.m. PREDICTORS OF AFFORDABLE HOUSING RESIDENTS’ SUPPORT FOR A SMOKING BAN, PRE- AND POST- ADOPTION Vaughan W. Rees, PhD*

72 SRNT 2017 · Florence, Italy

4:30 p.m. - 4:45 p.m. THE EFFECT OF A SMOKING BAN IN CASINOS ON ADMISSIONS AND REVENUE John A Tauras, PhD*; Frank J. Chaloupka, PhD 4:45 p.m. - 5:00 p.m. RESTRICTIONS ON THE USE OF E-CIGARETTES IN PUBLIC AND PRIVATE PLACES - CURRENT PRACTICE AND SUPPORT AMONG ADULTS IN GREAT BRITAIN Leonie S Brose, PhD*; Ann McNeill, PhD; Deborah Arnott, MBA; Hazel Cheeseman, MSc 5:00 p.m.-6:00 p.m. Villa Vittoria: Sala Onice – Ground Floor Meet-the-Editor Scott Leischow, Editor-in-Chief Tobacco Regulatory Science Journal 5:00 p.m.-6:00 p.m. Passi Perduti PDC Building Poster Session 4: Public Health 7:30 p.m.-10:30 p.m.

SRNT-E Gala Dinner (RSVP and additional fee required) Friday, March 10, 2017 March Friday,

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 73 SRNT 2017 · Florence, Italy

74 SRNT 2017 · Florence, Italy

75 SRNT 2017 · Florence, Italy

76 SRNT 2017 · Florence, Italy

SESSION SUMMARY SATURDAY MARCH 11, 2017 Saturday, March 11, 2017 March Saturday,

77 SRNT 2017 · Florence, Italy

78 SRNT 2017 · Florence, Italy

SATURDAY, MARCH 11, 2017

8:00 a.m.-11:00 a.m. Piazza Adua (Reception Area) Registration 8:00 a.m.-11:00 a.m. Retropresidenza (Passi Perduti - Lowest Level) PDC Building Speaker Ready Room 8:15 a.m.- 8:45 a.m. Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor) PDC Building SRNT Members Meeting 9:00 a.m.-10:30 a.m. Affari (2nd Floor) - Auda 2 Podium Presentation 5 Symposium 27 UNDERSTANDING DIVERSE PATTERNS OF POLY-TOBACCO AND CANNABIS PRODUCT USE AMONG YOUTH AND YOUNG ADULTS: LONGITUDINAL DATA FROM FOUR TOBACCO CENTERS FOR REGULATORY SCIENCE Chair: Suchitra Krishnan-Sarin, PhD, USA Co-Chair: Adam M Leventhal, PhD, USA Discussant: Robin J Mermelstein, PhD Audience: PH/E, HD SYM27A: CIGAR USE AND SUBSEQUENT CIGARETTE INITIATION Presenters: Grace Kong, PhD; Jessica L Barrington-Trimis, PhD; Margaret Mayer, MPH; Rob McConnell, MD; Adam M Leventhal, PhD; Suchitra Krishnan-Sarin, PhD SYM27B: E-CIGARETTE USE AND PROGRESSION TO CIGARETTE SMOKING AND DUAL PRODUCT USE Presenters: Jessica L Barrington-Trimis, PhD; Grace Kong, PhD; Adam M Leventhal, PhD; Tess Boley Cruz, PhD; Suchitra Krishnan-Sarin, PhD; Rob McConnell, MD Saturday, March 11, 2017 March Saturday, SYM27C: E-CIGARETTE AND COMBUSTIBLE TOBACCO PRODUCT USE AMONG YOUTH: WHICH COMES FIRST? Presenters: Melissa B Harrell, PhD; Christian D Jackson, MS; Joanne E Delk, MS; MeLisa Creamer, PhD; Cheryl L Perry, PhD SYM27D: ADOLESCENT MARIJUANA AND TOBACCO USE: OLD AND NEW CO-MORBIDITIES Presenters: Janet Audrain-McGovern, PhD; Jessica L Barrington-Trimis, PhD; Adam M Leventhal, PhD 9:00 a.m.-10:30 a.m. Affari (1st Floor) - Auda 1 Podium Presentation 5 Symposium 28 PRODUCT STANDARDS FOR CIGARETTES: MODELS TO ACHIEVE MAXIMUM PUBLIC HEALTH BENEFIT Chair: Irina Stepanov, PhD, USA Co-Chair: Dorothy Hatsukami, PhD, USA Discussant: Jack E Henningfield, PhD Audience: PC, P, I SYM28A: ESTABLISHING LIMITS FOR CIGARETTE SMOKE CONSTITUENT LEVELS PER MILLIGRAM NICOTINE Presenters: Irina Stepanov, PhD; Dorothy Hatsukami, PhD

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 79 Program · Saturday, March 11, 2017

SYM28B: REDUCING THE NICOTINE CONTENT TO MAKE CIGARETTES LESS ADDICTIVE Presenters: Neal L. Benowitz, MD SYM28C: CIGARETTE PHYSICAL DESIGN FEATURES THAT INCREASE PRODUCT ELASTICITY Presenters: Reinskje Talhout, PhD; Patricia Richter, PhD; Irina Stepanov, PhD; Christina Watson; Clifford Watson, PhD SYM28D: PROMISES AND PERILS OF POTENTIAL REGULATORY OPTIONS FOR CIGARETTES Presenters: Jack E. Hennigfield, PhD 9:00 a.m.-10:30 a.m. Auditorium-General Session Room PDC Building Podium Presentation 5 Symposium 29 E-CIGARETTES AND E-LIQUIDS: EVALUATING THE EFFECTS OF CONSTITUENTS Chair: Andrea King, PhD, USA Co-Chair: Suchitra Krishnan-Sarin, PhD, USA Discussant: Stephanie O’Malley, PhD Audience: PC, P, I SYM29A: IMPACT OF VARIOUS PRODUCT CHARACTERISTICS ON POTENTIAL INHALATION TOXICITY OF ELECTRONIC NICOTINE DELIVERY DEVICES (ENDS) Presenters: Maciej L Goniewicz, PhD SYM29B: CUE EXPOSURE EFFECTS OF 2ND AND 3RD GENERATION E-CIGARETTES AND ROLE OF E-LIQUID VEGETABLE GLYCERIN CONCENTRATIONS Presenters: Andrea King, PhD; Megan Howe, BS; Luke Newell; Patrick Mcnamara; Dingcai Cao SYM29C: IMPACT OF E-LIQUID FLAVORS ON NICOTINE INTAKE AND PHARMACOLOGY OF ELECTRONIC CIGARETTES Presenters: Neal Benowitz, MD; Gideon St.Helen, PhD SYM29D: INTERACTIVE EFFECTS OF MENTHOL AND NICTOINE AMONG YOUTH; AN EXAMINATION USING E-CIGARETTES Presenters: Suchitra Krishnan-Sarin, PhD; Stephanie O’Malley, PhD; Grace Kong, PhD; Dana Cavallo, PhD; Ral- itza Gueorguieva, PhD 9:00 a.m.-10:30 a.m. Affari (2nd Floor) Podium Presentation 5 Symposium 30 IS SMOKING CESSATION CLINICAL PRACTICE HAMPERED BY OUTDATED REGULATION OF PHARMACOTHERAPIES? Chair: Renee Bittoun, , Australia Discussant: Karl-Olov Fagerstrom, PhD Audience: C, T, P, I SYM30A: THE CONTROVERSY BETWEEN IMPLEMENTATION OF EVIDENCE BASED KNOWLEDGE AND MEDICATION LABELING IN THE EUROPEAN UNION. Presenters: Ivan Berlin SYM30B: REGULATORY CONSTRAINTS ON NRT IN THE US Presenters: Saul Shiffman, PhD SYM30C: IMPLEMENTING CHANGES IN PATIENT INFORMATION: THE AUSTRALIAN EXPERIENCE Presenters: Renee Bittoun

80 SRNT 2017 · Florence, Italy

9:00 a.m.-10:30 a.m. Palazzo dei Congressi: Verde Podium Presentation 5 Paper Session 11 Public Education Campaigns Chair: Richard Edwards, PhD, New Zealand Co-Chair: Leon Kosmider, PhD, Poland Audience: PH/E. P, HD, I 9:00 a.m. - 9:15 a.m. OUTCOME EVALUATION RESULTS FOR FDA’S THE REAL COST CAMPAIGN: IMPACT ON YOUTH’S RISK PERCEPTIONS, BELIEFS ABOUT SMOKING AND SMOKING BEHAVIORS Tesfa Alexander, PhD*; Jennifer Duke, PhD; Matthew Farrelly; Anna MacMonegle; James Nonnemaker, PhD; Xiaoquan Zhao, PhD; Pamela Rao, PhD; Janine Delahanty, PhD 9:00 a.m. - 9:15 a.m. DIGITAL EXPOSURE TO ANTI-SMOKING MESSAGING AND SMOKING-RELATED ATTITUDES AND INTENTIONS TO SMOKE Donna M Vallone, PhD, MPH*; Jennifer Cantrell, DrPH, MPA; Michael J Halenar, MPH; Haijun Xiao, MS; Jessica M Rath, PhD, MPH, CHES; Elizabeth C Hair, PhD, MA 9:15 a.m. - 9:30 a.m. CAN TV MASS MEDIA CAMPAIGNS LEAD TO CHANGES IN SMOKING BEHAVIOUR IN SCOTLAND? A STRUCTURAL VECTOR AUTOREGRESSION ANALYSIS Houra Haghpanahan, PhD*; Daniel Mackay; Jill Pell; David Bell; Tessa Langley; Sally Haw 9:30 a.m. - 9:45 a.m. A COST-EFFECTIVENESS ANALYSIS OF INCREASING THE DOSE OF TELEVISION ADVERTISING IN A NATIONAL ANTISMOKING MEDIA CAMPAIGN: RESULTS FROM A RANDOMIZED FIELD TRIAL Xin Xu, PhD*; Sean Simpson, MA; Deesha Patel, MPH; James Nonnemaker, PhD; Shanna Cox, MSPH; Kevin Davis, MA; Tim McAfee, MD 11, 2017 March Saturday, 10:00 a.m. - 10:15 a.m. ASSOCIATION BETWEEN MEDIA DOSES OF THE TIPS FROM FORMER SMOKERS™ CAMPAIGN AND CESSATION BEHAVIORS AND INTENTIONS TO QUIT AMONG CIGARETTE SMOKERS, 2012–2015 Kevin Davis, MA*; Deesha Patel, MPH; Shanna Cox, MSPH; Rebecca Glover-Kudon, PhD, MSPH; Paul Shafer, MA; Wil- liam Ridgeway, MA; Jennifer Duke, PhD 10:15 a.m. - 10:30 a.m. BRAIN PROCESSES INVOLVED IN SELF-RELATED PROCESSING DURING MESSAGE EXPOSURE ALSO USED DURING RECALL OF “THE REAL COST“ ANTI- SMOKING CAMPAIGN Elissa C Kranzler, MA, MSEd*; Ralf Schmaelzle, PhD; Rui Pei; Matthew B O’Donnell, PhD; Emily B Falk, PhD 9:00 a.m.-10:30 a.m. Affari (Ground Floor) Podium Presentation 5 Paper Session 12 Prenatal Exposure to Tobacco, E-Cigarettes and Marijuana Chair: Cheryl Oncken, PhD, USA Audience: BS, PC, HD

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 81 Program · Saturday, March 11, 2017

9:00 a.m. - 9:18 a.m. PRENATAL SMOKING EXPOSURE AND THE RISK FOR PSYCHIATRIC MORBIDITY IN SINGLETON SIBLING PAIRS Mikael Ekblad, MD, PhD*; Liisa Lehtonen; Jyrki Korkeila; Mika Gissler 9:18 a.m. - 9:36 a.m. PRENATAL TOBACCO AND MARIJUANA EXPOSURE AND ADULT USE OF ALTERNATE TOBACCO PRODUCTS AND BLUNTS Natacha M De Genna, PhD*; Lidush Goldschmidt, PhD; Nancy L Day, PhD; Marie D Cornelius, PhD 9:36 a.m. - 9:54 a.m. PRENATAL TOBACCO EXPOSURE AND ADULT ELECTRONIC CIGARETTE USE Natacha M De Genna, PhD*; Lidush Goldschmidt, PhD; Nancy L Day, PhD; Marie D Cornelius, PhD 9:54 a.m. - 10:12 a.m. PHYSIOLOGICAL REGULATION DURING THE FIRST YEAR OF LIFE AMONG INFANTS PRENATALLY EXPOSED TO CIGARETTES AND MARIJUANA Pamela Schuetze, PhD*; Rina D Eiden, PhD; Marilyn A Huestis 10:12 a.m. - 10:30 a.m. PRENATAL TOBACCO AND CANNABIS EXPOSURE AND TODDLER EMOTION REGULATION: MEDIATING ROLE OF AUTONOMIC REGULATION IN INFANCY Rina D Eiden, PhD*; Pamela Schuetze, PhD; Shannon Shisler, MA; Marilyn A Huestis, PhD 9:00 a.m.-10:30 a.m. Affari (4th Floor) Podium Presentation 5 Paper Session 13 Endgame Strategies For Tobacco Use Chair: Raydel Valdes-Saldago, PhD, Mexico Audience: P, I, LMIC 9:00 a.m. - 9:15 a.m. CAN ENDGAME INTERVENTIONS ACHIEVE A TOBACCO- FREE WORLD BY 2040? AND WITH WHAT QALY GAINS AND COST SAVINGS? Frederieke Sanne van der Deen*; Nick Wilson, MPH; Christine L Cleghorn, PhD; Giorgi Kvizhinadze, PhD; Linda J Cobiac, PhD; Tony Blakely, PhD 9:30 a.m. - 9:45 a.m. YOUNG ADULT SMOKERS’ PERCEPTIONS OF ENDGAME INTERVENTIONS: A QUALITATIVE ANALYSIS Janet Hoek*; Jude Ball; Heather Gifford; El-Shadan Tautolo; Richard Edwards; Stephanie Erick; Teresa Taylor 9:45 a.m. - 10:00 a.m. COULD SOCIAL MOVEMENTS GALVANISE ENDGAME MOMENTUM? Janet Hoek*; Richard Edwards 9:00 a.m.-10:30 a.m. Affari (1st Floor) - Room 2 Podium Presentation 5 Paper Session 14 Exposure to Tobacco and E-Cigarette Advertising Chair: Derek Cheung, PhD, Hong Kong Audience: PH/E, P, HD, I

82 SRNT 2017 · Florence, Italy

9:00 a.m. - 9:15 a.m. CIGARETTE PACKAGING TECHNOLOGY GIMMICKS: HOW TOBACCO COMPANIES MARKET PRODUCT TECHNOLOGY AND INNOVATION IN 14 COUNTRIES Carmen C Washington, MPH*; Joanna Cohen, PhD; Kevin Welding, PhD; Katherine Smith, PhD 9:15 a.m. - 9:30 a.m. YOUNG ADULT PERCEPTIONS OF THE BRITISH AMERICAN TOBACCO NEW ZEALAND AGREE/DISAGREE PLAIN PACKAGING COUNTER-CAMPAIGN Judith P McCool, PhD, MPH*; Becky Freeman, PhD; Cecilia Wong-Cornell, MPH 9:30 a.m. - 9:45 a.m. RESIDENTIAL VENDOR PROXIMITY AND REGULAR ADOLESCENT TOBACCO USE: THE WALKABILITY FACTOR? Mary Ann Pentz, PhD, MA*; Robert Urman; Feifei Liu; Jessica Barrington-Trimis, PhD, MS, MA; Jimi Huh, PhD; Tess B. Cruz, PhD; John Wilson, PhD, MS; Rob S. McConnell, MD 10:00 a.m. - 10:15 a.m. EXPOSURE TO POINT-OF-SALE MARKETING AND PRODUCT DISPLAYS OF CIGARETTES AND E-CIGARETTES AS A PREDICTOR OF SMOKING CESSATION Dale S Mantey, MPA*; Keryn E Pasch, Phd, MPA; Alexandra Loukas, PhD; Cheryl L Perry, PhD 10:15 a.m. - 10:30 a.m. ELECTRONIC CIGARETTE TV ADVERTISING: AMOUNT AND CONTENT AND THEIR IMPACT ON E-CIGARETTE USE Jidong Huang, PhD*; Glen Szczypka, MA; Steven Binns, MA; Frank Chaloupka, PhD; Sherry Emery, PhD 9:00 a.m.-10:30 a.m. Affari (1st Floor) - Room 1 Podium Presentation 5

Paper Session 15 11, 2017 March Saturday, Smoking Cessation in Vulnerable Populations Chair: Daniel Kotz, PhD, MsC, MPH, Germany Audience: C, T, HD, I, LMIC 9:00 a.m. - 9:15 a.m. ARE MODEST FINANCIAL INCENTIVES FOR SMOKING CESSATION AND TREATMENT ENGAGEMENT IN ADULT LOW-INCOME MEDICAID MEMBERS EFFECTIVE: RESULTS OF A REAL WORLD STUDY David L Fraser, MS*; Michael C Fiore, MD, MPH, MBA; Kathleen Kobinsky, MS; Stevens S Smith, PhD; Timothy B Baker, PhD 9:15 a.m. - 9:30 a.m. PSYCHOLOGICAL AND BEHAVIORAL MEDIATORS OF A MULTILEVEL INTERVENTION TO REDUCE TOBACCO SMOKE EXPOSURE IN LOW-INCOME CHILDREN LIVING WITH A SMOKER Stephen J. Lepore, PhD*; Bradley N. Collins, PhD; Donna L. Coffman, PhD 9:30 a.m. - 9:45 a.m. SEXUAL AND GENDER MINORITY DISCRIMINATION AND PERCEIVED SMOKER-RELATED STIGMA: ASSOCIATIONS WITH SMOKING BEHAVIORS AMONG SEXUAL AND GENDER MINORITY CURRENT OR FORMER SMOKERS Sharon Lipperman-Kreda, PhD*; Tamar MJ Antin, DrPH

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 83 Program · Saturday, March 11, 2017

9:45 a.m. - 10:00 a.m. PROMOTING SMOKING CESSATION AMONG VIETNAMESE AMERICANS USING A FAMILY-BASED LAY HEALTH WORKER INTERVENTION: A CLUSTER RANDOMIZED CONTROLLED TRIAL Janice Y Tsoh, PhD*; Nancy J Burke, PhD; Ginny Gildengorin, PhD; Khanh Le, MD, MPH; Ching Wong, BS; Jin Kim, PhD; Stephen J. McPhee, MD; Tung T Nguyen, MD 10:00 a.m. - 10:15 a.m. PREDICTORS OF SUCCESSFUL CESSATION FOR SMOKERS UNDER COMMUNITY CORRECTIONS SUPERVISION: THE IMPORTANCE OF MEDICATION ADHERENCE Karen L Cropsey, Psy.D.*; Brendan Clark, Ph.D.; Adrienne C Lahti, M.D.; Peter S Hendricks, Ph.D. 10:15 a.m. - 10:30 a.m. EXAMINING THE EFFECTS OF SUBSTANCE USE ON TOBACCO CESSATION OUTCOMES IN THE HELPING HAND 2 RANDOMIZED CONTROLLED TRIAL Joanna M Streck, B.A.*; Yuchiao Chang; Susan Regan; Jen- nifer K Kelley; Nancy A Rigotti 10:30 a.m.- 11:00 a.m. Passi Perduti (Basement - Lowest Level) PDC Building Refreshment Break 10:30 a.m.-11:30 a.m. Villa Vittoria: Sala Onice – Ground Floor Meet-the-Editor Renee Bittoun, Deputy Editor Journal of Smoking Cessation Journal 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Room 1 Podium Presentation 6 Symposium 31 ROLL YOUR OWN CIGARETTES: SHINING A LIGHT ON A NEGLECTED ASPECT OF THE SMOKING EPIDEMIC Chair: Richard Edwards, MPH MD, New Zealand Discussant: Ron Borland, PhD Audience: PH/E, HD, I, LMIC SYM31A: SMOKING OF ROLL-YOUR-OWN CIGARETTES IN THE UNITED STATES - LABORATORY STUDIES Presenters: Wallace Pickworth, PhD; Gillian Schauer, PhD; Erica Peters, PhD SYM31B: ROLL-YOUR-OWN CIGARETTES IN IRELAND: KEY PATTERNS AND TRENDS Presenters: David S Evans, PhD; Anne O’Farrell, PhD; Paul Hickey, MA SYM31C: PATTERNS OF ROLL-YOUR-OWN TOBACCO USE AMONG ADOLESCENTS AND YOUNG ADULTS IN NEW ZEALAND Presenters: Richard Edwards, MPH MD; Ben Healey, PhD; Janet Hoek, PhD SYM31D: HOW DO YOUNG ADULT ROLL-YOUR-OWN SMOKERS MANAGE NEGATIVE STEREOTYPES? Presenters: Janet Hoek, PhD; Shelagh Ferguson, PhD; Erin Court, BA; Karine Gallopel-Morvan, PhD

84 SRNT 2017 · Florence, Italy

11:00 a.m.-12:30 p.m. Affari (1st Floor) - Room 2 Podium Presentation 6 Symposium 32 ATTITUDES AND PERCEPTIONS TOWARD A REDUCED NICOTINE PRODUCT STANDARD FOR CIGARETTES Chair: Jennifer W Tidey, PhD, USA Co-Chair: Melissa Mercincavage, PhD, USA Discussant: Dorothy K Hatsukami, PhD Audience: PC, PH/E, P, I SYM32A: PERCEIVED NICOTINE CONTENT OF REDUCED NICOTINE CONTENT CIGARETTES AND MENTHOL STATUS AS CORRELATES OF PERCEIVED HEALTH RISKS Presenters: Lauren R Pacek, PhD; F. Joseph McClernon, PhD; Rachel L Denlinger-Apte, MPH; Melissa Mercincavage, PhD; Andrew A Strasser, PhD; Ryan Vandrey, PhD; Tracy T Smith, PhD; Natalie Nardone, PhD; Dorothy K Hatsukami, PhD; Joseph S Koopmeiners, PhD; Rachel V Kozink, MS; Eric C Donny, PhD SYM32B: EFFECTS OF NICOTINE DOSE IN CIGARETTES ON PERCEIVED HEALTH RISK AND SUBJECTIVE RESPONSE IN ADOLESCENT SMOKERS Presenters: Rachel N Cassidy, PhD; Rachel L Denlinger-Apte, MPH; Suzanne M Colby, PhD; Jennifer W Tidey, PhD; Kristina Jackson, PhD; Patricia A Cioe, PhD; Suchitra Krishnan-Sarin, PhD; Dorothy K Hatsukami, PhD SYM32C: IDENTIFYING THEMES OF RISK PERCEPTION IN SMOKERS WHO HAVE NEVER USED REDUCED NICOTINE CIGARETTES Presenters: Melissa Mercincavage, PhD; Megan L Saddleson, PhD; Kirsten Lochbuehler, PhD; Andrew A Strasser, PhD SYM32D: ACCEPTABILITY OF A REDUCED NICOTINE PRODUCT STANDARD FOR CIGARETTES AMONG SMOKERS PROVIDED WITH REDUCED NICOTINE CIGARETTES FOR SIX-WEEKS Presenters: Rachel L Denlinger-Apte, MPH; Jennifer W Tidey, PhD; Joseph S Koopmeiners, PhD; Dorothy K Hatsukami, 11, 2017 March Saturday, PhD; Eric C Donny, PhD 11:00 a.m.-12:30 p.m. Affari (2nd Floor) Podium Presentation 6 Symposium 33 NICOTINE ADDICTION AND WITHDRAWAL: INTEGRATING GENETIC, PHENOTYPIC, AND PHARMACOLOGIC FINDINGS Chair: Henry R. Kranzler, MD, USA Discussant: Caryn Lerman, PhD Audience: BS, PC, C, T, I SYM33A: GENETICS OF NICOTINE WITHDRAWAL SYMPTOMS Presenters: Joel Gelernter, MD SYM33B: GENOMEWIDE ASSOCIATION ANALYSIS FOR FTND SCORE SHOWS CHR. 14 SIGNAL IS ATTRIBUTABLE TO TIME TO FIRST MORNING CIGARETTE Presenters: Henry R Kranzler, MD SYM33C: CHRNA5 CRITICALLY REGULATES NICOTINE’S INFLUENCE OVER THE DOPAMINERGIC SYSTEM Presenters: Mariella De Biasi, PhD

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 85 Program · Saturday, March 11, 2017

SYM33D: IDENTIFICATION OF NOVEL GENETIC FACTORS ASSOCIATED WITH CYP2A6, NICOTINE METABOLITE RATIO AND SMOKING CESSATION OUTCOMES IN AFRICAN AND CAUCASIAN AMERICAN SMOKERS Presenters: Rachel Tyndale, PhD 11:00 a.m.-12:30 p.m. Palazzo dei Congressi: Verde Podium Presentation 6 Symposium 34 EMERGING METHODS FOR CHARACTERIZATION OF NEW AND MANIPULATED TOBACCO PRODUCTS Chair: Pamela I Clark, PhD, USA Discussant: Mirjana Djordjevic, PhD Audience: BS, PC, I SYM34A: THE CIGARETTE MICROBIOTA IS INFLUENCED BY BRAND, MENTHOLATION AND STORAGE CONDITIONS: IMPLICATIONS FOR POTENTAIL EXPOSURE TO TOBACCO-SPECIFIC NITORSAMINES AND BACTERIAL PATHOGENS Presenters: Emmanuel F Mongodin, PhD; Amy R Sapkota, PhD SYM34B: EMERGING ELECTROENCEPHALOGRAPHIC/ EVENT-RELATED POTENTIAL METHODS: POTENTIAL FOR EVALUATING NEW AND MANIPULATED TOBACCO PRODUCTS Presenters: Edward Bernat, PhD SYM34C: USING NOVEL TECHNIQUES TO IDENTIFY HARMFUL EXPOSURES FROM TOBACCO PRODUCTS Presenters: Marielle C Brinkman, BS SYM34D: SWEET FLAVORS IN ELECTRONIC CIGARETTES Presenters: Hyoshin Kim, PhD 11:00 a.m.-12:30 p.m. Affari (2nd Floor) - Auda 2 Podium Presentation 6 Symposium 35 INNOVATIVE BRAIN STIMULATION TECHNIQUES FOR TREATING TOBACCO DEPENDENCE Chair: Christine E Sheffer, PhD, USA Discussant: Warren K Bickel, PhD Audience: PC, C, T SYM35A: CAN TRANSCRANIAL MAGNETIC STIMULATION BE USED TO ENHANCE COGNITIVE BEHANVIORAL THERAPY FOR SMOKING CESSATION? Presenters: Andreas J Fallgatter, MD; Alica Dieler; Thomas Dresler; Ann-Christine Ehlis; Florian Haeussing; Agnes Kroc- zek; Martin Herrmann SYM35B: THE FEASIBILITY OF ENHANCING SMOKING RELAPSE PREVENTION WITH TRANSCRANIAL MAGNETIC STIMULATION Presenters: Christine E Sheffer, PhD; Warren K Bickel, PhD; Thomas H Brandon, PhD; Christopher T Franck, PhD; Luana Panissidi, MA; Syed A Abdali, MS; Sara E Lunden, MPH; Neelam Prashad, BA; Antonio Mantovani, MD, PhD SYM35C: TRANSCRANIAL MAGNETIC STIMULATION FOR SMOKING CESSATION: A DOUBLE-BLIND, SHAM- CONTROLLED, RANDOMIZED TRIAL Presenters: Xingbao Li, MD; Mark S George, MD; Kathleen T Brady, MD, PhD; Karen J Hartwell, MD; Scott Henderson, BS

86 SRNT 2017 · Florence, Italy

SYM35D: TRANSLATING BASIC SCIENCE KNOWLEDGE OF NEURAL CIRCUITS TO TREATMENT OPTIONS FOR TOBACCO DEPENDENCE Presenters: Collen A Hanlon, PhD SYM35E: CONTINUOUS THETA BURST TMS AS A TOOL TO CHANGE DECISION-MAKING IN SMOKERS Presenters: Sarah E Snider, PhD; Colleen A Hanlon, PhD; Jeff S Stein, PhD; Warren K Bickel, PhD 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Auda 1 Podium Presentation 6 Symposium 36 UNDERSTANDING AND INTERVENING ON ALCOHOL USE IN SMOKERS WHO DRINK HEAVILY Chair: Christopher W. Kahler, PhD, USA Discussant: Peter Selby, MD Audience: PC, PH/E, HD, I SYM36A: DAILY FLUCTUATIONS IN SMOKING TEMPTATION AND THE IMPACT OF ALCOHOL USE ON THE TEMPTATION-SMOKING CONNECTION IN HEAVY DRINKING SMOKERS: RESULTS FROM AN IVR STUDY Presenters: Amy Cohn, PhD; Hoda Elmasry, MPH; Stephen Armeli, PhD; Sarah Ehlke, MS, MA; Thomas Brandon, PhD SYM36B: AN INTEGRATED BEHAVIORAL INTERVENTION FOR HEAVY-DRINKING SMOKERS: RESULTS FROM A RANDOMIZED PILOT STUDY Presenters: Lisa M. Fucito, PhD; Tess Hanrahan; Kathleen Carroll; Srinivas Muvvala; Stephanie O’Malley SYM36C: A DOUBLE-BLIND RANDOMIZED PLACEBO- CONTROLLED TRIAL OF ORAL NALTREXONE FOR HEAVY DRINKING SMOKERS SEEKING SMOKING CESSATION TREATMENT Presenters: Christopher W. Kahler, PhD; Patricia Cioe, PhD; Golfo Tzilos; Nichea Spillane; Lorenzo Leggio; Susan Ramsey; Richard Brown; Stephanie O’Malley SYM36D: VARENICLINE EFFECTS ON ALCOHOL 11, 2017 March Saturday, DRINKING, SMOKING, AND EXPLICIT AND IMPLICIT COGNITIVE-MOTIVATION PROCESSES IN ALCOHOL DEPENDENT SMOKERS SEEKING ALCOHOL TREATMENT Presenters: Stephanie S. O’Malley, PhD; Alan Zweben; Lisa Fucito; Ralitza Gueorguieva; Srinivas Muvvala; Janna Cousijn; Reinout Wiers 11:00 a.m.-12:30 p.m. Affari (4th Floor) Podium Presentation 6 Symposium 37 PSYCHO-SOCIAL INTERVENTIONS FOR SMOKING CESSATION IN PREGNANCY: AN SRNT-EUROPE SYMPOSIUM Chair: Linda C Bauld, BA (Hons), PhD, UK Discussant: Michael Ussher, BSc, MSc, PhD Audience: Waiting on this per the chair - TBD? SYM37A: SMOKING CESSATION INTERVENTIONS IN PREGNANCY AND POST-PARTUM: HOW INTERESTED ARE WOMEN IN ACCESSING SUPPORT AND USING SERVICES? Presenters: Sophie Orton; Laura Vanderbloemen; Katherine Bowker; Tim Coleman; Jo Leonardi-Bee; Sue Cooper; Ste- phen Sutton; Michael Ussher; Felix Naughton

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 87 Program · Saturday, March 11, 2017

SYM37B: BARRIERS AND FACILITATORS TO SMOKING CESSATION DURING PREGNANCY AND ACCESSING PSYCHO-SOCIAL INTERVENTIONS: THE VIEWS OF PREGNANT WOMEN, THEIR PARTNERS AND HEALTH PROFESSIONALS IN THE UK Presenters: Lesley Sinclair; Kathryn Angus; Jennifer McKell; Allison Ford; Linda Bauld; Felix Naughton SYM37C: WILLINGNESS TO ACCEPT FINANCIAL INCENTIVES FOR SMOKING CESSATION IN PREGNANCY: A COMPARISON FRANCE-UNITED KINGDOM Presenters: Noémi Berlin; Leontine Goldzahl; Pat Hoddinott; Linda Bauld; Ivan Berlin SYM37D: SMOKING CESSATION SUPPORT FOR PREGNANT WOMEN: A SURVEY OF ENGLISH STOP SMOKING SERVICES Presenters: Sue Cooper; Sophie Orton; Naomi Coleman- Haynes; Sarah Lewis; Katherine Bowker; Tim Coleman; Andy McEwen 11:00 a.m.-12:30 p.m. Auditorium-General Session Room PDC Building Podium Presentation 6 Paper Session 16 Trends in Tobacco Product Use Chair: Geofrey Fong, PhD, Canada Audience: PH/E, I, LMIC 11:00 a.m. - 11:15 a.m. COUNTRY-SPECIFIC PROFILES AND GLOBAL PATTERNS OF THE TOBACCO EPIDEMIC. IMPLICATIONS OF CURRENT PROFILES OF SMOKING AND POPULATIONS AGE STRUCTURE FOR TOBACCO-RELATED HEALTH OUTCOMES IN THE FUTURE Raydel Valdes Salgado, PhD, MPH, MS* 11:15 a.m. - 11:30 a.m. DIFFERENTIAL CIGARETTE CONSUMPTION TRAJECTORIES FROM YOUNG ADULTHOOD TO MID-LIFE BY RACE AND GENDER Kelvin Choi, PhD, MPH*; Melanie Sabado, PhD 11:30 a.m. - 11:45 a.m. LONGITUDINAL RELATIONSHOPS BETWEEN E-CIGARETTE USE AND SMOKING INITIATION IN UK ADOLESCENTS Sally J Haw, *; Catherine Best; Farhana Haseen; Dorothy Cur- rie; Gozde Ozacinki 12:00 noon - 12:15 p.m. DO NEVER-SMOKERS MAKE UP AN INCREASING SHARE OF SNUS USERS AS CIGARETTE SMOKING DECLINES? THE NORWEGIAN EXPERIMENT Karl Erik Lund, PhD*; Tord F Vedoy, PhD; Linda Bauld, PhD 12:15 p.m. - 12:30 p.m. DAILY CANNABIS USE AMONG CIGARETTE SMOKERS IN THE UNITED STATES, 2002-2014: IMPLICATIONS FOR THE FUTURE OF TOBACCO CONTROL? Renee D Goodwin, PhD, MPH*; Lauren Pacek, PhD; Jan Copeland, PhD; Scott Moeller, PhD; Lisa Dierker, PhD; Andrea Weinberger, PhD; Michael Zvolensky, PhD; Misato Gbedemah, MPH; Melanie Wall, PhD; Deborah Hasin, PhD

88 SRNT 2017 · Florence, Italy

11:00 a.m.-12:30 p.m. Affari (Ground Floor) Podium Presentation 6 Paper Session 17 Toxicity of Tobacco Products Chair: Maciej L. Goniewicz, PharmD, PhD, USA Audience: BS, PC, C, I 11:00 a.m. - 11:15 a.m. ALDEHYDE EMISSIONS FROM ELECTRONIC CIGARETTES: RELATION TO ATOMIZER AGE, PRODUCT MANUFACTURING VARIABILITY, AND INTRA-PUFF PARTICLE GENERATION INTERMITTENCY Alan Shihadeh, ScD*; Mohamad Baassiri, ME; Rola Salman, BS; Soha Talih, PhD; Nareg Karaoghlanian, BE 11:15 a.m. - 11:30 a.m. COMPENSATORY PUFFING BEHAVIOR WITH LOWER NICOTINE STRENGTH E-LIQUID CAN INCREASE CARBONYL EXPOSURE Lynne E Dawkins, PhD*; Catherine F Kimber, BSc; Leon Kosmider, PhD; Jolanta Kurek, MSc; Mira Doig, PhD; Colin Feyerabend, PhD; Olivia Corcoran, PhD 11:30 a.m. - 11:45 a.m. PRESENCE OF THE ORAL AND ESOPHAGEAL CARCINOGEN N’-NITROSONORNICOTINE IN SALIVA OF E-CIGARETTE USERS Irina Stepanov, PhD*; Gabriela Bustamante; Galina Yakovlev; Katrina Yershova; Bin Ma, PhD; Joni Jensen, MPH; Dorothy Hatsukami, PhD 11:45 a.m. - 12:00 noon ELECTRONIC CIGARETTE AEROSOL EXTRACTS INDUCE SIGNIFICANT DNA DAMAGE IN NORMAL AND CANCER CELLS Lurdes Queimado, MD, PhD*; Jimmy Manyanga, BS; Lacy Brame, MS; Dehra McGuire, BS; David Rubenstein, PhD; Theodore Wagener, PhD; Ilangovan Ramachandran, PhD; Vengatesh Ganapathy, PhD Saturday, March 11, 2017 March Saturday, 12:00 noon - 12:15 p.m. SMOKING-ASSOCIATED DNA HYPOMETHYLATION IN BLOOD AS A SURROGATE FOR DNA HYPOMETHYLATION AND GENE DEREGULATION IN SMOKERS’ LUNG Ite A Laird-Offringa, PhD*; Theresa Ryan Stueve, PhD; Wen- Qing Li, PhD; Jianxin Shi, PhD; Crystal N Marconett, PhD; Tongwu Zhang, PhD; Chenchen Yang, BS; Daniel Mullen, BS; William Wheeler, PhD; Xing Hua, PhD; Zea Borok, MD PhD; Neil E Caporaso, MD; Angela C Pesatori 12:15 p.m. - 12:30 p.m. HIGH LEVELS OF ORAL NITROSAMINE-DERIVED DNA ADDUCTS IN SMOKERS WHO DEVELOP ORAL/HEAD AND NECK CANCER Samir S Khariwala, MD MS*; Bin Ma, PhD; Chris Ruszczak, PhD; Steven Carmella, M.S.; Stephen Hecht, PhD; Irina Stepanov, PhD 12:30 p.m.-1:30 p.m. Villa Vittoria: Sala Onice – Ground Floor Meet-the-Editor Adam Leventhal, Associate Editor for Nicotine and Tobacco Drug and Alcohol Dependence Journal 12:30 p.m.-2:00 p.m. Passi Perduti PDC Building Poster Session 5 Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 89 SRNT 2017 · Florence, Italy

90 SRNT 2017 · Florence, Italy

91 SRNT 2017 · Florence, Italy

92 SRNT 2017 · Florence, Italy

INDEX-AUTHOR

93 SRNT 2017 · Florence, Italy

94 SRNT 2017 · Florence, Italy

A Berg, Carla ...... 35, 50 Berlin, Ivan ...... 80, 88 Abdali, Syed A ...... 86 Berlin, Noémi ...... 88 Abrams, David ...... 53 Bernat, Edward ...... 86 Ackerman, Chris ...... 62 Berrueta, Mabel ...... 48 Adams, Lynn ...... 48 Bertrand, Sandrine S ...... 50 Addicott, Merideth A ...... 45 Best, Catherine ...... 88 Addy, Nii A ...... 51 Bhasin, Shikha ...... 50 Adruino, Roberto C ...... 54 Bhatnagar, Prashasti ...... 66 Afifi, Rima ...... 31 Bhattacharya, Arpita ...... 52 Aguirre, Claudia ...... 70 Biasi, Mariella De ...... 46, 85 Ahluwalia, Jasjit S ...... 69, 70 Bickel, Warren K ...... 86, 87 Alain, Anne-Emilie ...... 50 Binns, Steven ...... 83 Alexander, Tesfa ...... 44, 81 Bittoun, Renee ...... 80, 84, 115 Allen, Alicia M ...... 66 Blaga, Oana M ...... 66 Allen, Sharon ...... 66 Blakely, Tony ...... 82 Althabe, Fernando ...... 48 Blecher, Evan ...... 46 Ambrose, Bridget ...... 32 Blendy, Julie A ...... 64 Amos, Amanda ...... 48 Boatman, Jeffery A ...... 51 Ampelas, Anna-Eva ...... 34 Boatright, Amy ...... 47 Angus, Kathryn ...... 88 Bock, Beth C ...... 47 Anthenelli, Robert ...... 47 Bonevski, Billie ...... 53, 68 Antin, Tamar MJ ...... 83 Bonner, Pamela E ...... 46, 65 Aranda, Sanchia ...... 68 Borek, Nicolette ...... 69 Arheart, Kristopher ...... 48 Borland, Ron . . . 34, 37, 50, 53, 71, Aribo, Oceane ...... 50 84, 107 Armeli, Stephen ...... 87 Borok, Zea ...... 89 Arnott, Deborah ...... 34, 48, 73 Bowker, Katherine ...... 87, 88 Aronowitz, Catherine ...... 72 Bowman, Jenny A ...... 54 Arora, Monika ...... 50 Boyd, Mark ...... 53 Arrieta, Alejandro ...... 67 Brady, Kathleen T ...... 86 Asfar, Taghrid ...... 31, 48 Brame, Lacy ...... 89 Ashari, Dien ...... 64 Brandon, Thomas H . . . . 45, 86, 87 Ashley, David L ...... 32 Branston, Robert ...... 55 Aubin, Lisa St ...... 47 Braymiller, Jessica L ...... 52 Audrain-McGovern, Janet . . . . . 79 Brewer, Judson A ...... 52 Auty, Samantha ...... 45 Brewer, Noel T ...... 71 Aveyard, Paul ...... 69 Breysse, Patrick ...... 72 Brinkman, Marielle C ...... 86 Brinzaniuc, Alexandra ...... 66 B Brose, Leonie S ...... 48, 73 Brown, Elizabeth ...... 55 Baassiri, Mohamad ...... 89 Brown, Jennifer L ...... 66 Backinger, Cathy L ...... 32, 45 Brown, Richard ...... 87 Baker, Amanda ...... 31, 53, 67 Brunette, Mary F ...... 45 Baker, Timothy B ...... 83 Bublitz, Margaret ...... 63 Balakrishna, Shrilatha ...... 65 Buczynski, Matthew W . . . . . 49, 50 Bali, Fatma ...... 48 Budney, Alan J ...... 45 Ball, Jude ...... 82 Bullen, Chris ...... 53 Barrington-Trimis, Jessica L . . 48, 79, Bunn, Janice Y ...... 66 83 Burhoo, Premduth ...... 65 Barry, Rachel A ...... 44, 45 Burke, Nancy J ...... 84 Bartlett, Christopher ...... 45 Bustamante, Gabriela ...... 89 Bar-Zeev, Yael ...... 66, 68 Bauld, Linda C . . . . . 32, 63, 67, 68, 88, 87, 113 C Beach, Evan S ...... 46 Beguinot, Emmanuelle ...... 64 Cador, Martine ...... 50 Belizan, Jose ...... 48 Caillé-Garnier, Stéphanie . . . . . 50 Bell, David ...... 81 Cantrell, Jennifer . . . . .48, 50, 81 Bell, Spencer ...... 71 Cao, Dingcai ...... 80 Bell, Stephanie ...... 53 Caporaso, Neil E ...... 89 Bello, Mariel S ...... 70 Carlson, Samantha ...... 66 Bennett, Morgane A ...... 48 Carmella, Steven ...... 89 Benowitz, Neal L . . . . 31, 37, 47, 48, Carpenter, Matthew J ...... 47 51, 52, 70, 80, 107 Carreras, Giulia ...... 72

95 SRNT 2107 · Author Index

Carroll, Kathleen ...... 87 Curry, Sue ...... 47 Cassel, Kevin D ...... 72 Curry, Susan J ...... 32 Cassidy, Rachel N ...... 51, 85 Castaldelli-Maia, João Mauricio . . . 65 Cavallo, Dana ...... 80 D Cepeda-Benito, Antonio ...... 66 Chaloupka, Frank J . . . . 46, 54, 73, 83 D’Este, Catherine ...... 53, 68 Chan, Sophia Siu Chee ...... 54 D’Silva, Joanne ...... 70 Chang, Yuchiao ...... 47, 84 Dadich, Ann ...... 68 Chee, Siu ...... 54 Dar, Reuven ...... 52 Cheeseman, Hazel ...... 73 Davis, Kevin ...... 81 Chellian*, Ranjithkumar ...... 65 Dawkins, Lynne E ...... 89 Chellini, Elisabetta ...... 72 Day, Fiona ...... 68 Chen, Ii-Lun ...... 32 Day, Nancy L ...... 82 Chen, Ning ...... 52 Dean, Judith ...... 53 Chereches, Razvan M ...... 66 DeAtley, Teresa E ...... 71 Cherukupalli, Rajeev ...... 54 DeBiasi, Mariella ...... 64 Cheslack-Postava, Keely . . . . . 66 Deen, Frederieke Sanne van der . . 82 Cheung, Derek ...... 82 Degree, Kaylah ...... 72 Cheung, Ho ...... 54 Delahanty, Janine ...... 81 Cheung, Yannes Tsz-Yan . . . . . 54 Delk, Joanne E ...... 79 Choi, Kelvin ...... 88 Dempsey, Delia ...... 48 Chon, Sandy ...... 53 Denlinger, Rachel L ...... 51, 63 Cinciripini, Paul ...... 52 Denlinger-Apte, Rachel L ...... 85 Cioe, Patricia A ...... 85, 87 Der-Avakian, Andre ...... 45 Clark, Brendan ...... 84 Dermody, Sarah S ...... 51 Clark, Pamela I ...... 86 deWinter, Tamara ...... 46 Cleghorn, Christine L ...... 82 Dezfuli, Ghazaul ...... 64 Cleland, Charles M ...... 68 Dieler, Alica ...... 86 Cobiac, Linda J ...... 82 Dierker, Lisa ...... 52, 88 Coffman, Donna L ...... 72, 83 DiPalma, Devon ...... 65 Cohen, Joanna E . . . . 32, 37, 49, 50, Djordjevic, Mirjana ...... 86 62, 65, 66, 72, 83, 107, 109 Dogar, Omara ...... 63 Cohn, Amy ...... 61, 87 Doig, Mira ...... 89 Cohn, Amy C ...... 63 Donny, Eric C . . . . . 31, 45, 51, 85 Cohn, Amy M ...... 33 Doogan, Nathan J ...... 66 Colby, Suzanne M ...... 33, 85 Dowty, Rachel M ...... 67 Cole, Rob ...... 65 Dresler, Carolyn ...... 45 Coleman, Tim ...... 87, 88 Dresler, Thomas ...... 86 Coleman-Haynes, Naomi . . . . . 88 Driezen, Pete ...... 50 Collins, Bradley N ...... 72, 83 Drobes, David J ...... 45 Collins, Lauren ...... 61 Drope, Jeffrey ...... 66 Collins, Linda M ...... 32 Duke, Jennifer ...... 81 Conway, Kevin ...... 69 Dunbar, Zachary ...... 48 Cooper, Maria R ...... 49 Duncan, Dustin T ...... 55 Cooper, Sue ...... 87, 88 Dunlop, Adrian ...... 53, 68 Copeland, Jan ...... 88 Dunsiger, Shira ...... 47 Corcoran, Olivia ...... 89 Duong, Thomas B ...... 68 Cornacchione, Jennifer ...... 44 Dusen, Duncan Van ...... 49 Cornelius, Marie D ...... 82 Duwve, Joan ...... 67 Cortini, Barbara ...... 72 Court, Erin ...... 84 Courtney, Ryan ...... 63 Cousijn, Janna ...... 87 E Cox, Alison ...... 32 Cox, Lisa Sanderson . . . . . 69, 70 Edwards, Richard . . . . . 81, 82, 84 Cox, Shanna ...... 81 Eggers, Matthew ...... 55 Cravatt, Benjamin F ...... 50 Ehlis, Ann-Christine ...... 86 Creamer, MeLisa . . . . . 49, 62, 79 Ehlke, Sarah ...... 87 Crook, Brittani ...... 49 Eichberg, Christie ...... 71 Cropsey, Karen L ...... 84 Eiden, Rina D ...... 82 Cruz, Tess B ...... 83 Eisen, Tim ...... 46 Cruz, Tess Boley ...... 79 Eissenberg, Thomas ...... 72 Cummings, Michael K . . . . 34, 47, 53 Ekblad, Mikael ...... 82 Cunningham, Mary C ...... 61 Eker, Figen ...... 64 Currie, Dorothy ...... 88 Elf, Jessica L ...... 72.

96 SRNT 2017 · Florence, Italy

Ellerbeck, Edward F ...... 70 Ghandhi, Shashank ...... 48 Elmasry, Hoda ...... 87 Gibbons, Luz ...... 48 Emery, Sherry ...... 33, 83 Gibson, Laura A ...... 44 Erick, Stephanie ...... 82 Gifford, Heather ...... 33, 70, 82 Eriksen, Michael P ...... 44 Gilbert, David G ...... 45 Etter, Jean-Francois ...... 45 Gildengorin, Ginny ...... 84 Evans, David E ...... 45 Gilks, Charles F ...... 53 Evans, David S ...... 84 Gilmore, Anna B ...... 55 Giovino, Gary ...... 50, 69 Gipson, Cassandra D ...... 64 F Gissler, Mika ...... 82 Gitik, Miri ...... 71 Fagan, Pebbles ...... 72 Glasser, Allison M ...... 32, 61 Fagerstrom, Karl ...... 31 Glover, Marewa ...... 66, 68 Fagerstrom, Karl-Olov ...... 80 Glover-Kudon, Rebecca ...... 81 Fairchild, Victoria ...... 72 Glynn, Thomas J ...... 32 Falk, Emily B ...... 81 Goenaga, Julianna ...... 64 Faller, Rachel Williams ...... 45 Goldenson, Nicolas I ...... 70 Fallgatter, Andreas J ...... 86 Goldman, David ...... 71 Fan, Lu ...... 65 Goldschmidt, Lidush ...... 82 Farrell, Michael ...... 53, 68 Goldzahl, Leontine ...... 88 Farrelly, Matthew ...... 81 Golub, Jonathan E ...... 53, 72 Felicitas-Perkins, Jamie Q . . . . . 72 Goma, Fastone ...... 65 Ferguson, Shelagh ...... 84 Goniewicz, Maciej L . . . . 34, 36, 37, Ferguson, Stuart G ...... 69 45, 48, 51, 80, 89 Feyerabend, Colin ...... 89 Goodwin, Renee D ...... 66, 88 Fiore, Michael C ...... 83 Gordon, Terry ...... 48 Fisher, Miranda ...... 71 Gorini, Giuseppe ...... 72 Fleischer, Nancy L ...... 54 Gould, Cheryl ...... 33 Foll, Bernard Le ...... 47, 50 Gould, Gillian S ...... 33, 66, 68 Fong, Geoffrey T . . . 32, 46, 50, 53, 65 Gould, Thomas J ...... 65, 71 Fong, Geofrey ...... 88 Grainger-Gasser, Alice ...... 50 Ford, Allison ...... 88 Grana, Rachel ...... 48 Ford, Pauline ...... 53 Grant, Ashley ...... 66 Fouad, Fouad ...... 31 Gray, Kevin M ...... 47, 71 Foulds, Jonathan ...... 50 Grayless, Megan M ...... 49 Fournier, Marie-Line ...... 50 Green, Annika C ...... 65 Fowler, Christie D ...... 46, 49 Gritz, Ellen R ...... 54 Franck, Christopher T ...... 86 Gueorguieva, Ralitza . . . . . 80, 87 Franco, Armani Del ...... 64 Guignard, Romain ...... 64 Frank, Summer ...... 54 Guillaumier, Ashleigh . . . . . 53, 68 Fraser, David L ...... 83 Gupta, Amita ...... 72 Freeman, Becky ...... 83 Gupta, Seema ...... 71 Freund, Megan ...... 68 Gupte, Nikhil ...... 53, 72 Froeliger, Brett ...... 47, 71 Guy, Mignonne C ...... 72 Fucito, Lisa M ...... 31, 87

H G Haeussing, Florian ...... 86 Gaalema, Diann E ...... 66 Haghpanahan, Houra ...... 81 Gaffey, Allison ...... 63 Hair, Elizabeth C ...... 48, 81 Gallopel-Morvan, Karine . . . . 64, 84 Hajek, Peter ...... 69 Gammon, Doris ...... 55 Halenar, Michael J ...... 81 Gan, Quan ...... 34 Hall, Brandon J ...... 65 Ganapathy, Vengatesh ...... 89 Hamamura, Faith ...... 72 Garcia, Raul ...... 64 Hammond, David . . 61, 63, 64, 71, 72 Garrison, Kathleen A ...... 52 Hanlon, Colleen A ...... 87 Gartner, Coral ...... 53 Hanrahan, Tess ...... 87 Gbedemah, Misato ...... 88 Hardin, James W ...... 71 Gelernter, Joel ...... 85 Harrell, Melissa B . . . . . 49, 62, 79 Genna, Natacha M De ...... 82 Hartmann-Boyce, Jamie ...... 32 George, Mark S ...... 86 Hartwell, Karen J ...... 86 George, Tony P ...... 44, 52 Haseen, Farhana ...... 88 Getz, Kayla R ...... 72 Hasin, Deborah ...... 66, 88

97 SRNT 2107 · Author Index

Hatsukami, Dorothy K . 31, 32, 51, 79, K 85, 89 Haw, Sally J ...... 81, 88 Kaai, Susan C ...... 65 Hawk Jr ., Larry W ...... 52, 69 Kahler, Christopher W ...... 87 Hays, Taylor ...... 47 Kalkhoran, Sara M ...... 47 Healey, Ben ...... 84 Kalousova, Lucie ...... 54 Healton, Cheryl ...... 32 Kaprio, Jaakko ...... 34 Hecht, Stephen ...... 89 Karaoghlanian, Nareg ...... 89 Heckman, Bryan W ...... 47 Keith, Diana R ...... 66 Henderson, Patricia N ...... 70 Kelder, Steven H ...... 49, 62 Henderson, Patricia Nez ...... 33 Kellar, Kenneth J ...... 64 Henderson, Scott ...... 86 Kelley, Jennifer H ...... 47 Henderson, Tracey ...... 48 Kelley, Jennifer K ...... 84 Hendricks, Peter S ...... 84 Kelly, Pete ...... 68 Hennigfield, Jack E...... 80 Kennedy, Ryan D . . . . . 32, 50, 62 Henningfield, Jack E ...... 79 Kevin, Luk Tzu Tsun ...... 47 Herman, Melissa A ...... 50 Khadse, Sandhya ...... 72 Hernandez, Carol ...... 70 Khariwala, Samir S ...... 89 Herrmann, Martin ...... 86 Kientz, Julie ...... 52 Herzog, Thaddeus A ...... 72 Kim, Hyoshin ...... 86 Hickey, Paul ...... 84 Kim, Jin ...... 84 Higgins, Stephen T . . . . . 36, 51, 66 Kimber, Catherine F ...... 89 Hiscock, Rosemary ...... 55 King, Andrea ...... 80 Hitchman, Sara C ...... 55, 71 King, Brian A ...... 62 Hoddinott, Pat ...... 88 Kinikar, Aarti ...... 72 Hoek, Janet ...... 82, 84 Kiparoglou, Vasiliki ...... 55 Hoffman, Allison C ...... 45 Kira, Anette ...... 66 Holiday, Erica ...... 71 Kirchner, Thomas R ...... 67, 112 Holter, Michael C ...... 64 Kirkpatrick, Matthew G ...... 70 Hong, Zhang ...... 48 Kittner, Deirdre L ...... 71 Hopp, Craig ...... 63 Kobinsky, Kathleen ...... 83 Hornik, Robert C ...... 44 Kong, Grace ...... 33, 79, 80 Howe, Megan ...... 80 Koopmeiners, Joseph S . . . . 51,. 85 Hsu, Ku-Lung ...... 50 Korhonen, Tellervo ...... 34 Hua, Xing ...... 89 Korkeila, Jyrki ...... 82 Huang, Jidong ...... 83 Koru-Sengul, Tulay ...... 48 Huang, Susan ...... 68 Kosmider, Leon ...... 81, 89 Huestis, Marilyn A ...... 82 Kotz, Daniel ...... 47, 54, 83 Hughes, John R ...... 45 Koval, Robin ...... 61 Huh, Jimi ...... 83 Kozink, Rachel V ...... 85 Hyland, Andrew ...... 32 Kranzler, Elissa C ...... 81 Kranzler, Henry R ...... 85 Krishnan-Sarin, Suchitra . . 45, 79, 80, I 85 Kroczek, Agnes ...... 86 Islam, Farahnaz ...... 71, 72 Kurek, Jolanta ...... 89 Islami, Farah ...... 64 Kurti, Allison N ...... 66 Kutlu, Munir Gunes ...... 65, 71 Kvizhinadze, Giorgi ...... 82 J

Jabba, Sairam V ...... 46, 65 L Jackson, Christian D ...... 79 Jackson, Kristina ...... 85 Labib, Kareem ...... 68 Jacob, Peyton ...... 48 Lagasse, Lisa P ...... 50 Jain, Shonul ...... 48 Lahti, Adrienne C ...... 84 Jay, Stephen J ...... 67 Laird-Offringa, Ite A ...... 89 Jennings, Ernestine ...... 47 Lam, Hy ...... 68 Jensen, Eric ...... 48 Lam, Tai-Hing ...... 54 Jensen, Joni ...... 89 Lando, Harry ...... 31 Jeong, SooHee ...... 63 Langleben, Daniel ...... 72 Jibril, Abdi ...... 66 Langley, Tessa ...... 81 Johnson, Amanda ...... 61 Lantz, Paula M ...... 54 Jordt, Sven-Eric ...... 46, 65 Lanza, Stephanie T ...... 52. Jorgensen, Dorothy ...... 72 Lassi, Glenda ...... 46 Lazard, Allison ...... 44

98 SRNT 2017 · Florence, Italy

Le, Khanh ...... 84 Mayo, Matthew S ...... 70 Lebina, Limakatso ...... 53 Maziak, Wasim ...... 31 Lee, David ...... 48 Mbulo, Lazarous ...... 50 Lee, Dustin C ...... 45 McAfee, Tim ...... 81 Lee, Lily ...... 48, 55 McClernon, F . Joseph . . . . 51, 71, 85 Lee, Stella ...... 44 McClernon, Francis J ...... 45 Leggio, Lorenzo ...... 87 McClure, Erin A ...... 33, 44 Lehtonen, Liisa ...... 82 McConnell, Rob S ...... 48, 79, 83 Leischow, Scott ...... 31, 73, 114 McCool, Judith P ...... 83 Lencucha, Raphael ...... 66 McCrae, Tarsha ...... 55 Leonardi-Bee, Jo ...... 87 McDonald, Emily A ...... 44 Lepore, Stephen J ...... 72, 83 McEwen, Andy ...... 88 Lerman, Caryn ...... 52, 70, 85 McGuire, Dehra ...... 89 Leventhal, Adam M . . . . 45, 70, 79, McKell, Jennifer ...... 88 89, 116 Mcnamara, Patrick ...... 80 Levin, Edward D ...... 64, 65 McNeill, Ann . . . 31, 35, 48, 53, 55, 73 Levy, David T ...... 54 McPhee, Stephen J ...... 84 Lewis, M . Jane ...... 62 McRae, Thomas ...... 47 Lewis, Sarah ...... 88 McRobbie, Hayden ...... 62 Li, Lin ...... 71 Mead, Erin ...... 68 Li, Wen-Qing ...... 89 Meghea, Cristian I ...... 66 Li, William Ho-Cheung ...... 54 Meiser, Bettina ...... 68 Li, Xingbao ...... 86 Melis, Miriam ...... 50 Liautaud, Madalyn M ...... 70 Meng, Gang ...... 65 Ling, Pamela M ...... 44 Mercincavage, Melissa ...... 85 Lipperman-Kreda, Sharon . . . . . 83 Mermelstein, Robin J . . . . . 33, 79 Liu, Feifei ...... 83 Meurk, Carla ...... 53 Liu, Jiaying ...... 44 Meza, Rafael ...... 54 Lochbuehler, Kirsten ...... 85 Miao, Shida ...... 46 Lopez, Alexa A ...... 66 Middlestadt, Susan E ...... 67 Loukas, Alexandra ...... 49, 83 Miller, Mollie E ...... 63 Lounsbury, David ...... 68 Ming, Leung ...... 71 Louviere, Jordan ...... 72 Moeller, Scott ...... 88 Lovett, Ray ...... 33 Mohamed, Zahurin ...... 65 Lucas, Annelies ...... 47 Mongodin, Emmanuel F ...... 86 Lund, Ingeborg ...... 64 Moodie, Crawford ...... 64 Lund, Karl Erik ...... 88 Morales, Mark ...... 52 Lunden, Sara E ...... 86 Moran, Meghan B ...... 61, 62 Luo, Xianghua ...... 51 Morello, Paola ...... 48 Ly, Christina ...... 49 Morgan, Jennifer C ...... 71 Lynch, Tania ...... 72 Motlhaoleng, Katlego ...... 53 Lyttle, Susan ...... 48 Mukhopadhyay, Bhavna B . . . . . 71 Muleta, Hemen ...... 66 Mullen, Daniel ...... 89 M Munafò, Marcus R . . . . 46, 55, 110 Muvvala, Srinivas ...... 87 Ma, Bin ...... 89 Myers, Matt ...... 32 Mackay, Daniel ...... 81 MacMonegle, Anna ...... 81 Macy, Jonathan T ...... 67 N Maddox, Raglan ...... 33, 70 Maloney, Sarah ...... 72 Nadas, Arthur ...... 48 Mantey, Dale S ...... 83 Nagib, Ahmed ...... 68 Mantovani, Antonio ...... 86 Nair, Saritha ...... 68 Manyanga, Jimmy ...... 89 Nardone, Natalie ...... 48, 51, 85 Marconett, Crystal N ...... 89 Nargis, Nigar ...... 50 Marcus, Bess H ...... 47 Naughton, Felix ...... 87, 88 Marr, Brain ...... 52 Neisewander, Janet L ...... 64 Marti, C . Nathan ...... 49 Nelson, Deborah ...... 66 Martinez, Jaime L ...... 70 Newcombe, David ...... 63 Martinson, Neil ...... 53 Newcomer, John W ...... 45 Maruyama, Tracey A Richers . . . . 44 Newell, Luke ...... 80 Matter, Chris M ...... 70 Ng, Hanna ...... 63 Mave, Vidya ...... 72 Nguyen, Linh Thi ...... 68 Mayer, Margaret ...... 79 Nguyen, Nam Truong ...... 68 Mayo, Ashley ...... 63 Nguyen, Trang Thi ...... 68

99 SRNT 2107 · Author Index

Nguyen, Tung T ...... 68, 84 Pickworth, Wallace ...... 84 Nguyen-Thanh, Viet ...... 64 Pierce, John P ...... 61 Niaura, Ray ...... 53 Pipe, Andrew ...... 47 Niaura, Raymond . . . . . 32, 61, 63 Piper, Megan E ...... 31, 52 Noar, Seth M ...... 44, 71 Pistis, Marco ...... 50 Nollen, Nikka L ...... 52 Pokhrel, Pallav ...... 72 Nollen, Nikki L ...... 70 Polis, Ilham Y ...... 50 Nonnemaker, James ...... 55, 81 Popova, Lucy ...... 44 Norman, Leslie ...... 62 Powell, Gregory L ...... 64 Nunes, Eric J ...... 51 Prashad, Neelam ...... 86 Prochaska, Judith J ...... 37, 107

O Q O’Connor, Richard J ...... 72 O’Donnell, Matthew B ...... 81 Qiaoping, Yuan ...... 71 O’Donnell, Rachel ...... 48 Quach, Thu ...... 68 O’Farrell, Anne ...... 84 Quah, Anne C .K ...... 65 O’Malley, Stephanie S . . . . 52, 80, 87 Queimado, Lurdes ...... 89 Oldmeadow, Christopher . . . . 54, 68 Oliver, Jason A ...... 45 Oncken, Cheryl ...... 68, 81 R Ong’ang’o, Jane ...... 65 Orlan, Elizabeth ...... 44 Rabin, Rachel A ...... 44 Orleans, Tracy ...... 32 Raichur, Priyanka ...... 72 Orton, Sophie ...... 87, 88 Ramachandran, Ilangovan . . . . . 89 Ozacinki, Gozde ...... 88 Ramsey, Susan ...... 87 Rao, Pamela ...... 81 Rath, Jessica M ...... 48, 81 P Ray, Lara A ...... 70 Reboussin, Beth A ...... 44 Pacek, Lauren R ...... 85, 88 Redner, Ryan ...... 66 Pal, Prasanta ...... 52 Rees, Vaughan W ...... 72 Palafox, Sherilyn ...... 72 Regan, Susan ...... 47, 84 Palipudi, Krishna ...... 50 Rezvani, Amir H ...... 65 Pandy, Vijayapandi ...... 65 Ribisl, Kurt M ...... 71 Pang, Raina D ...... 70 Richter, Kimber P ...... 44 Panissidi, Luana ...... 86 Richter, Patricia ...... 80 Parascandola, Mark ...... 46 Ridgeway, William ...... 81 Parikh, Vinay ...... 65 Ries, Richard ...... 52 Park, Elyse R ...... 47 Rigotti, Nancy A . . .31, 36, 47, 62, 84 Park, Emily (Sa Nan) ...... 68 Rizo, Javier ...... 52 Park, Jinwoo ...... 51 Roberto, Marisa ...... 50 Park, Su Hyun ...... 48, 55 Roberts, Megan E ...... 66 Parsons, Loren H ...... 50 Rogers, Todd ...... 55 Partos, Timea ...... 55 Rose, Jennifer S ...... 52 Pasch, Keryn E ...... 49, 83 Rose, Shyanika W ...... 61, 63 Passey, Megan ...... 36 Rosen, Rochelle ...... 47 Patel, Deesha ...... 81 Rosenberry, Zachary R ...... 44 Paterson, Keriata ...... 66 Ross, Hana ...... 46 Paul, Chris ...... 53 Rossem, Carolien van ...... 47 Paul, Christine L ...... 67, 68 Rubenstein, David ...... 89 Pearson, Jennifer L . . . . 32, 48, 61, 63 Rupprecht, Laura E ...... 51 Pei, Rui ...... 81 Russell, Michael A ...... 52 Pell, Jill ...... 81 Ruszczak, Chris ...... 89 Peltier, Richard ...... 48 Peng, Annie R ...... 52, 70 Pentz, Mary Ann ...... 83 S Pergadia, Michele L ...... 45 Perry, Cheryl L ...... 49, 62, 79, 83 Sabado, Melanie ...... 88 Pesatori, Angela C ...... 89 Saddleson, Megan L ...... 85 Pester, Mollie S ...... 70 Sakuma, Kari-Lyn K ...... 72 Peters, Erica N ...... 33, 44, 84 Salgado, Raydel Valdes . . . . 45, 88 Petronio, Maria Grazia ...... 72 Salloum, Ramzi G . . . . . 31, 64, 72 Picciotto, Marina R ...... 64, 65 Salman, Rola ...... 89

100 SRNT 2017 · Florence, Italy

Samet, Jonathan M ...... 62 Stanton, Cassandra A ...... 61, 66 Sangalang, Angeline ...... 44 Stein, Jeff S ...... 87 Sapkota, Amy R ...... 86 Stepanov, Irina ...... 79, 80, 89 Sargent, James D ...... 61 Stockings, Emily A ...... 54 Savin, Micah J ...... 54 Stone, Matthew D ...... 70 Schauer, Gillian L ...... 44, 84 Strasser, Andrew A ...... 85 Schayck, Onno C .P . van . . . . 47, 54 Streck, Joanna M ...... 84 Scheffels, Janne ...... 64 Stroud, Laura R ...... 63 Schensul, Jean J ...... 68 Stueve, Theresa Ryan ...... 89 Scheuermann, Taneisha S . . . . 70. Suen, Yi Nam ...... 47 Schillo, Barbara A ...... 70 Suerken, Cynthia ...... 44 Schmaelzle, Ralf ...... 81 Sullivan, Nicolette ...... 45 Schnoll, Robert ...... 52 Suryavanshi, Nishi ...... 72 Schuetze, Pamela ...... 82 Sutfin, Erin L...... 44 Schwartz, Rob ...... 33 Sutton, Stephen ...... 87 Scott, Sheryl ...... 70 Sved, Alan F ...... 51 Searles, Andrew ...... 68 Swayampakala, Kamala ...... 71 Sebrie, Ernesto M ...... 71 Szczypka, Glen ...... 83 Selby, Peter ...... 31, 47, 53, 87 Selya, Arielle S ...... 52 Semple, Sean ...... 48 T Sestini, Piersante ...... 72 Shafer, Paul ...... 81 Talbot, Eugene ...... 62 Shah, Vandana ...... 71 Talhout, Reinskje ...... 80 Shahawy, Omar El ...... 55, 68 Talih, Soha ...... 89 Shakeshaft, Anthony ...... 53, 68 Tamplin, Stephen A ...... 50 Sharma, Ratika ...... 53 Tamura, Kosuke ...... 55 Shaw, Tim ...... 68 Tarcea, Monica ...... 72 Shearston, Jenni A ...... 48, 55 Tauras, John A ...... 73 Sheffer, Christine E ...... 86 Tautolo, El-Shadan . . . . . 33, 70, 82 Sheikh, Abdullahi ...... 66 Taylor, Natalie ...... 68 Sheikh, Aziz ...... 54 Taylor, Seth R ...... 65 Shelley, Donna ...... 68 Taylor, Teresa ...... 82 Sheon, Nicolas M ...... 44 Team, The PATH Study ...... 69 Sheridan, Janie ...... 63 Teplitskaya, Lyubov ...... 48 Sherman, Scott E . . . 31,. 48, 55, 68 Thomas, David ...... 33, 70 Sherwood, Emma ...... 68 Thomas, Janet ...... 66 Shi, Jianxin ...... 89 Thompson, Mary ...... 50 Shi, Zhenhao ...... 72 Thrasher, James F . . . 54, 64, 71, 72 Shiffman, Saul M . . . . . 35, 52, 80 Thrasher, Jim ...... 50, 65 Shihadeh, Alan ...... 31, 89 Tidey, Jennifer W . . . . . 51, 63, 85 Shisler, Shannon ...... 82 Tindle, Hilary A ...... 47 Shoaib, Mohammed ...... 65 Tingle, Malcolm ...... 63 Shurtleff, David ...... 63 Tiwari, Cheenu ...... 46 Siddiqi, Kamran ...... 31, 63, 66 Toll, Ben ...... 31 Sidhu, Sohrab ...... 44 Tonstad, Serena ...... 61, 111 Silva, Phillip R ...... 51 Tosun, Nicole ...... 66 Siman, Nina ...... 68 Travers, Mark ...... 48 Simonavicius, Erikas ...... 48 Trigo, Jose M ...... 50 Simpson, Colin ...... 54 Trinidad, Dennis R ...... 72 Simpson, Sean ...... 81 Tsoh, Janice Y ...... 68, 84 Sinclair, Lesley ...... 88 Tumolo, Jessica M ...... 65 Singer, Daniel E ...... 47 Turner, Jill R ...... 64, 71 Skelton, Eliza ...... 53 Turner, Steve ...... 48 Slade, Susan ...... 65 Twyman, Laura ...... 68 Smith, Katherine C . . . . . 62, 65, 83 Tyndale, Rachel F ...... 52, 70, 86 Smith, Philip ...... 66 Tzelepis, Flora ...... 53, 68 Smith, Stevens S ...... 83 Tzilos, Golfo ...... 87 Smith, Tracy T . . . . 31,. 50, 51, 85 Snider, Sarah E ...... 87 Sommer, Toby J ...... 46 Soule, Eric K ...... 32 U Spigt, Mark ...... 47 Spillane, Nichea ...... 87 Urman, Robert ...... 48, 83 St .Helen, Gideon ...... 80 Ussher, Michael ...... 87 Stanger, Catherine ...... 45

101 SRNT 2107 · Author Index

V Wiers, Reinout ...... 87 Wiggers, John H ...... 54 Valdes-Saldago, Raydel ...... 82 Wigginton, Britta ...... 53 Vallone, Donna M ...... 48, 81 Wileyto, E . Paul ...... 52 Vanderbloemen, Laura ...... 87 Willette, Blair ...... 65 VanDevanter, Nancy ...... 68 Wilson, John ...... 83 Vandrey, Ryan ...... 85 Wilson, Nick ...... 82 Vandry, Ryan ...... 51 Wiseman, Kimberly D ...... 44 Vannan, Annika ...... 64 Wolfe, Gary W ...... 63 Variava, Ebrahim ...... 53 Wolfson, Mark ...... 44 Varlow, Megan ...... 68 Wong, Ching ...... 68, 84 Vasilenko, Sara A ...... 52 Wong-Cornell, Cecilia ...... 83 Vedoy, Tord F ...... 88 Wye, Paula M ...... 54 Verdi, Simona ...... 72 Vergara-Lopez, Chrystal ...... 63 Vidrine, Damon J ...... 54 X Viechtbauer, Wolfgang . . . . . 47, 54 Vilardaga, Roger ...... 52 Xiao, Haijun ...... 81 Vilcassim, MJ Ruzmyn ...... 48 Xu, Xin ...... 81 Villaluz, Nicole ...... 70 Villanti, Andrea C . . . . 32, 46, 61, 63 Vink, Jacqueline ...... 49, 109 Vock, David M ...... 51 Y Vogl, Lisa M ...... 48 Volinsky, Allyson C ...... 44 Yadav, Amit ...... 50 Yakovlev, Galina ...... 89 Yan, Tsz ...... 54 Yang, Chenchen ...... 89 W Yang, Qinghua ...... 44 Yershova, Katrina ...... 89 Waa, Andrew M ...... 33, 70 Ylioja, Thomas ...... 47 Wagener, Theodore ...... 89 Yohn, Nicole ...... 64 Wahlquist, Amy E ...... 47 Yong, Hua ...... 71 Walker, Denise D ...... 45 Yong, Hua-Hie ...... 50, 53 Walker, Matthew W ...... 44 Yurekli, Ayda ...... 46 Walker, Natalie ...... 31, 34, 53, 63 Yusufali, Afzal Hussein ...... 48 Wall, Melanie M ...... 66, 88 Walsberger, Scott ...... 68 Walter, Karoline ...... 71 Wang, An-Li ...... 72 Z Ward, Kenneth D ...... 31 Washington, Carmen C ...... 83 Zaveri, Nurulain T ...... 46 Watson, Christina ...... 80 Zawertailo, Laurie ...... 47 Watson, Clifford ...... 80 Zeller, Mitchell ...... 32 Weaver, Scott R ...... 44 Zeng, Emily Y ...... 52 Weiger, Caitlin ...... 61, 66 Zhang, Helena ...... 47 Weinberger, Andrea ...... 88 Zhang, Tongwu ...... 89 Weitzman, Michael ...... 48, 55 Zhao, Xiaoquan ...... 81 Welding, Kevin ...... 62, 65, 83 Zhu, Andy ZX ...... 70 Wells, Corinne ...... 65 Zimmerman, Julie B ...... 46 West, Robert . . . 31, 37, 47, 54, 67, Zimmerman, Mia ...... 62 107, 112 Zvolensky, Michael ...... 88 Wheeler, William ...... 89 Zweben, Alan ...... 87 Wickham, Robert J ...... 51

102 SRNT 2017 · Florence, Italy

103 SRNT 2017 · Florence, Italy

104 SRNT 2017 · Florence, Italy

105 SRNT 2017 · Florence, Italy

106 SRNT 2017 · Florence, Italy

SCHEDULE- AT-A-GLANCE Schedule-at-a-Glance

107 SRNT 2017 · Florence, Italy

108 SRNT 2017 · Florence, Italy

TUESDAY, MARCH 7, 2017

3:00 p.m.-5:00 p.m. Piazza Adua Reception Area Registration

WEDNESDAY, MARCH 8, 2017

7:30 a.m.-5:00 p.m. Piazza Adua Reception Area Registration 9:00 a.m.-12:00 noon Sala Auda 1 – Primo Piano (1st Floor) PDA Building (Palazzo Degli Affari Building) Pre-Conference Workshop #1 Novel Approaches to Implementing Tobacco Treatment Within Health Systems 9:00 a.m.-12:00 noon Sala Affari: Room 2 – Primo Piano (1st Floor) PDA Building Pre-Conference Workshop #2 Is Nicotine Reduction Really a Viable Policy Option for Tobacco Control? 9:00 a.m.-12:00 noon Sala Affari: Room 1 – Secondo Piano (2nd Floor) PDA Building Pre-Conference Workshop #3 Developing Evidence-Based Control Policies Targeting Waterpipe Tobacco Smoking: Time for Action. 9:00 a.m.-12:00 noon Sala Affari: Piano Terra (Ground Floor) PDA Building Pre-Conference Workshop #4

Working Globally to Support Rapid Learning for E-Cigarette Schedule-at-a-Glance Policy, Surveillance and Policy Research 9:00 a.m.-12:00 noon Sala Affari: Room 2 – Secondo Piano (2nd Floor) PDA Building Pre-Conference Workshop #5 Introduction to the Multiphase Optimization Strategy (MOST) for Building More Effective, Efficient, Economical, and Scalable Behavioral and Biobehavioral Interventions 8:30 a.m.-12:00 noon Auditorium-General Session Room PDC Building Pre-Conference Workshop #6 FDA’s Population Health Standard: Balancing the Risks and Benefits in Regulatory Decision-making 9:00 a.m.-12:00 noon Sala Affari: Room 1 – Primo Piano (1st Floor) PDA Building Pre-Conference Workshop #7 Tobacco and Marijunana Co-use in Adolescents and Young Adults

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 109 SRNT 2017 · Schedule-at-a-Glance

8:30 a.m.-12:00 noon Sala Affari: Auda 2 – Secondo Piano (2nd Floor) PDA Building Pre-Conference Workshop #8 Reducing The Impacts of Commercial Tobacco on Indigenous Peoples: Best Practices For Engaging with Indigenous Peoples in Research 9:00 a.m.-12:00 noon Sala Affari: Quarto Piano – Top Floor (4th Floor) PDA Building Pre-Conference Workshop #9 What does our Tobacco Work Mean to Us? Translating Knowledge through Art in Florence 8:30 a.m.-12:00 noon Villa Vittoria: Sala Verde (2nd Floor) PDC Building SRNT-E Satellite Symposium: Comparing Regulations on Tobacco and Nicotine Products Sponsored by SRNT-Europe 1:00 p.m.-6:30 p.m. Retropresidenza (Passi Perduti - Lowest Level) PDC Building Speaker Ready Room 1:00 p.m.-3:15 p.m. Network Meetings Plan to join your colleagues and attend the Network meeting of interest. 1:00 p.m.-2:00 p.m. Adolescent Network Meeting: Villa Vittoria: Sala 101 - Primo Piano (1st Floor) Genetics Network Meeting: Villa Vittoria: Sala Onice - Terra Piano (Ground Floor) Global Health Network Meeting: Villa Vittoria: Sala 9 - Terra Piano (Ground Floor) Health Disparities Network Meeting: Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor) 2:15 p.m.-3:15 p.m. Basic Science Network Meeting: Villa Vittoria: Sala Onice - Terra Piano (Ground Floor) Public Health Policy Network Meeting: Villa Vittoria: Sala 4 - Terra Piano (Ground Floor) Treatment Network Meeting: Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor) 3:30 p.m.-4:45 p.m. Transdisciplinary Topical Discussions #1-#7 are held concurrently (These roundtable sessions are held concurrently, and have been selected to address a diverse array of pressing questions in our field.) TTD #1 Sala Affari: Room 1 – Primo Piano (1st Floor) PDA Building E-health Smoking Cessation Interventions: Do They Really Work? Moderator(s): Saul Shiffman, PhD TTD #2 Sala Auda 1 – Primo Piano (1st Floor) PDA Building NRT Bought Over the Counter: Are Gums and Patches Possibly Not Effective in the Real World? Moderator(s): Ann McNeill, PhD

110 SRNT 2017 · Florence, Italy

TTD #3 Sala Affari: Auda 2 – Secondo Piano (2nd Floor) PDA Building Polysubstance Abuse: How to Treat Tobacco Alongside Other Addictions? Moderator(s): Carla Berg, PhD TTD #4 Sala Affari: Room 2–Primo Piano (1st Floor) PDA Building Financial Incentives for Quitting Tobacco: An Effective and Ethical Approach? Moderator(s): Stephen Higgins, PhD TTD #5 Sala Affari: Room 1 –Secondo Piano (2nd Floor) PDA Building Making the Delivery of Tobacco Cessation Treatment Routine in Health Care Systems: What are the Challenges? Moderator(s): Nancy Rigotti, PhD TTD #6 Sala Affari: Piano Terra (Ground Floor) PDA Building Vape Shops: Just Another Tobacco Product Retailer or a Smoking Cessation Service? Moderator(s): Maciej L. Goniewicz, PhD, Pharm D TTD #7 Sala Affari: Quarto Piano–Top Floor (4th Floor) PDA Building How Do We Reduce Children’s Exposure to Second-Hand Tobacco Smoke Globally? Moderator(s): Megan Passey, PhD 5:00 p.m.-6:00 p.m. Auditorium-General Session Room PDC Building Keynote Presidential Symposium (Opening Session) Nicotine + Other Addictive Behaviors: Addressing the Added Complexities Across the Translational Continuum Neal L. Benowitz, MD, Chief, Division of Clinical Pharmacology, University of California San Francisco, USA; Ron Borland PhD, FASSA, Nigel Gray Distinguished Fellow in

Cancer Prevention, The Cancer Council Victoria, Melbourne, Schedule-at-a-Glance Australia; Joanna E. Cohen, PhD, Director, Institute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public, Baltimore, USA; Judith J. Prochaska, PhD, MPH, Associate Professor of Medi- cine, Department of Medicine, Stanford University, USA; Robert West, PhD, Professor of Health Psychology, University College London, UK 6:00 p.m.-7:30 p.m. Passi Perduti (Basement - Lowest Level) PDC Building Opening Reception (All attendees are welcome! Cash bar and hors d’oeuvres)

THURSDAY, MARCH 9, 2017

8:00 a.m.-5:00 p.m. Piazza Adua (Reception Area) Registration 8:00 a.m.-5:00 p.m. Retropresidenza (Passi Perduti - Lowest Level) PDC Building Speaker Ready Room

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 111 SRNT 2017 · Schedule-at-a-Glance

9:00 a.m.-3:30 p.m. Salone Club (Lower level) PDC Building Exhibits Open 9:00 a.m.-10:30 a.m. Auditorium-General Session Room PDC Building Welcome/Awards/Plenary 9:00 a.m. Welcome & Opening Remarks by the Presidents of SRNT-E & SRNT Ivan Berlin, PhD Deborah Ossip, PhD 9:10 a.m. Awards Tom Glynn, PhD 9:30 a.m. Plenary Epidemiology and Public Health Themed Lecture and 2017 Doll-Wynder Award Winner “How to Think - Not Feel - About Tobacco Harm Reduction” Kenneth E. Warner; Avedis Donabedian Distinguished University Professor 10:30 a.m.-11:00 a.m. Salone Club (Lower level) PDC Building Exhibitor Time Refreshment Break 11:00 a.m.-12:30 p.m. Affari (2nd Floor) - Auda 2 Podium Presentation 1: Symposium 1 Health Communication for Non-Cigarette Tobacco Products Audience: P, I, LMIC 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Room 1 Podium Presentation 1: Symposium 2 Exploring Marijuana and Tobacco Co-Use: A Problematic Rela- tionship That Can No Longer Be Ignored Audience: PH/E, PC, HD, I 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Room 2 Podium Presentation 1: Symposium 3 In Memory of Athina Markou: A Legacy of Transitional Science on Nicotine Withdrawal and Reward Audience: BS, PC, T 1:00 a.m.-12:30 p.m. Affari (2nd Floor) Podium Presentation 1: Symposium 4 Exploring Dimensions of Flavors: Toxicity, Preference, and Use Audience: BS, PC, PH/E, I 11:00 a.m.-12:30 p.m. Verde PDC Building Podium Presentation 1: Symposium 5 The Economics of Tobacco Control: Key Findings From the NCI & WHO Tobacco Control Monograph Audience: P, I, LMIC

112 SRNT 2017 · Florence, Italy

11:00 a.m.-12:30 p.m. Affari (4th Floor) Podium Presentation 1: Symposium 6 The CHRNA5-A3-B4 Gene Cluster: From Discovery to Causality, Mechanism, and Therapeutics Audience: BS, PC, I 11:00 a.m.-12:30 p.m. Auditorium-General Session Room PDC Building Podium Presentation 1: Paper Session 1 Novel Findings From Clinical Trials Audience: C, T, I 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Auda 1 Podium Presentation 1: Paper Session 2 Secondhand Exposure Assessment Audience: PC, PH/E, I, LMIC 11:00 a.m.-12:30 p.m. Affari (Ground Floor) Podium Presentation 1: Paper Session 3 Correlates of Novel Product Use Audience: PH/E, P, HD, I, LMIC 12:30 p.m.-2:00 p.m. Passi Perduti PDC Building Poster Session 1: Clinical 12:30 p.m.-2:00 p.m. Passi Perduti (Basement - Lowest Level) Lunch Break Pick up your complimentary boxed lunch, starting at 12:15 p.m. 12:45 p.m.-2:00 p.m. Villa Vittoria: Sala 101 - Primo Piano (1st Floor) Past Presidents Luncheon (by invitation only) Schedule-at-a-Glance 12:45 p.m.-1:45 p.m. Villa Vittoria: Sala 4 – Terra Piano (Ground Floor) Meet-the-Editor Joanna Cohen, Deputy Editor Tobacco Control Journal 2:00 p.m.- 3:00 p.m. Auditorium-General Session Room PDC Building Pre-Clinical/Basic Science Plenary Themed Lecture Genetic Overlap Between Cigarette Smoking and Other Sub- stance Use Jacqueline Vink, Professor, Behavioral Science Institute, Rad- boud University, Nijmegen, The Netherlands 3:00 p.m.- 3:30 p.m. Salone Club (Lower level) PDC Building Exhibitor Time Refreshment Break 3:30 p.m.-5:00 p.m. Affari (4th Floor) Podium Presentation 2: Symposium 7 Endocannabinoid Modulation of Nicotine Dependence: Sympo- sium in Memoriam of Dr. Larry Parsons Audience: BS, PC, I

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 113 SRNT 2017 · Schedule-at-a-Glance

3:30 p.m.-5:00 p.m. Affari (1st Floor) - Room 2 Podium Presentation 2: Symposium 8 Global Tobacco Control Disparities: Where Are We? Where Are We Going? Audience: P, HD, I, LMIC 3:30 p.m.-5:00 p.m. Affari (2nd Floor) Podium Presentation 2: Symposium 9 Contributions of Basic Science to Public Policy Audience: BS, P, I 3:30 p.m.-5:00 p.m. Affari (Ground Floor) Podium Presentation 2: Symposium 10 Understanding Non-Adherence to Smoking Interventions: Detec- tion, Reasons, Individual Differences, and Consequences Audience: C, T, I 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Auda 1 Podium Presentation 2: Symposium 11 Development and Testing of Smartphone Apps for Smoking Cessation Audience: PC, C, T, I 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Room 1 Podium Presentation 2: Symposium 12 Time-Varying Effect Modeling to Shed New Light on the Develop- mental Course of Nicotine Product Use in the US Audience: PH/E, P 3:30 p.m.-5:00 p.m. Auditorium- General Session Room PDC Building Podium Presentation 2: Symposium 13 The Potential of Electronic Cigarettes for Reducing the Harm of Tobacco in Priority Populations: People, Places, Policies, Promo- tion, and Practices Audience: PH/E, P, HD, I, LMIC 3:30 p.m.-5:00 p.m. Verde PDC Building Podium Presentation 2: Paper Session 4 Treatment in Smokers With Comorbidities Audience: C, HD, I, T 3:30 p.m.-5:00 p.m. Affari (2nd Floor) - Auda 2 Podium Presentation 2: Paper Session 5 Tax and Price Policy Audience: PH/E, P, HD, I 5:00 p.m.-6:00 p.m. Villa Vittoria: Sala Onice – Terra Piano (Ground Floor) Meet-the-Editor Marcus Munafo, Deputy Editor Nicotine and Tobacco Research Journal 5:00 p.m.-6:00 p.m. Passi Perduti PDC Building Poster Session 2: Policy, Pre-Clinical

114 SRNT 2017 · Florence, Italy

FRIDAY, MARCH 10, 2017

8:00 a.m.-5:00 p.m. Piazza Adua (Reception Area) Registration 8:00 a.m.-5:00 p.m. Retropresidenza (Passi Perduti - Lowest Level) PDC Building Speaker Ready Room 8:15 a.m.-8:45 a.m. Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor) PDC Building SRNT-Europe Members Meeting (All members are welcome to attend.) 9:00 a.m.-10:00 a.m. Auditorium-General Session Room PDC Building Clinical Plenary Themed Lecture Treatment of Patients With Tobacco Addiction: Improving Current Practice and Future Perspectives Serena Tonstad, MD, MPH, PhD, Head Physician, Preventive Cardiology section, Department of Endocrinology, Obesity and Preventive Medicine at Oslo University Hospital, Oslo, Norway and a Professor, School of Public Health, Loma Linda University, Loma Linda, California 9:30 a.m.-3:30 p.m. Salone Club (Lower level) PDC Building Exhibits Open 10:00 a.m.- 10:30 a.m. Salone Club (Lower level) PDC Building Exhibitor Time Refreshment Break Schedule-at-a-Glance 10:30 a.m.-12:00 noon Affari (2nd Floor) - Auda 2 Podium Presentation 3: Symposium 14 Natural, Organic, Additive-Free, and Eco-Friendly Themes in Cigarette Packaging and Advertising: The New “Light,” “Low,” and “Mild”? Audience: PH/E, P, I 10:30 a.m.-12:00 noon Auditorium-General Session Room PDC Building Podium Presentation 3: Symposium 15 E-Cigarette Use Among Youth and Young Adults: Findings From the US Surgeon General’s Report Audience: PH/E, P, I 10:30 a.m.-12:00 noon Affari (Ground Floor) Podium Presentation 3: Symposium 16 Cytisine Update: Moving Research Forward Toward a Globally Affordable Tobacco Cessation Medication Audience: C, T, I

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 115 SRNT 2017 · Schedule-at-a-Glance

10:30 a.m.-12:00 noon Affari (1st Floor) - Room 1 Podium Presentation 3: Symposium 17 Examining Links Between Menthol Use and Smoking Persis- tence in Vulnerable Populations Audience: PC, PH/E, HD, I, LMIC 10:30 a.m.-12:00 noon Affari (1st Floor) - Room 2 Podium Presentation 3: Symposium 18 Beyond Plain Packaging: Pack Inserts and Dissuasive Cigarettes Audience: P, PC, I, LMIC 10:30 a.m.-12:00 noon Verde PDC Building Podium Presentation 3: Symposium 19 The Brighter Side of Nicotine: Beyond Nicotine Addiction and Towards Development of Beneficial Nicotinic Drugs Audience: PC, C, T, I 10:30 a.m.-12:00 noon Affari (4th Floor) Podium Presentation 3: Paper Session 6 Nicotine and Animal Models Audience: BS, PC 10:30 a.m.-12:00 noon Affari (1st Floor) - Auda 1 Podium Presentation 3: Paper Session 7 Smoking in Low and Medium Income Countries Audience: PH/E, P, LMIC 10:30 a.m.-12:00 noon Affari (2nd Floor) Podium Presentation 3: Paper Session 8 Smoking and E-Cigarette Use in Pregnancy Audience: PH/E, C, HD, I 12:00 noon-1:30 p.m. Passi Perduti PDC Building Poster Session 3: Public Health 12:00 noon-1:30 p.m. Passi Perduti (Basement - Lowest Level) Lunch Break Pick up your complimentary boxed lunch, starting at 11:45 a.m. 12:00 noon-1:30 p.m. Villa Vittoria: Sala 9 - Terra Piano (Ground Floor) PDC Building Trainee Network Senior Investigator Roundtables 12:15 p.m.-1:15 p.m. Villa Vittoria: Sala 101 – Primo Piano (1st Floor) Meet-the-Editor Robert West, Deputy Editor Addiction Journal 1:30 p.m.-2:00 p.m. Auditorium-General Session Room PDC Building Jarvik-Russell New Investigator Awards Paper Session Ecological Momentary Tobacco Control Thomas R. Kirchner, PhD, Clinical Associate Professor of Public Health, Medicine, and Urban Science at NYU College of Global Public Health, USA

116 SRNT 2017 · Florence, Italy

2:00 p.m.- 3:00 p.m.

Policy Theme Plenary Lecture Population Level Policies to Prevent Chronic Disease: Applying Lessons From Nicotine and Tobacco Research Linda Bauld, Professor of Health Policy, University of Stirling and Chair in Behavioural Research for Cancer Prevention, Cancer Research UK. President-elect of SRNT-Europe 3:00 p.m.-3:30 p.m. Salone Club (Lower level) PDC Building Exhibitor Time (Last time to visit) Refreshment Break 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Room 2 Podium Presentation 4: Symposium 20 Increasing Reach Within and Beyond Health Care Settings to Im- prove Access to Tobacco use Treatment: Leveraging Community and Treatment Settings in Asia, Australia and the United States Audience: C, T, I 3:30 p.m.-5:00 p.m. Affari (2nd Floor) Podium Presentation 4: Symposium 21 E-Cigarettes and Other Global Tobacco Exposures During Pregnancy Audience: PH/E, HD, I 3:30 p.m.-5:00 p.m. Auditorium-General Session Room PDC Building Podium Presentation 4: Symposium 22 Tobacco Use Transitions Among Youth and Adults: Descriptive Longitudinal Data From Waves 1 and 2 of the Path Study Audience: PH/E 3:30 p.m.-5:00 p.m.

Affari (Ground Floor) Schedule-at-a-Glance Podium Presentation 4: Symposium 23 Nicotine Preloading: Effectiveness and Mechanisms Audience: C, T, I 3:30 p.m.-5:00 p.m. Affari (4th Floor) Podium Presentation 4: Symposium 24 Advances in Understanding Nicotine Dependence in African American Smokers: A Transdisciplinary Perspective Audience: PC, C, HD, I, LMIC 3:30 p.m.-5:00 p.m. Affari (1st Floor) - Auda 1 Podium Presentation 4: Symposium 25 The Role of Research in Meeting FCTC Commitments to Indig- neous Peoples: What Progress Have We Made? Audience: PH/E, P, HD, I, LMIC 3:30 p.m.-5:00 p.m. Affari (2nd Floor) - Auda 2 Podium Presentation 4: Symposium 26 New Mechanistic and Translational Views of the Hippocampus in Nicotine Dependence and Relapse: Evidence Bridging Mouse and Human Audience: BS, PC, T

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 117 SRNT 2017 · Schedule-at-a-Glance

3:30 p.m.-5:00 p.m. Affari (1st Floor) - Room 1 Podium Presentation 4: Paper Session 9 Tobacco Product Health Warnings Audience: PC, P, I, LMIC 3:30 p.m.-5:00 p.m. Verde PDC Building Podium Presentation 4: Paper Session 10 Attitudes Towards Secondhand Exposure Policies Audience: OH/E, P, I, LMIC 5:00 p.m.-6:00 p.m. Villa Vittoria: Sala Onice – Ground Floor Meet-the-Editor Scott Leischow, Editor-in-Chief Tobacco Regulatory Science Journal 5:00 p.m.-6:00 p.m. Passi Perduti PDC Building Poster Session 4: Public Health 7:30 p.m.-10:30 p.m.

SRNT-E Gala Dinner (RSVP and additional fee required)

SATURDAY, MARCH 11, 2017

8:00 a.m.-11:00 a.m. Piazza Adua (Reception Area) Registration 8:00 a.m.-11:00 a.m. Retropresidenza (Passi Perduti - Lowest Level) PDC Building Speaker Ready Room 8:15 a.m.- 8:45 a.m. Villa Vittoria: Sala Verde – Secondo Piano (2nd Floor) PDC Building SRNT Members Meeting 9:00 a.m.-10:30 a.m. Affari (2nd Floor)-Auda 2 PDC Building Podium Presentation 5: Symposium 27 Understanding Diverse Patterns of Poly-Tobacco and Cannabis Product Use Among Youth and Young Adults: Longitudinal Data From Four Tobacco Centers for Regulatory Science Audience: PH/E, HD 9:00 a.m.-10:30 a.m. Affari (1st Floor) - Auda 1 Podium Presentation 5: Symposium 28 Product Standards for Cigarettes: Models to Achieve Maximum Public Health Benefit Audience: PC, P, I 9:00 a.m.-10:30 a.m. Auditorium- General Session Room PDC Building Podium Presentation 5: Symposium 29 E-Cigarettes and E-Liquids: Evaluating the Effects of Constitu- ents Audience: PC, P, I

118 SRNT 2017 · Florence, Italy

9:00 a.m.-10:30 a.m. Affari (2nd Floor) Podium Presentation 5: Symposium 30 Is Smoking Cessation Clinical Practice Hampered by Outdated Regulation of Pharmacotherapies? Audience: C, T, P, I 9:00 a.m.-10:30 a.m. Verde PDC Building Podium Presentation 5: Paper Session 11 Public Education Campaigns Audience: PH/E, P, HD, I 9:00 a.m.-10:30 a.m. Affari (Ground Floor) Podium Presentation 5: Paper Session 12 Prenatal Exposure to Tobacco, E-Cigarettes, and Marijuana Audience: BS, PC, HD 9:00 a.m.-10:30 a.m. Affari (4th Floor) Podium Presentation 5: Paper Session 13 Endgame Strategies for Tobacco Use Audience: P, I, LMIC 9:00 a.m.-10:30 a.m. Affari (1st Floor) - Room 2 Podium Presentation 5: Paper Session 14 Exposure to Tobacco and E-Cigarette Advertising Audience: PH/E, P, HD, I 9:00 a.m.-10:30 a.m. Affari (1st Floor) - Room 1 Podium Presentation 5: Paper Session 15 Smoking Cessation in Vulnerable Populations Audience: C, T, HD, I, LMIC 10:30 a.m.- 11:00 a.m. Passi Perduti (Basement - Lowest Level) PDC Building Schedule-at-a-Glance Refreshment Break 10:30 a.m.-11:30 a.m. Villa Vittoria: Sala Onice – Ground Floor Meet-the-Editor Renee Bittoun, Deputy Editor Journal of Smoking Cessation Journal 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Room 1 Podium Presentation 6: Symposium 31 Roll Your Own Cigarettes: Shining a Light on a Neglected Aspect of the Smoking Epidemic Audience: PH/E, HD, I, LMIC 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Room 2 Podium Presentation 6: Symposium 32 Attitudes and Perceptions Toward a Reduced Nicotine Product Standard for Cigarettes Audience: PC, PH/E, P, I 11:00 a.m.-12:30 p.m. Affari (2nd Floor) Podium Presentation 6: Symposium 33 Nicotine Addiction and Withdrawal: Integrating Genetic, Pheno- typic, and Pharmacologic Findings Audience: BS, PC, C, T, I

Audience Key: BS: Basic Science; PC: Pre-Clinical; C: Clinical; PH/E: Public Health/ Epidemiology; P: Policy; HD: Health Disparities; I: International; LMIC: Lower-Middle Income Countries; T=Treatment 119 SRNT 2017 · Schedule-at-a-Glance

11:00 a.m.-12:30 p.m. Verde PDC Building Podium Presentation 6: Symposium 34 Emerging Methods for Characterization of New and Manipulated Tobacco Products Audience: BS, PC, I 11:00 a.m.-12:30 p.m. Affari (2nd Floor) - Auda 2 Podium Presentation 6: Symposium 35 Innovative Brain Stimulation Techniques for Treating Tobacco Dependence Audience: PC, C, T 11:00 a.m.-12:30 p.m. Affari (1st Floor) - Auda 1 Podium Presentation 6: Symposium 36 Understanding and Intervening on Alcohol Use in Smokers Who Drink Heavily Audience: PC, PH/E, HD, I 11:00 a.m.-12:30 p.m. Affari (4th Floor) Podium Presentation 6: Symposium 37 Psycho-Social Interventions for Smoking Cessation in Pregnancy An SRNT-Europe Symposium Audience: C, HD, I, T 11:00 a.m.-12:30 p.m. Auditorium- General Session Room PDC Building Podium Presentation 6: Paper Session 16 Trends in Tobacco Product Use Audience: PH/E, I, LMIC 11:00 a.m.-12:30 p.m. Affari (Ground Floor) Podium Presentation 6: Paper Session 17 Toxicity of Tobacco Products Audience: BS, PC, C, I 12:30 p.m.-1:30 p.m. Villa Vittoria: Sala Onice – Ground Floor Meet-the-Editor Adam Leventhal, Associate Editor for Nicotine and Tobacco Drug and Alcohol Dependence Journal 12:30 p.m.-2:00 p.m. Passi Perduti PDC Building Poster Session 5

120 SRNT 2017 · Florence, Italy

121 SRNT 2017 · Schedule-at-a-Glance

122 SRNT 2017 · Florence, Italy

123 SRNT 2017 · Schedule-at-a-Glance

124